
<html lang="en"     class="pb-page"  data-request-id="a360fa8e-09cd-4688-8351-d2dccc94d815"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-22;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.8b01309;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Molecular Basis for Multiple Omapatrilat Binding Sites within the ACE C-Domain: Implications for Drug Design" /></meta><meta name="dc.Creator" content="Gyles&#xA;E.  Cozier" /></meta><meta name="dc.Creator" content="Lauren B.  Arendse" /></meta><meta name="dc.Creator" content="Sylva L.  Schwager" /></meta><meta name="dc.Creator" content="Edward D.  Sturrock" /></meta><meta name="dc.Creator" content="K. Ravi  Acharya" /></meta><meta name="dc.Description" content="Omapatrilat was designed as a vasopeptidase inhibitor with dual activity against the zinc metallopeptidases angiotensin-1 converting enzyme (ACE) and neprilysin (NEP). ACE has two homologous cataly..." /></meta><meta name="Description" content="Omapatrilat was designed as a vasopeptidase inhibitor with dual activity against the zinc metallopeptidases angiotensin-1 converting enzyme (ACE) and neprilysin (NEP). ACE has two homologous cataly..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 29, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01309" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01309" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01309" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01309" /></link>
        
    
    

<title>Molecular Basis for Multiple Omapatrilat Binding Sites within the ACE C-Domain: Implications for Drug Design | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01309" /></meta><meta property="og:title" content="Molecular Basis for Multiple Omapatrilat Binding Sites within the ACE C-Domain: Implications for Drug Design" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0011.jpeg" /></meta><meta property="og:description" content="Omapatrilat was designed as a vasopeptidase inhibitor with dual activity against the zinc metallopeptidases angiotensin-1 converting enzyme (ACE) and neprilysin (NEP). ACE has two homologous catalytic domains (nACE and cACE), which exhibit different substrate specificities. Here, we report high-resolution crystal structures of omapatrilat in complex with nACE and cACE and show omapatrilat has subnanomolar affinity for both domains. The structures show nearly identical binding interactions for omapatrilat in each domain, explaining the lack of domain selectivity. The cACE complex structure revealed an omapatrilat dimer occupying the cavity beyond the S2 subsite, and this dimer had low micromolar inhibition of nACE and cACE. These results highlight residues beyond the S2 subsite that could be exploited for domain selective inhibition. In addition, it suggests the possibility of either domain specific allosteric inhibitors that bind exclusively to the nonprime cavity or the potential for targeting specific substrates rather than completely inhibiting the enzyme." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01309"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01309">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01309&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01309&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01309&amp;href=/doi/10.1021/acs.jmedchem.8b01309" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 10141-10154</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01299" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01318" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Molecular Basis for Multiple Omapatrilat Binding Sites within the ACE C-Domain: Implications for Drug Design</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Gyles E. Cozier</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gyles E. Cozier</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biology and Biochemistry, University of Bath, Claverton Down, Bath BA2 7AY, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gyles%0AE.++Cozier">Gyles E. Cozier</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lauren B. Arendse</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lauren B. Arendse</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Integrative Biomedical Sciences, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, 7925 Cape Town, Republic of South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lauren+B.++Arendse">Lauren B. Arendse</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sylva L. Schwager</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sylva L. Schwager</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Integrative Biomedical Sciences, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, 7925 Cape Town, Republic of South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sylva+L.++Schwager">Sylva L. Schwager</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Edward D. Sturrock</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Edward D. Sturrock</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Integrative Biomedical Sciences, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, 7925 Cape Town, Republic of South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Edward+D.++Sturrock">Edward D. Sturrock</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">K. Ravi Acharya</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">K. Ravi Acharya</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biology and Biochemistry, University of Bath, Claverton Down, Bath BA2 7AY, United Kingdom</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: (+44)1225-386238. Fax: (+44)1225-386779. E-mail: <a href="/cdn-cgi/l/email-protection#f59786869e8794b59794819ddb9496db809e"><span class="__cf_email__" data-cfemail="046677776f7665446665706c2a65672a716f">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=K.+Ravi++Acharya">K. Ravi Acharya</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3009-4058" title="Orcid link">http://orcid.org/0000-0002-3009-4058</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01309&amp;href=/doi/10.1021%2Facs.jmedchem.8b01309" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 10141–10154</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 29, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 August 2018</li><li><span class="item_label"><b>Published</b> online</span>29 October 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 21 November 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01309" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01309</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01309"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1506</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">10</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01309" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Molecular Basis for Multiple Omapatrilat Binding Sites within the ACE C-Domain: Implications for Drug Design&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Gyles\nE.&quot;,&quot;last_name&quot;:&quot;Cozier&quot;},{&quot;first_name&quot;:&quot;Lauren&quot;,&quot;last_name&quot;:&quot;B. Arendse&quot;},{&quot;first_name&quot;:&quot;Sylva&quot;,&quot;last_name&quot;:&quot;L. Schwager&quot;},{&quot;first_name&quot;:&quot;Edward&quot;,&quot;last_name&quot;:&quot;D. Sturrock&quot;},{&quot;first_name&quot;:&quot;K.&quot;,&quot;last_name&quot;:&quot;Ravi Acharya&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;10141-10154&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01309&quot;},&quot;abstract&quot;:&quot;Omapatrilat was designed as a vasopeptidase inhibitor with dual activity against the zinc metallopeptidases angiotensin-1 converting enzyme (ACE) and neprilysin (NEP). ACE has two homologous catalytic domains (nACE and cACE), which exhibit different substrate specificities. Here, we report high-resolution crystal structures of omapatrilat in complex with nACE and cACE and show omapatrilat has subnanomolar affinity for both domains. The structures show nearly identical binding interactions for omapatrilat in each domain, explaining the lack of domain selectivity. The cACE complex structure revealed an omapatrilat dimer occupying the cavity beyond the S2 subsite, and this dimer had low micromolar inhibition of nACE and cACE. These results highlight residues beyond the S2 subsite that could be exploited for domain selective inhibition. In addition, it suggests the possibility of either domain specific allosteric inhibitors that bind exclusively to the nonprime cavity or the potential for targeting specific subst&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01309&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01309" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01309&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01309" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01309&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01309" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01309&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01309&amp;href=/doi/10.1021/acs.jmedchem.8b01309" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01309" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01309" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (12 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01309%26sid%3Dliteratum%253Aachs%26pmid%3D30372620%26genre%3Darticle%26aulast%3DCozier%26date%3D2018%26atitle%3DMolecular%2BBasis%2Bfor%2BMultiple%2BOmapatrilat%2BBinding%2BSites%2Bwithin%2Bthe%2BACE%2BC-Domain%253A%2BImplications%2Bfor%2BDrug%2BDesign%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D22%26spage%3D10141%26epage%3D10154%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292425" title="Oligomers">Oligomers</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/jmcmar.2018.61.issue-22/20181121/jmcmar.2018.61.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/medium/jm-2018-013098_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01309&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Omapatrilat was designed as a vasopeptidase inhibitor with dual activity against the zinc metallopeptidases angiotensin-1 converting enzyme (ACE) and neprilysin (NEP). ACE has two homologous catalytic domains (nACE and cACE), which exhibit different substrate specificities. Here, we report high-resolution crystal structures of omapatrilat in complex with nACE and cACE and show omapatrilat has subnanomolar affinity for both domains. The structures show nearly identical binding interactions for omapatrilat in each domain, explaining the lack of domain selectivity. The cACE complex structure revealed an omapatrilat dimer occupying the cavity beyond the S<sub>2</sub> subsite, and this dimer had low micromolar inhibition of nACE and cACE. These results highlight residues beyond the S<sub>2</sub> subsite that could be exploited for domain selective inhibition. In addition, it suggests the possibility of either domain specific allosteric inhibitors that bind exclusively to the nonprime cavity or the potential for targeting specific substrates rather than completely inhibiting the enzyme.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01135" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01135" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The human zinc dipeptidylcarboxypeptidase angiotensin-1 converting enzyme (ACE, EC 3.4.15.1) plays an important role in cardiovascular physiology.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Not only is it part of the renin–angiotensin–aldosterone system (RAAS), where it converts angiotensin I to the vasoactive peptide hormone angiotensin II,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> but in addition it cleaves the vasodilatory peptide bradykinin (BK).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Because of this central role in blood pressure regulation, it has been a key target for controlling the blood pressure response. Two isoforms of ACE are known, testis (tACE) and somatic (sACE) ACE, which consist of one and two catalytically active domains, respectively. In sACE, these are known as the N- and C-domains (nACE and cACE, respectively), and although they have similar amino acid sequences and structural topology, they differ in their substrate specificity and inhibitor binding.<a onclick="showRef(event, 'ref4 ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6 ref7 ref8">(4−8)</a></div><div class="NLM_p">Although a range of ACE inhibitors such as captopril, lisinopril, enalapril, ramipril, and perindopril have been routinely used for the treatment of hypertension and myocardial infarction as well as diabetic nephropathy, up to 28% of patients develop side effects after long-term treatment.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> These side effects not only include a persistent dry cough but also in some cases the more serious condition of angioedema, which indicates diverse involvement of ACE and its peptide substrates in multiple pathways.<a onclick="showRef(event, 'ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13">(11−13)</a> A characteristic feature of ACE inhibitors currently used clinically is that they bind both nACE and cACE with similar affinities, thereby causing increased plasma BK, which has been a major reason for drug discontinuation in certain patients. Development of domain-selective inhibitors for either nACE or cACE would allow more control for patient treatment depending on their condition, with lower risks of adverse effects. Inhibition of cACE is known to reduce circulating Ang II, while plasma BK levels would still be under the control of nACE.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In contrast, it has been shown in animal models that Ac-SDKP levels are increased by inhibition of nACE alone, and this produces antifibrotic and anti-inflammatory effects.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> This suggests that selectively inhibiting nACE would have minimal effects on the RAAS and allow for the targeted treatment of tissue injury and fibrosis without affecting blood pressure.</div><div class="NLM_p">Neutral endopeptidase (neprilysin, NEP) is capable of cleaving a wide variety of peptides relevant to hypertension including BK, substance P, atrial natriuretic peptide, enkephalins, and angiotensins.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> This led to the proposal that inhibition of both ACE and NEP could improve treatment for conditions such as hypertension.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> NEP and ACE are both zinc metallopeptidases, and the similarity between these enzymes, exemplified by their overlapping substrate specificity, enabled the development of single molecules that inhibit both enzymes (i.e., vasopeptidase inhibitors). One such inhibitor, omapatrilat ((4<i>S</i>,7<i>S</i>,10a<i>S</i>)-5-oxo-4-[[(2<i>S</i>)-3-phenyl-2-sulfanylpropanoyl]amino]-2,3,4,7,8,9,10,10a-octahydropyrido[2,1-<i>b</i>][1,3]thiazepine-7-carboxylic acid) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), was developed as a dual enzyme inhibitor,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and indeed showed increased reduction in blood pressure when compared to inhibition of ACE alone. Omapatrilat has nanomolar (nM) affinities for both NEP and ACE,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> it is reported to inhibit the cleavage of nACE and cACE specific substrates similarly,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and it inhibits a third bradykinin degrading enzyme aminopeptidase P.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> In addition, the incidence of angioedema was significantly higher and more severe in the subjects treated with omapatrilat (2.17%) than in those receiving the normal ACE inhibitor enalapril (0.68%).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The increased incidence of this serious, potentially life-threatening complication was presumed to be related to the accumulation of bradykinin and other related peptides during treatment.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/medium/jm-2018-013098_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of omapatrilat, phosphinic tripeptide FII, BPPb, and angiotensin II, with the PDB atom numbering for omapatrilat indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01309&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Here, we describe the high resolution crystal structures of nACE and cACE in complex with omapatrilat and we also report in vitro inhibition data for omapatrilat against the individual ACE domains. Omapatrilat displayed nonselective inhibition, inhibiting both nACE and cACE in the subnanomolar range. The kinetic data is consistent with the structural data, which shows many, and mostly conserved protein–inhibitor interactions for the Zn<sup>2+</sup>-bound omapatrilat molecule within the active site of each domain. However, the complex with cACE also shows that two additional omapatrilat molecules are able to bind in the binding site cavity, and it is consistent with binding of an omapatrilat dimer. This lends support for the design of an extended molecule exploiting the larger active site groove to provide enhanced specificity for cACE.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86221" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86221" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Overall Structure</h3><div class="NLM_p">The nACE and cACE omapatrilat complexes crystallized in <i>P</i>1 and <i>P</i>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub> space groups, and the structures were determined at high resolutions of 1.80 and 1.37 Å, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). There was one molecule of cACE and two molecules of nACE in their respective asymmetric units. As previously shown, the overall fold of both nACE and cACE is mainly α-helical, forming an ellipsoid, with the active site buried in the center in the form of a two-lobed cavity comprised of the S′ and S subsites flanking the catalytic Zn<sup>2+</sup> ion. Clear, unambiguous electron density that could be attributed to the inhibitor bound in the S<sub>1</sub>, S<sub>1</sub>′, and S<sub>2</sub>′ subsites was observed in the m<i>F</i><sub>o</sub> – D<i>F</i><sub>c</sub> omit maps for both the nACE and cACE omapatrilat complexes. (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A,B). Consistent with omapatrilat being a high affinity inhibitor, there are extensive interactions with the protein and active site zinc ion, as described in detail below.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. X-ray Data Collection and Refinement Statistics</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">cACE omapatrilat</th><th class="colsep0 rowsep0" align="center">nACE omapatrilat</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">resolution (Å)</td><td class="colsep0 rowsep0" align="left">[85.13–7.50]</td><td class="colsep0 rowsep0" align="left">[74.00–9.86]</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">(1.39–1.37)</td><td class="colsep0 rowsep0" align="left">(1.83–1.80)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">space group</td><td class="colsep0 rowsep0" align="left"><i>P</i>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub></td><td class="colsep0 rowsep0" align="left"><i>P</i>1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cell dimensions (a, b, c) (Å)</td><td class="colsep0 rowsep0" align="left">56.6, 85.1, 134.3</td><td class="colsep0 rowsep0" align="left">73.16, 76.95, 83.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">angles (α, β, γ) (deg)</td><td class="colsep0 rowsep0" align="left">90.0, 90.0, 90.0</td><td class="colsep0 rowsep0" align="left">88.83, 64.22, 75.21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">molecules/asymmetric unit</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">total/unique reflections</td><td class="colsep0 rowsep0" align="left">6,747,076</td><td class="colsep0 rowsep0" align="left">1,930,117</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">136,769</td><td class="colsep0 rowsep0" align="left">141,750</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">completeness (%)</td><td class="colsep0 rowsep0" align="left">[100.0] 100.0 (100.0)</td><td class="colsep0 rowsep0" align="left">[99.6] 97.4 (100.0)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>merge</sub></td><td class="colsep0 rowsep0" align="left">[0.043] 0.205 (6.916)</td><td class="colsep0 rowsep0" align="left">[0.031] 0.066 (0.954)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>pim</sub></td><td class="colsep0 rowsep0" align="left">[0.006] 0.029 (1.043)</td><td class="colsep0 rowsep0" align="left">[0.009] 0.018 (0.264)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">⟨<i>I</i>/σ(<i>I</i>)⟩</td><td class="colsep0 rowsep0" align="left">[13.2] 62.4 (0.8)</td><td class="colsep0 rowsep0" align="left">[69.5] 20.9 (2.9)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CC<sub>1/2</sub></td><td class="colsep0 rowsep0" align="left">[1.000] 1.000 (0.544)</td><td class="colsep0 rowsep0" align="left">[1.000] 1.000 (0.903)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">multiplicity</td><td class="colsep0 rowsep0" align="left">[43.7] 49.3 (44.2)</td><td class="colsep0 rowsep0" align="left">[13.0] 13.6 (13.9)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Refinement Statistics</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>work</sub>/<i>R</i><sub>free</sub></td><td class="colsep0 rowsep0" align="left">0.145/0.175</td><td class="colsep0 rowsep0" align="left">0.164/0.204</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rmsd in bond lengths (Å)</td><td class="colsep0 rowsep0" align="left">0.007</td><td class="colsep0 rowsep0" align="left">0.005</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rmsd in bond angles (deg)</td><td class="colsep0 rowsep0" align="left">1.028</td><td class="colsep0 rowsep0" align="left">0.910</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Ramachandran Statistics (%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">favored</td><td class="colsep0 rowsep0" align="left">98.8</td><td class="colsep0 rowsep0" align="left">98.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">allowed</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">outliers</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Average <i>B</i>-Factors (Å<sup>2</sup>)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">protein</td><td class="colsep0 rowsep0" align="left">24.2</td><td class="colsep0 rowsep0" align="left">40.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ligand</td><td class="colsep0 rowsep0" align="left">38.2</td><td class="colsep0 rowsep0" align="left">64.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">water</td><td class="colsep0 rowsep0" align="left">33.5</td><td class="colsep0 rowsep0" align="left">39.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Number of Atoms</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">protein</td><td class="colsep0 rowsep0" align="left">9723</td><td class="colsep0 rowsep0" align="left">19 711</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ligand</td><td class="colsep0 rowsep0" align="left">481</td><td class="colsep0 rowsep0" align="left">695</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">water</td><td class="colsep0 rowsep0" align="left">643</td><td class="colsep0 rowsep0" align="left">754</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDB code</td><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6H5W">6H5W</a></td><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6H5X">6H5X</a></td></tr></tbody></table></div></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/medium/jm-2018-013098_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic representation of omapatrilat bound to the ACE domains. A–D are overlaid with the final 2m<i>F</i><sub>o</sub> – D<i>F</i><sub>c</sub> (blue, contoured at 1σ level) electron density map and the m<i>F</i><sub>o</sub> – D<i>F</i><sub>c</sub> (green, contoured at 3σ level) electron density omit map for (A) omapatrilat–nACE, (B) omapatrilat–cACE (molecule 1), (C) omapatrilat–cACE (molecule 2), and (D) omapatrilat–cACE (molecule 3) complexes. The zinc ion is shown as a lilac sphere with the coordinating side chains shown as sticks. α-Helices and β-strands are shown in rose and dark cyan, respectively. (E,F) Omapatrilat molecules 2 and 3, respectively, overlaid with polder maps.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01309&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Sections of the first 100 residues of both molecules in the asymmetric unit of nACE show high temperature factors (<i>B</i>-factors), and in protein chain B the electron density is poor with some evidence of a secondary conformation of this region. These features are often observed in nACE crystal structures, and this part of the chain has been attributed to a flexible lid-like structure that may open and close to control peptide access into the active site.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> While in some previous structures (e.g., the nACE complex with sampatrilat, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6F9V">6F9V</a>), it was possible to model the second conformation,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> the density for the omapatrilat complex was not sufficient for this purpose.</div><div class="NLM_p">As reported previously for the sampatrilat–cACE complex structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6F9T">6F9T</a>),<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Cys-496 was modified, most likely oxidized to an <i>S</i>-hydroxycysteine. This modification is clearly seen for the current cACE complex with omapatrilat and has been modeled as the same <i>S</i>-hydroxycysteine (Cso) residue.</div><div class="NLM_p last">Closer examination of the electron density maps for the cACE/omapatrilat complex indicated electron density that was consistent with two additional omapatrilat molecules bound in the S subsite lobe of the binding cavity (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C,D). The details of these additional, “newly observed” binding sites are described below.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Inhibitor Binding Sites</h3><div class="NLM_p">As described above, in both the nACE and cACE complexes an omapatrilat molecule binds in the S<sub>1</sub>, S<sub>1</sub>′, and S<sub>2</sub>′ subsites. Listed in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, and depicted in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, are the extensive interactions with the inhibitor molecules from the protein chain and Zn<sup>2+</sup> ion. Omapatrilat (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) was designed as a tripeptide mimic,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> having a carboxylic acid “C-terminal”, a bicyclic group to occupy the S<sub>2</sub>′ and S<sub>1</sub>′ subsites, and a sulfur containing phenylalanine analogue to interact with the Zn<sup>2+</sup> ion and extend into the S<sub>1</sub> subsite. The crystal structures reported here show that the omapatrilat molecule occupies almost identical positions in the two nACE chains and the cACE chain, in a conformation typical of small peptides and peptide mimic inhibitors.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Comparison of Amino Acid Residues Involved in nACE and cACE Interactions with Omapatrilat<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">nACE (A)</th><th class="colsep0 rowsep0" align="center">nACE (B)</th><th class="colsep0 rowsep0" align="center">tACE(1)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Direct Hydrogen Bond Interactions</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Gln259</td><td class="colsep0 rowsep0" align="center">Gln259</td><td class="colsep0 rowsep0" align="center">Gln281</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">His331</td><td class="colsep0 rowsep0" align="center">His331</td><td class="colsep0 rowsep0" align="center">His353</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ala332</td><td class="colsep0 rowsep0" align="center">Ala332</td><td class="colsep0 rowsep0" align="center">Ala354</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">His361</td><td class="colsep0 rowsep0" align="center">His361</td><td class="colsep0 rowsep0" align="center">His383</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Lys489</td><td class="colsep0 rowsep0" align="center">Lys489</td><td class="colsep0 rowsep0" align="center">Lys511</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">His491</td><td class="colsep0 rowsep0" align="center">His491</td><td class="colsep0 rowsep0" align="center">His513</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tyr498</td><td class="colsep0 rowsep0" align="center">Tyr498</td><td class="colsep0 rowsep0" align="center">Tyr520</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tyr501</td><td class="colsep0 rowsep0" align="center">Tyr501</td><td class="colsep0 rowsep0" align="center">Tyr523</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Water-Mediated Interactions</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Lys489</td><td class="colsep0 rowsep0" align="center">Lys489</td><td class="colsep0 rowsep0" align="center">Lys511</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center">Hydrophobic Interactions</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ser333</td><td class="colsep0 rowsep0" align="center">Ser333</td><td class="colsep0 rowsep0" align="center">Ser355</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Thr358</td><td class="colsep0 rowsep0" align="center">Thr358</td><td class="colsep0 rowsep0" align="center">Val380</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">His361</td><td class="colsep0 rowsep0" align="center">His361</td><td class="colsep0 rowsep0" align="center">His383</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">His365</td><td class="colsep0 rowsep0" align="center">His365</td><td class="colsep0 rowsep0" align="center">His387</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Phe435</td><td class="colsep0 rowsep0" align="center">Phe435</td><td class="colsep0 rowsep0" align="center">Phe457</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Phe490</td><td class="colsep0 rowsep0" align="center">Phe490</td><td class="colsep0 rowsep0" align="center">Phe512</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">His491</td><td class="colsep0 rowsep0" align="center">His491</td><td class="colsep0 rowsep0" align="center">His513</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tyr501</td><td class="colsep0 rowsep0" align="center">Tyr501</td><td class="colsep0 rowsep0" align="center">Tyr523</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Edo12</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">omapatrilat 3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup><sup>a</sup></sup><p class="last">Chains A and B from the asymmetric unit of nACE, and the main omapatrilat (<b>1</b>) binding site for cACE are shown. Conserved interactions are on the same row.</p></div></div></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/medium/jm-2018-013098_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Ligplot representation of the binding site interactions of (A) omapatrilat–nACE chain A, (B) omapatrilat–nACE chain B, (C) omapatrilat–cACE (molecule 1), (D) omapatrilat–cACE (molecule 2 conformation A and molecule 3), and (E) omapatrilat–cACE (molecule 2 conformation B). H-bond/electrostatic interactions are shown in green, hydrophobic interactions in red, and water molecules as cyan spheres. Residues solely involved in hydrophobic interactions are represented by red, semicircular symbols.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01309&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/medium/jm-2018-013098_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Schematic representation of (A) omapatrilat–cACE (molecule 1), (B) omapatrilat–cACE (molecule 2), and (C) omapatrilat–cACE (molecule 3) binding sites showing the interactions involved with the three omapatrilat molecules. The zinc ion and water molecules are shown as lilac and red spheres, respectively, and the coordinating side chains shown as sticks. α-Helices and β-strands are shown in rose and dark cyan, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01309&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The “C-terminal” carboxylic acid is tightly bound, with the O1 atom hydrogen bonding to Gln259, Lys489, and Tyr498 in nACE (Gln281, Lys511, and Tyr520 in cACE), and the O2 atom in a water mediated interaction with Lys489/511 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The atoms of the bicyclic omapatrilat group that mimic a peptide backbone interact with the side chains of His331 and His491 and the backbone of Ala332 of nACE (His353, His 513, and Ala354 of cACE). The O4 atom of omapatrilat interacts with His361 and Tyr501 of nACE (His383 and Tyr501 of cACE) and along with S2 forms a bidentate interaction with the Zn<sup>2+</sup> ion. The strong bidentate interaction with the Zn<sup>2+</sup> ion is consistent with the high affinity and slow off-rate observed for omapatrilat in the inhibition assays (see below). There are also a series of hydrophobic interactions in the S<sub>2</sub>′ and S<sub>1</sub>′ subsites with residues Thr358, His361, Phe435, His491, and Tyr501 of nACE (Val380, His383, Phe457, His513, and Tyr523 of cACE). With the phenylalanine side chain like moiety being the only part of omapatrilat to extend into the S subsites lobe of the binding cavity, the interactions are restricted to being hydrophobic with Ser333 and Phe490 of nACE (Ser355 and Phe512 of cACE). In addition, there is a hydrophobic interaction with an ethylene glycol molecule in chain A of nACE, whereas in cACE the third omapatrilat molecule provides a hydrophobic environment. Despite all these hydrophobic interactions, this “phenylalanine side chain” is the most flexible part of the omapatrilat molecule highlighted by comparatively less clear electron density and higher <i>B</i>-factors than the rest of the inhibitor. Therefore, the crystal structures show that there is an almost identical set of binding interactions observed for omapatrilat in both nACE and cACE.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Additional Omapatrilat Molecule Binding Sites in cACE</h3><div class="NLM_p">Examination of the experimental electron density maps for the S subsites lobe of the binding cavity in both nACE and cACE usually shows a variety of electron density beyond the bound inhibitor/substrate that can be attributed to water molecules and substituents of the buffers and crystallization condition used, such as various polyethylene glycol (PEG) molecules. However, in the present cACE omapatrilat complex structure, the density suggested that two extra omapatrilat molecules (omapatrilat 2 and 3) were bound, as shown by the 2m<i>F</i><sub>o</sub> – D<i>F</i><sub>c</sub> electron density map and the m<i>F</i><sub>o</sub> – D<i>F</i><sub>c</sub> omit map (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C,D). The density for these molecules is not complete and is strongest for the heavier sulfur, oxygen, and nitrogen atoms. Therefore, to help confirm that the density does indeed result from omapatrilat molecules, Polder maps were generated which showed almost complete density for omapatrilat 2 and clear density for omapatrilat 3 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>E,F).</div><div class="NLM_p">The level of electron density observed indicates that these binding sites do not have full occupancy and were refined at 66 and 58% for omapatrilats 2 and 3, respectively. An area of electron density that can be best modeled as an ethylene glycol molecule with 82% occupancy is located close to the phenylalanine like side chain of omapatrilat 2, which itself shows poor density even in the Polder map. To avoid steric clashes between the phenylalanine ring and the ethylene glycol molecule, a second conformation of omapatrilat 2 was modeled, although the data indicates that this moiety of the omapatrilat molecule is highly flexible.</div><div class="NLM_p">A view of the binding cavity within the cACE overall structure (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>) shows that these two extra omapatrilat molecules bind on one side, and occupy most of the remaining length of the S subsite lobe not bound by omapatrilat 1.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/medium/jm-2018-013098_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Two views showing the binding cavity (transparent green surface) of omapatrilat–cACE complex structure indicating how the omapatrilat molecules occupy most of the nonprime cavity. The zinc atom is shown as lilac sphere, omapatrilat molecules as sticks, α-helices as rose cylinders, and β-strands in dark cyan.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01309&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The binding interactions for omapatrilat 2 and 3 are shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>. Omapatrilat 3 has no direct hydrogen bond interactions with the protein, whereas omapatrilat 2 binds to arginines 124 and 522, as well as an ethylene glycol molecule. Residue Arg124 provides further evidence for presence of the additional omapatrilat molecules. In the cACE complex structure, it adopts a dual conformation where orientation B is typical for this enzyme, but this would occupy the same position as omapatrilat 3. So not only is the predominant conformation A (refined at 63% occupancy) allowing room for omapatrilat 3 to bind, it also provides important interactions with omapatrilat 2. Omapatrilat 2 has water mediated interactions involving two water molecules and only two residues (Glu123 and Trp220), whereas six residues (Asn85, Arg124, Asn136, Glu143, Ser516, and Ser517) interact through four water molecules with omapatrilat 3. Omapatrilat 2 has a more extensive set of hydrophobic interactions with four residues (Glu123, Met223, Glu403, and Pro519) and an ethylene glycol molecule, compared to omapatrilat 3, which interacts with only two residues (Asn85 and Val518) and omapatrilat 1. The overall more extensive interactions for omapatrilat 2 compared to omapatrilat 3 is consistent with the density being clearer, and occupancy higher for omapatrilat 2.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Amino Acid Residues Involved in cACE Interactions with the Two Secondary Omapatrilat (2 and 3) Molecules Bound<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cACE (2)</th><th class="colsep0 rowsep0" align="center">cACE (3)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="center">Direct Hydrogen Bond Interactions</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Arg124</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Arg522</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Edo2</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="center">Water-Mediated Interactions</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Glu123</td><td class="colsep0 rowsep0" align="center">Asn85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Trp220</td><td class="colsep0 rowsep0" align="center">Arg124</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">Asn136</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">Glu143</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">Ser516</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="center">Ser517</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="center">Hydrophobic Interactions</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Glu123</td><td class="colsep0 rowsep0" align="center">Asn85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Met223</td><td class="colsep0 rowsep0" align="center">Val518</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Glu403</td><td class="colsep0 rowsep0" align="center">omapatrilat 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Pro519</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Edo6</td><td class="colsep0 rowsep0" align="center"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup><sup>a</sup></sup><p class="last">No interactions are equivalent between the two binding sites.</p></div></div></div><div class="NLM_p last">As stated above, both omapatrilats 2 and 3 were refined with an occupancy of above 50%, thereby suggesting that at least some of the time both are bound to cACE. This is of particular note because the distance between the S2 atoms of the molecules when both are bound is 2.01 Å, which suggests a disulfide like bond can form. From the crystal structure alone, it is not possible to elucidate whether each molecule of omapatrilat can bind individually or whether an inhibitor dimer where two molecules are linked through their S2 atoms is required for binding.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Comparison of Ligand Binding Beyond S<sub>2</sub> Subsite</h3><div class="NLM_p">To date, the vast majority of substrates and inhibitors that have been cocrystallized with nACE, cACE, and AnCE (the Drosophila homologue) have been small, equivalent to a 2–4 residue peptide chain, and therefore bind only in the S<sub>2</sub>, S<sub>1</sub>, S<sub>1</sub>′, and S<sub>2</sub>′ subsites at most. Larger molecules that have been tested were often either hydrolyzed by the enzymes such that only a short product remains<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> or were so flexible beyond the S<sub>2</sub> subsite that this region was not visible in the electron density maps.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> There have been some examples where the length of a P<sub>2</sub> group has facilitated interaction with a longer protein side chain that would otherwise not be considered part of the S<sub>2</sub> subsite, one such example being the nACE complex with RXP407 that shows an interaction with Arg381.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> However, information about interactions with the S<sub>3</sub> and more distant subsites has been observed in only four previous structures. First, both nACE and cACE were cocrystallized with a phosphinic tripeptide (FII), and similar to omapatrilat, the complex with cACE showed an additional inhibitor molecule bound.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Two further crystal structures of cACE, those in complex with angiotensin II and BPPb,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> contained peptide chains longer than four residues visible in the electron density maps, and in the case of BPPb, the full 11-mer was clearly shown. Finally, in the structure of AnCE in complex with BPPb, six residues of the inhibitor were observed.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The complex of cACE with omapatrilat described here provides a fifth structure, and further information about the binding cavity beyond the S<sub>2</sub> subsite.</div><div class="NLM_p"><a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a> show the position and orientation within the binding cavity and an overlay of the ligands, respectively. This comparison of all five structures shows that the binding within the S<sub>2</sub>, S<sub>1</sub>, S<sub>1</sub>′, and S<sub>2</sub>′ subsites is similar, with the ligand structures overlaying closely. This is to be expected, with binding close to the active site Zn<sup>2+</sup> ion being closely controlled in a confined space and the C-terminal binding position being highly conserved. Beyond this region, the binding cavity widens, giving much more space and many more potential binding interactions, and this is highlighted by the wide variety of positions and orientations adopted by the ligands in these subsites. There are some similarities such as BPPb bound to cACE and AnCE closely align up to the S<sub>4</sub> subsite, beyond which BPPb is no longer visible in the electron density in the AnCE complex. Angiotensin II also aligns with those BPPb peptides in the S<sub>3</sub> subsite, but the P<sub>4</sub> residue adopts a different position, and if the final P<sub>5</sub> residue had been visible, it would likely also be in a different position to the BPPb molecule. FII has a very different shape to the peptides, however, the C-terminal mimic half of the second molecule that is bound does have some similarity in position to the P<sub>3–6</sub> residues of BPPb in cACE, but the second half of its structure does not overlay and instead is closer in position to the omapatrilat 2 and 3 molecules. This second half of FII and both omapatrilat molecules bind to the opposite face of the binding cavity to that seen for the other ligands. Therefore, the additional omapatrilat molecules in the structure reported here are binding to regions (additional conformational space) of the cACE cavity that have not previously been implicated in ligand binding. Omapatrilat 2 in particular highlights a hydrophobic region comprising of Trp220, Met223, and Pro519 (Trp198, Trp201, and Pro497 in nACE), and the hydrogen bond interactions with Arg124 (Ser100 in nACE) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/medium/jm-2018-013098_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Comparison of the location inside the binding cavity for ligands that interact beyond the S<sub>2</sub> subsite. (A) Omapatrilat–cACE, (B) phosphinic tripeptide–cACE, (C) BPPb–cACE, (D) Angiotensin II–cACE (for clarity only one conformation is shown), and (E) BPPb–AnCE. Proteins are depicted as an internal surface colored by electrostatic potential, ligands and the zinc binding residues are shown as sticks with zinc ions shown as lilac spheres. NB: There was no zinc ion bound in the BPPb–cACE crystal structure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01309&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/medium/jm-2018-013098_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Two views of the overlay of ligands to show binding orientations that extend beyond the S<sub>2</sub> subsite. Omapatrilat, BPPb, angiotensin II, and phosphinic tripeptide from cACE complexes are shown as magenta, light-blue, green, and lime sticks, respectively, and BPPb from AnCE complex is shown as orange sticks.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01309&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Combining the information from the previous structures with that of omapatrilat–cACE complex indicates that most of the binding cavity can be involved in interactions with ligands. While this makes predicting the interactions for a particular ligand more difficult, it does allow for a significant amount of flexibility in inhibitor design.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Kinetic Analysis of nACE and cACE Inhibition by Omapatrilat</h3><div class="NLM_p">Kinetic analysis of nACE and cACE inhibition by omapatrilat was carried out using single domain recombinant ACE proteins and the peptide substrate Cbz-Phe-His-Leu (Z-FHL) in end point fluorogenic assays (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). The Morrison equation, for inhibition under tight binding conditions (where <i>K</i><sub>i</sub><sup>app</sup> ≤ [enzyme]), was fitted to the inhibition data yielding typical active-site titration curves (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>C,D). Under tight binding conditions, the assumptions made by classical inhibition models no longer hold true, so <i>K</i><sub>i</sub> values cannot accurately be determined from IC<sub>50</sub> plots, as exemplified in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>. Because of the slow binding nature of many protease inhibitors, inhibitors are typically preincubated with the enzyme prior to the addition of substrate to ensure that inhibition constants are measured under steady-state conditions. Even though it is well established that omapatrilat is a reversible competitive inhibitor, <i>K</i>i<sup>app</sup> did not vary with substrate concentration for either domain, indicating that omapatrilat has a very slow off rate and did not dissociate from the enzyme during the time of the experiment, in which case <i>K</i><sub>i</sub> = <i>K</i><sub>i</sub><sup>app</sup>/(1 + [S]/<i>K</i><sub>m</sub>) does not hold true and <i>K</i><sub>i</sub><sup>app</sup> approximates <i>K</i><sub>i</sub>. There was no significant difference in the affinity of omapatrilat for the two domains, with <i>K</i><sub>i</sub> values in the subnanomolar range for both nACE and cACE. This is agreement with the report by Azizi et al., showing that omapatrilat similarly inhibited the somatic ACE-mediated hydrolysis of N- and C-domain site-specific substrates, AcSDKP and hippuryl-histidyl-leucine, at subnanomolar concentrations.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In addition, the kinetic data is consistent with the extensive and almost identical set of binding interactions observed for omapatrilat in both nACE and cACE complex structures described above.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/medium/jm-2018-013098_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Inhibition of nACE and cACE activity by omapatrilat. (A,B) IC<sub>50</sub> log plots (variable slope) and (C,D) Morrison plots generated using the same data (Et unconstrained). Enzyme and inhibitor were incubated at 22 °C for 15 min, and reactions were initiated by the addition of Z-FHL substrate (nACE <i>K</i><sub>m</sub> 600 μM; cACE <i>K</i><sub>m</sub> 60 μM). Reactions were carried out in triplicate, and assays were carried out at different substrate concentrations (nACE, final Z-FHL concentrations 0.3 and 1.2 mM; cACE, final Z-FHL concentrations 0.15, 0.3, and 1.2 mM). The final enzyme concentration in each reaction was 4 and 2 nM for nACE and cACE, respectively, which corresponded well with the enzyme concentration (Et) determined by the Morrison equation. IC<sub>50</sub> and <i>K</i><sub>i</sub> values are average values at all substrate concentrations ± standard deviation of the mean.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01309&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Kinetic Analysis of nACE and cACE Inhibition by Omapatrilat Dimer</h3><div class="NLM_p">Assessment of omapatrilat dimer inhibitor potential for nACE and cACE was carried out using Z-FHL and a bradykinin-like MCA-RPPGFSAFK(Dnp)-OH substrate (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). Omapatrilat dimer displayed low micromolar inhibition of cACE with Z-FHL (IC<sub>50</sub> 2.8 μM) and MCA-RPPGFSAFK(Dnp)-OH (IC<sub>50</sub> 1.8 μM). Additionally, omapatrilat dimer inhibition of nACE was comparable to cACE for Z-FHL and MCA-RPPGFSAFK(Dnp)-OH (IC<sub>50</sub> 2.2 and  2.1 μM, respectively).</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/medium/jm-2018-013098_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (A) Omapatrilat dimerization monitored by HPLC. The sample was analyzed using a Poroshell 120 EC-C 18 column on the Agilent 1260 infinity HPLC system. 10 μL of sample was injected onto the column at the indicated time points. Conditions: A, 1% ACN, 0.1% TFA; B, 95% ACN, 0.1% TFA; 0–100% B over 10 min; 0.5 mL/min, 214 nm. Peaks corresponding to the monomer and dimer were observed at 7.8 and 9.1 min, respectively. (B,C) Inhibition of nACE and cACE activity by omapatrilat dimer: IC<sub>50</sub> log plots for inhibition of the ACE mediated turnover of (B) Z-FHL (final concentration 500 μM, nACE <i>K</i><sub>m</sub> 600 μM, cACE <i>K</i><sub>m</sub> 60 μM) and (C) MCA-MCA-RPPGFSAFK(Dnp)-OH (final concentration 5 μM, nACE <i>K</i><sub>m</sub> 3.6, cACE <i>K</i><sub>m</sub> 2.4 μM) substrates. Enzyme and inhibitor were preincubated at 22 °C for 15 min, and reactions were initiated by the addition of substrate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01309&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Toward Structure-Based Design of Next Generation ACE Inhibitors: Dual ACE C-Domain Selective/NEP Inhibitors</h3><div class="NLM_p">Dual ACE/NEP inhibitors that selectively inhibit cACE, leaving the nACE free to degrade bradykinin, are predicted to have reduced side effect profiles while maintaining efficacy, providing a promising new approach to the development of vasopeptidase inhibitors.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Several C-domain selective inhibitors described to date have been derived from potent nonselective ACE inhibitors, with structural modifications significantly reducing N-domain binding.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> These structures of nACE and cACE in complex with omapatrilat, together with previously reported cACE structures in complex with C-selective inhibitors, provide a good starting point for the structure-based design of dual ACE C-domain/NEP inhibitors. Mutagenesis studies have shed light on active-site residues important for conferring domain selectivity<a onclick="showRef(event, 'ref11 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref11 ref32 ref33 ref34">(11,32−34)</a> and exploiting these regions for inhibitor design has proved an effective approach for obtaining domain-selective ACE inhibitors.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> In addition, crystal structures of the NEP ectodomain in complex with various inhibitors have provided insight into the specificity of NEP.<a onclick="showRef(event, 'ref36 ref37 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38 ref39 ref40">(36−40)</a> In the absence of a crystal structure of NEP in complex with omapatrilat, in silico docking was used to predict the binding interactions between omapatrilat and NEP (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>A). <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>B shows omapatrilat docked into the active site of NEP aligned to the nACE– and cACE–omapatrilat complexes. The predicted omapatrilat binding mode in NEP differs form that observed in the ACE structures, with the benzyl group occupying the S<sub>1</sub>′ binding site while the 7,6 fused bicyclic thiazepinone ring binds at the edge of the S<sub>2</sub>′ binding pocket with the majority of the ring system positioned within the large open cavity between the two subdomains of NEP. This is in agreement with the observation that the prime side of NEP is primarily responsible for inhibitor selectivity and potency, with the S<sub>1</sub>′ pocket showing the most stringent specificity and preferentially binding aromatics or large hydrophobic groups.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In the predicted NEP–omapatrilat complex, the thiol group of omapatrilat chelates the zinc ion while the amide carbonyl interacts with Arg717. The carboxylic acid forms a salt bridge with Arg110 and both the carboxylic acid and the thiazepinone carbonyl interact with Asn542. Because the S2′ site is largely unoccupied, the position of flexible residues Trp693 and Phe106, on the boundary of the S1′ and S2′ binding pockets, which typically adopt different position depending on the bound ligand, do not appear to affect the docking pose of omapatrilat.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/medium/jm-2018-013098_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Predicted binding pose for omapatrilat in the active-site of NEP. Omapatrilat (cyan) was docked into NEP PDB structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R1H">1R1H</a> (green) using Schrödinger’s XP Glide. (A) Close up of the omapatrilat binding site with polar contacts indicated by dotted lines and the catalytic Zn<sup>2+</sup> ion shown in purple. (B) Predicted binding pose for omapatrilat (green) in the active-site of NEP, aligned to the nACE- and cACE-omapatrilat structures, with omapatrilat shown in yellow and magenta, respectively. Domain specific ACE active-site residues important for conferring domain selectivity are shown as sticks with nACE specific residues in orange and cACE specific residues in cyan.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01309&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> ACE Inhibitors Targeting Regions Beyond the S<sub>2</sub> Subsite</h3><div class="NLM_p">To date, all ACE inhibitor development has concentrated on utilizing the conserved zinc and S<sub>2</sub>′, S<sub>1</sub>′, and S<sub>1</sub> subsite interactions to give potency and targeted the small differences between nACE and cACE in these and the S<sub>2</sub> subsite to give specificity. While this has produced some success, developing drug-like specific inhibitors has been a challenge. The additional omapatrilat molecules bound to cACE, and the kinetic data showing inhibition by the omapatrilat dimer suggest regions beyond the S<sub>2</sub> subsite could be exploited for drug design. This not only includes the possibility of extended zinc binding inhibitors targeting these regions, giving more potential for domain specific inhibition, but also a novel class of non-zinc binding inhibitors that bind only to outer areas of the binding cavity.</div><div class="NLM_p last">ACE domains are involved in the hydrolysis of a selection of peptide substrates, and these substrates extend beyond the S<sub>2</sub> subsite in a variety of orientations upon binding. The overlay of the cACE–omapatrilat complex with the ACE structures in complex with BPPb and angiotensin II, and the kinetic data presented in this study, indicate that the omapatrilat dimer binds in the nonprime lobe and acts as a noncompetitive inhibitor. In which case, the omapatrilat dimer could be a starting point to develop domain specific and more potent allosteric inhibitors by targeting unconserved regions of the nonprime lobe. The allosteric binding site of the dimer is proximal to the obligatory substrate binding site, so it is also conceivable that other peptide substrates may bind in the same region as the omapatrilat dimer, in which case the inhibition could be competitive in these instances. The kinetic data and cACE–omapatrilat crystal structure show that it is possible for small molecules to bind in the nonprime lobe without utilizing interactions with the catalytic zinc ion. Even if no natural ACE substrate binds to the same side of the binding site as the omapatrilat dimer, it is interesting to speculate that inhibitors solely targeted to areas of the binding cavity distant from the catalytic site could take advantage of differences in substrate binding caused by variation in their sequence and length. This approach may produce substrate specific inhibition while leaving the general activity of the enzyme largely unchanged, and like domain-specific inhibition, it has the potential to reduce adverse side effects and may be worth exploring further. It would be of significant benefit in investigating the possibility of substrate specific inhibitors by knowing which areas of the nonprime lobe to target. Therefore, crystal structures of the ACE domains in complex with full-length substrates would be of great benefit.</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Comparison of Omapatrilat Dimer Binding Region in cACE with nACE</h3><div class="NLM_p">In contrast to the high degree of conservation found in the S<sub>2</sub>, S<sub>1</sub>, S<sub>1</sub>′, and S<sub>2</sub>′ subsites, the region around the omapatrilat dimer binding site in cACE contains many residues that are not conserved in nACE (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> lists all these residues beyond the S<sub>2</sub> subsite). Therefore, this would make it a good region to target for domain specificity. The unconserved residues are located over the whole cavity surface where the omapatrilat dimer binds, and this gives a large degree of flexibility in what molecule could be designed to target them. One of the closest to the catalytic site has already been utilized for domain specificity, where nACE Arg381 (Glu403 in cACE) has been attributed to the nACE specificity of RXP 407.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Other unconserved residues of similar distance from the catalytic site include Asn66, Glu143, and Ser516 of cACE (Ser39, Ser119, and Asn494 of nACE), with Glu143 and Ser516 both interacting with the omapatrilat dimer. Targeting residues further from the catalytic site using the conventional P<sub>2</sub>, P<sub>1</sub>, P<sub>1</sub>′, and P<sub>2</sub>′ scaffold could prove challenging in producing a drug-like molecule of not too large size, although meeting these challenges maybe necessary in order to obtain the desired domain specificity. An option for potentially overcoming this hurdle could be to design inhibitors that span from interacting with the catalytic zinc ion at one end, to targeting the unconserved residues highlighted by the omapatrilat dimer binding region at the other that is not extending all the way to the S<sub>2</sub>′ subsite. This would reduce the length of molecule required, retain the strong interactions with the zinc ion for high affinity binding, and gain the domain specificity by reaching the less conserved regions of the enzyme.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Nonconserved Residues around the Omapatrilat Dimer Binding Site beyond the S<sub>2</sub> Subsite</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cACE</th><th class="colsep0 rowsep0" align="center">nACE</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tyr62</td><td class="colsep0 rowsep0" align="left">Ala35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Asn66</td><td class="colsep0 rowsep0" align="left">Ser39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Asn70</td><td class="colsep0 rowsep0" align="left">Asp43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Asn85</td><td class="colsep0 rowsep0" align="left">Ala58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ile88</td><td class="colsep0 rowsep0" align="left">Ser61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ala89</td><td class="colsep0 rowsep0" align="left">Gln62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Lys118</td><td class="colsep0 rowsep0" align="left">Ala94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Asp121</td><td class="colsep0 rowsep0" align="left">Thr97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Glu123</td><td class="colsep0 rowsep0" align="left">Gly99</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Arg124</td><td class="colsep0 rowsep0" align="left">Ser100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Glu143</td><td class="colsep0 rowsep0" align="left">Ser119</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ala208</td><td class="colsep0 rowsep0" align="left">Tyr186</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tyr213</td><td class="colsep0 rowsep0" align="left">Phe191</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ser219</td><td class="colsep0 rowsep0" align="left">Tyr197</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Met223</td><td class="colsep0 rowsep0" align="left">Trp201</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Glu403</td><td class="colsep0 rowsep0" align="left">Arg381</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ser516</td><td class="colsep0 rowsep0" align="left">Asn494</td></tr></tbody></table></div></div><div class="NLM_p last">The binding of an omapatrilat dimer in the cACE complex structure was a fortuitous observation, therefore the molecular structure has not been designed or optimized for this region. However, the dimer already has a micromolar affinity for the ACE domains, which is often the starting point for SAR studies. As mentioned above, when considering designing a molecule that binds in the nonprime cavity away from the catalytic site, there is a wide range of unconserved residues that could be targeted to achieve domain specificity (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). One example is the region where omapatrilat 2 binds in the cACE complex, which has more space than observed in nACE due to sequence differences. Residues Ala208, Ser219, and Met223 of cACE are replaced by Tyr186, Tyr197, and Trp201 in nACE, and therefore this larger pocket in cACE could be an ideal region to target for domain selective inhibition.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61116" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61116" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In summary, this study has shown that omapatrilat is a nonspecific, subnanomolar inhibitor of both nACE and cACE, and this can be explained by the near identical binding orientation and almost completely conserved, extensive interactions observed in the high resolution structures of these domains in complex with omapatrilat.</div><div class="NLM_p">Interestingly, two further omapatrilat molecules likely to be a dimer linked by a disulfide like bond between their S2 atoms, were observed in the nonprime lobe of the binding cavity of cACE but distant from the catalytic site. Kinetic studies showed that the omapatrilat dimer was a micromolar inhibitor of both nACE and cACE using both short and long substrates, thereby suggesting it is a noncompetitive, allosteric inhibitor.</div><div class="NLM_p last">These data suggest that not only could more potent and domain specific extended zinc binding inhibitors be designed to additionally target the more distant nonprime subsites, but also new classes of non-zinc binding inhibitors could be developed that only bound in the nonprime lobe. By not utilizing the strong, conserved zinc and prime subsites binding interactions (which make specificity more difficult), one strategy could use the omapatrilat dimer as a starting point for domain specific, allosteric inhibitors, while another could target differences in substrate binding within the large nonprime lobe to develop substrate specific inhibition. Both of these approaches would have the aim of producing drugs with reduced side effects.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31715" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31715" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Enzymes and Omapatrilat</h3><div class="NLM_p last">Fully glycosylated (D629 and Δ36NJ) and minimally glycosylated (N389 and G13) N- and C-domain human ACE proteins, respectively, were generated by expression in cultured mammalian CHO cells and purified to homogeneity as described previously.<a onclick="showRef(event, 'ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43">(41−,43)</a> Purity was assessed using SDS-PAGE and shown to be >95% pure. Omapatrilat was obtained from American Custom Chemicals Corp. and Sigma-Aldrich.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> X-ray Crystallographic Studies</h3><div class="NLM_p">The minimally glycosylated ACE domains were preincubated with omapatrilat in a 4:1 v/v ratio of protein (8 mg mL<sup>–1</sup> cACE and 5 mg mL<sup>–1</sup> nACE both in 50 mM Hepes, pH 7.5, 0.1 mM PMSF) and 5 mM inhibitor for 1 h (cACE on ice, nACE at room temperature). Cocrystals were obtained with 1 μL of the protein–inhibitor complex mixed with an equal volume of reservoir solution (0.1 M MIB buffer pH 4.0, 5% glycerol, and 15% PEG 3350 for cACE, and 30% PEG 550 MME/PEG 20000, 0.1 M Tris/Bicine pH 8.5, and 60 mM divalent cations, Molecular Dimensions Morpheus A9 for nACE), which was suspended above the well as a hanging drop.</div><div class="NLM_p last">X-ray diffraction data were collected on station I03 at the Diamond Light Source (Didcot, UK). Crystals were kept at constant temperature (100 K) under the liquid nitrogen jet during data collection. Images were collected using a PILATUS3 6M detector (Dectris, Switzerland). Raw data images were indexed and integrated with DIALS<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> and then scaled using AIMLESS<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> from the CCP4 suite.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Initial phases were obtained by molecular replacement with PHASER<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> using PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6F9T">6F9T</a><a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> for cACE and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EN5">6EN5</a><a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> for nACE as the search models. Further refinement was initially carried out using REFMAC5<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> and then Phenix,<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> with COOT<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> used for rounds of manual model building. Ligand and water molecules were added based on electron density in the <i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> Fourier difference map. MolProbity<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> was used to help validate the structures. Crystallographic data statistics are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. All figures showing the crystal structures were generated using CCP4mg<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and Pymol,<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> and schematic binding interactions are displayed using Ligplot<sup>+</sup>.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Cavity surfaces were produced using Hollow,<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> and the surface electrostatic potential was calculated and displayed using PDB2PQR<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> and APBS.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> ACE Inhibition Assays: Omapatrilat</h3><div class="NLM_p last">Fresh 10 mM omapatrilat stocks were prepared in DMSO on the day of the experiment and immediately diluted in ACE assay buffer (100 mM potassium phosphate buffer, pH 8.3, 300 mM NaCl, 10 μM ZnCl<sub>2</sub>) to working stock concentrations to limit disulfide bond formation. Omapatrilat integrity was monitored at 50 μM by HPLC to ensure that disulfide bond formation was <5% during the course of the experiments. Fully glycosylated nACE and cACE proteins were preincubated with inhibitor for 15 min at 22 °C, and reactions were initiated by the addition of Cbz-Phe-His-Leu (Z-FHL, Bachem Ltd., nACE <i>K</i><sub>m</sub> 600 μM; cACE <i>K</i><sub>m</sub> 60 μM). Final concentrations in the 50 μL reactions were as follows: nACE 4 nM, cACE 2 nM; omapatrilat 0–10 nM; Z-FHL 0.15/0.3/1.2 mM. Each reaction was carried out in triplicate. After incubation at 37 °C for 10 min, the reactions were stopped by the addition of 165 μL of 0.34 M NaOH containing 2 mg/mL of the derivatizing agent <i>o</i>-phthalaldyde. Derivatization was carried out for 10 min at 22 °C and stopped by the addition of 25 μL of 3 M HCl. Fluorescence intensities were measured at λex = 360 nm and λem = 485 nm using a fluorescence spectrophotometer (Varian Inc.). Graph-Pad Prism software (San Diego, USA) was used to fit inhibition models to the data using nonlinear regression. To determine IC<sub>50</sub> values, log(inhibitor) vs response (<i>V</i><sub>i</sub>/<i>V</i><sub>o</sub>) (variable slope) curves were fitted to the data where <i>V</i><sub>i</sub> is initial velocity in the presence of inhibitor and <i>V</i><sub>o</sub> is initial velocity in the absence of inhibitor. To determine <i>K</i><sub>i</sub><sup>app</sup> values, the Morrison equation was fitted to the data: <i>Y</i> = (1 – ((((Et + <i>X</i> + (<i>K</i><sub>i</sub><sup>app</sup>)) – (((Et + <i>X</i> + (<i>K</i><sub>i</sub><sup>app</sup>))<sup>2</sup>) – 4 × Et × <i>X</i>)<sup>0.5</sup>))/(2 × Et))), where <i>Y</i> is <i>V</i><sub>i</sub>/<i>V</i><sub>o</sub> and <i>X</i> is inhibitor concentration.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Omapatrilat Dimer</h3><div class="NLM_p last">For kinetic analysis of ACE inhibition by the omapatrilat dimer, a 1 mM omapatrilat stock in ACE assay buffer was left at room temperature and dimer formation was monitored by HPLC over ∼6 days until complete conversion to the dimer was observed. The sample was analyzed using a Poroshell 120 EC-C 18 column on the Agilent 1260 infinity HPLC system. 10 μL of sample was injected onto the column at the indicated time points. Conditions: A: 1% ACN, 0.1% TFA; B: 95% ACN, 0.1% TFA; 0–100% B over 10 min; 0.5 mL/min, 214 nm. Omapatrilat dimer was preincubated with fully glycosylated nACE and cACE for 15 min at 22 °C, and reactions were initiated with substrate. Reactions were carried out in triplicate, and final omapatrilat dimer concentrations were 0–20 μM. End-point Z-FHL assays were carried out as described above. For the bradykinin-like FRET peptide, MCA-RPPGFSAFK(Dnp)-OH substrate (R&D Systems), 50 μL of substrate was added to 50 μLof enzyme–inhibitor and increase in fluorescent with time was measured at λex = 320 nm and λem = 405 nm. Final concentrations in the 100 μL reactions were as follows: substrate 5 μM, nACE 0.6 nM, cACE 0.3 nM). To determine IC<sub>50</sub> values, log(inhibitor) vs response (<i>V</i><sub>i</sub>/<i>V</i><sub>o</sub>) (variable slope) curves were fitted to the data using Graph-Pad Prism software (San Diego, USA).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> In Silico Docking</h3><div class="NLM_p last">The Schrodinger 9.7 Glide docking program (Schrödinger, Inc., New York, NY, USA) was used for the docking experiments. The following NEP X-ray crystal structures were retrieved from the Protein Data Bank (PDB) for docking method validation <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1DMT">1DMT</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R1H">1R1H</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R1I">1R1I</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R1J">1R1J</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Y8J">1Y8J</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QPJ">2QPJ</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YB9">2YB9</a>. Water molecules and heteroatoms other than the zinc ion and the bound inhibitor were deleted from the PDB files. Protein structures were prepared for docking using Protein Preparation Wizard, Schrödinger 9.7 (Schrödinger, Inc., New York, NY, USA,) to correct bond orders, add hydrogen atoms and optimize their position for optimal hydrogen bond formation, create zero-order bonds to metals, and to minimize heavy atoms to a RMSD threshold of 0.3 Å using OPLS_2005 force fields. The Schrodinger 9.7 Glide docking program (Schrödinger, Inc., New York, NY, USA) was used for the docking experiments. All NEP structures were superimposed and a docking grid box, grid size 30 Å × 30 Å × 30 Å, centered on the centroid phosphoramidon ligand (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1DMT">1DMT</a>), was generated using Glide-Receptor Grid Generation with default parameters for van der Waals radius scaling. Docking was performed using the extra precision (XP) Glide docking method. After method validation, which involved redocking the bound inhibitors into their original X-ray crystal structures (cross-docking of inhibitors into the other NEP structures did not typically result in the correct binding pose because of conformational difference between structures depending on the bound ligand in the cocrystal), omapatrilat with the sulfhydryl group in the deprotonated state for zinc coordination was docked into the full set of NEP structures, and despite the variation in the conformation of active site residues between structures, a similar binding mode, with the benzyl group in the S<sub>1</sub>′ subsite, was predicted for omapatrilat within all the structures. Images of the inhibitor–enzyme complex were created using PyMOL molecular viewer software.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01309" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45148" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45148" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01309" class="ext-link">10.1021/acs.jmedchem.8b01309</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01309/suppl_file/jm8b01309_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01309/suppl_file/jm8b01309_si_001.csv">jm8b01309_si_001.csv (0.45 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The atomic coordinates and structure factors for N- and C-domains ACE bound to omapatrilat complexes have been deposited in the RCSB Protein Data Bank with the codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6H5W">6H5W</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6H5X">6H5X</a>, respectively. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.8b01309" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64432" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64432" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">K. Ravi Acharya</span> - <span class="hlFld-Affiliation affiliation">Department
of Biology and Biochemistry, University
of Bath, Claverton Down, Bath BA2
7AY, United Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3009-4058" title="Orcid link">http://orcid.org/0000-0002-3009-4058</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0c6e7f7f677e6d4c6e6d7864226d6f227967"><span class="__cf_email__" data-cfemail="650716160e1704250704110d4b04064b100e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gyles
E. Cozier</span> - <span class="hlFld-Affiliation affiliation">Department
of Biology and Biochemistry, University
of Bath, Claverton Down, Bath BA2
7AY, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lauren B. Arendse</span> - <span class="hlFld-Affiliation affiliation">Department
of Integrative Biomedical Sciences, Institute of Infectious Disease
and Molecular Medicine, University of Cape
Town, Observatory, 7925 Cape Town, Republic of South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sylva L. Schwager</span> - <span class="hlFld-Affiliation affiliation">Department
of Integrative Biomedical Sciences, Institute of Infectious Disease
and Molecular Medicine, University of Cape
Town, Observatory, 7925 Cape Town, Republic of South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edward D. Sturrock</span> - <span class="hlFld-Affiliation affiliation">Department
of Integrative Biomedical Sciences, Institute of Infectious Disease
and Molecular Medicine, University of Cape
Town, Observatory, 7925 Cape Town, Republic of South Africa</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>G.E.C. performed all the crystallography experiments, analyzed the data, and wrote the manuscript. L.B.A. carried out the in vitro inhibition assays, performed the in silico docking experiments, and contributed to the writing of the manuscript. S.L.S. carried out all the protein expression work. E.D.S. supervised the biochemical work and edited the manuscript. K.R.A. supervised the structural study, analyzed the data, and edited the manuscript. All authors reviewed the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e1894-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18786" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18786" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the scientists at stations IO3 (proposal no. mx12342) of Diamond Light Source, Didcot, Oxfordshire (UK), for their support during X-ray diffraction data collection. This work was supported by the Medical Research Council (U.K.) project grant G1001685 (to K.R.A.) and the National Research Foundation (South Africa) CPRR grant 13082029517 (to E.D.S.). K.R.A. and E.D.S. also thank the University of Cape Town (South Africa) and University of Bath (UK), respectively, for the Visiting Professorship.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ACE</td><td class="NLM_def"><p class="first last">angiotensin-1 converting enzyme</p></td></tr><tr><td class="NLM_term">AnCE</td><td class="NLM_def"><p class="first last">Drosophila ACE homologue</p></td></tr><tr><td class="NLM_term">BK</td><td class="NLM_def"><p class="first last">bradykinin</p></td></tr><tr><td class="NLM_term">BPP</td><td class="NLM_def"><p class="first last">bradykinin potentiating peptide</p></td></tr><tr><td class="NLM_term">cACE</td><td class="NLM_def"><p class="first last">ACE C-domain</p></td></tr><tr><td class="NLM_term">FII</td><td class="NLM_def"><p class="first last">phosphinic tripeptide</p></td></tr><tr><td class="NLM_term">nACE</td><td class="NLM_def"><p class="first last">ACE N-domain</p></td></tr><tr><td class="NLM_term">NEP</td><td class="NLM_def"><p class="first last">neprilysin</p></td></tr><tr><td class="NLM_term">RAAS</td><td class="NLM_def"><p class="first last">renin–angiotensin–aldosterone system</p></td></tr><tr><td class="NLM_term">sACE</td><td class="NLM_def"><p class="first last">somatic ACE</p></td></tr><tr><td class="NLM_term">tACE</td><td class="NLM_def"><p class="first last">testis ACE</p></td></tr><tr><td class="NLM_term">Z-FHL</td><td class="NLM_def"><p class="first last">Cbz-Phe-His-Leu</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37125" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37125" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 57 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riordan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehlers, M. R.</span></span> <span> </span><span class="NLM_article-title">Ace revisited: a new target for structure-based drug design</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">891</span>– <span class="NLM_lpage">902</span>, <span class="refDoi"> DOI: 10.1038/nrd1227</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1038%2Fnrd1227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=14668810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1agu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=891-902&author=K.+R.+Acharyaauthor=E.+D.+Sturrockauthor=J.+F.+Riordanauthor=M.+R.+Ehlers&title=Ace+revisited%3A+a+new+target+for+structure-based+drug+design&doi=10.1038%2Fnrd1227"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">ACE revisited: A new target for structure-based drug design</span></div><div class="casAuthors">Acharya, K. Ravi; Sturrock, Edward D.; Rirodan, James F.; Ehlers, Mario R. W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">891-902</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Current-generation angiotensin-coverting enzyme (ACE) inhibitors are widely used for cardiovascular diseases, including high blood pressure, heart failure, heart attack and kidney failure, and have combined annual sales in excess of US $6 billion.  However, the use of these ACE inhibitors, which were developed in the late 1970s and early 1980s, is hampered by common side effects.  Moreover, we now know that ACE actually consists of two parts (called the N- and C-domains) that have different functions.  Therefore, the design of specific domain-selective ACE inhibitors is expected to produce next-generation drugs that might be safer and more effective.  Here we discuss the structural features of current inhibitors and outline how next-generation ACE inhibitors could be designed by using the three-dimensional mol. structure of human testis ACE.  The ACE structure provides a unique opportunity for rational drug design, based on a combination of in silico modeling using existing inhibitors as scaffolds and iterative lead optimization to drive the synthetic chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq00n8hyDan07Vg90H21EOLACvtfcHk0ljXBocdYRjVgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1agu78%253D&md5=cf5e5ee0b4126287dc1cdef5f605ed58</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd1227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1227%26sid%3Dliteratum%253Aachs%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26aulast%3DRiordan%26aufirst%3DJ.%2BF.%26aulast%3DEhlers%26aufirst%3DM.%2BR.%26atitle%3DAce%2520revisited%253A%2520a%2520new%2520target%2520for%2520structure-based%2520drug%2520design%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D891%26epage%3D902%26doi%3D10.1038%2Fnrd1227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skeggs, L. T.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shumway, N. P.</span></span> <span> </span><span class="NLM_article-title">The preparation and function of the hypertensin-converting enzyme</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">1956</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">299</span>, <span class="refDoi"> DOI: 10.1084/jem.103.3.295</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1084%2Fjem.103.3.295" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=13295487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADyaG28Xot1Ohtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1956&pages=295-299&author=L.+T.+Skeggsauthor=J.+R.+Kahnauthor=N.+P.+Shumway&title=The+preparation+and+function+of+the+hypertensin-converting+enzyme&doi=10.1084%2Fjem.103.3.295"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation and function of the hypertensin-converting enzyme</span></div><div class="casAuthors">Skeggs, Leonard T., Jr.; Kahn, Joseph R.; Shumway, Norman P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">1956</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">295-9</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    </div><div class="casAbstract">On perfusing isolated rat kidneys with purified hypertensin I (I) and II (II), II was found to result in large and sustained elevations in the perfusion pressure, whereas similar doses, or doses increased 12 times, of I were completely without effect.  The enzyme converting I to II was isolated from horse plasma in a semipurified form by means of (NH4)2SO4 fractionation, dialysis, and isoelec. pptn.  The soln. was chilled to 0-1°, the pH adjusted to 5.2 with concd. NaOAc buffer pH 4.0.  A light-green ppt. formed, and was dissolved in 0.05M Na phosphate buffer at pH 7.8.  The soln. was pale green and free of hypertensinase.  The yield of enzyme was 5.5 g./10 gal. of horse blood.  It was stable at pH 4, but was entirely destroyed at pH 3 and a temp. of 25°.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlp_RChQQYk7Vg90H21EOLACvtfcHk0li8GOCkFL8ZAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG28Xot1Ohtg%253D%253D&md5=ffff296cc37181d4e4721e22b20a69e4</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1084%2Fjem.103.3.295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.103.3.295%26sid%3Dliteratum%253Aachs%26aulast%3DSkeggs%26aufirst%3DL.%2BT.%26aulast%3DKahn%26aufirst%3DJ.%2BR.%26aulast%3DShumway%26aufirst%3DN.%2BP.%26atitle%3DThe%2520preparation%2520and%2520function%2520of%2520the%2520hypertensin-converting%2520enzyme%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1956%26volume%3D103%26spage%3D295%26epage%3D299%26doi%3D10.1084%2Fjem.103.3.295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdos, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, Y.</span></span> <span> </span><span class="NLM_article-title">A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin</span>. <i>Biochim. Biophys. Acta, Protein Struct.</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>214</i></span>,  <span class="NLM_fpage">374</span>– <span class="NLM_lpage">376</span>, <span class="refDoi"> DOI: 10.1016/0005-2795(70)90017-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1016%2F0005-2795%2870%2990017-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=4322742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADyaE3cXkvFCrtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=1970&pages=374-376&author=H.+Y.+Yangauthor=E.+G.+Erdosauthor=Y.+Levin&title=A+dipeptidyl+carboxypeptidase+that+converts+angiotensin+I+and+inactivates+bradykinin&doi=10.1016%2F0005-2795%2870%2990017-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin</span></div><div class="casAuthors">Yang, Hsiu-Ying Tsai; Erdos, Ervin G.; Levin, Yehuda</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Protein Structure</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">214</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">374-6</span>CODEN:
                <span class="NLM_cas:coden">BBPTBH</span>;
        ISSN:<span class="NLM_cas:issn">0005-2795</span>.
    </div><div class="casAbstract">Kininase II (dipeptidyl carboxypeptidase), 200-fold purified from swine plasma, inactivated the hypotensive peptide bradykinin and converted angiotensin I into the hypertensive angiotensin II; these reactions were inhibited by dipeptide split products and the B-chain of insulin.  When tert-butyloxycarbonyl-Phe(NO2)-Phe-Gly was used as the substrate for the enzyme, having an optimum pH of 7.4 in 0.1M Tris buffer, the enzyme activity was increased by the addn. of NaCl, but was inhibited by o-phenanthroline and EDTA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5yLY-yEGOlrVg90H21EOLACvtfcHk0li8GOCkFL8ZAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXkvFCrtrg%253D&md5=0454518853a0788c5dd54812589835a2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2F0005-2795%2870%2990017-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2795%252870%252990017-6%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%2BY.%26aulast%3DErdos%26aufirst%3DE.%2BG.%26aulast%3DLevin%26aufirst%3DY.%26atitle%3DA%2520dipeptidyl%2520carboxypeptidase%2520that%2520converts%2520angiotensin%2520I%2520and%2520inactivates%2520bradykinin%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Protein%2520Struct.%26date%3D1970%26volume%3D214%26spage%3D374%26epage%3D376%26doi%3D10.1016%2F0005-2795%2870%2990017-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Araujo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melo, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cesari, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juliano, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juliano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmona, A. K.</span></span> <span> </span><span class="NLM_article-title">Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">8519</span>– <span class="NLM_lpage">8525</span>, <span class="refDoi"> DOI: 10.1021/bi9928905</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi9928905" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=8519-8525&author=M.+C.+Araujoauthor=R.+L.+Meloauthor=M.+H.+Cesariauthor=M.+A.+Julianoauthor=L.+Julianoauthor=A.+K.+Carmona&title=Peptidase+specificity+characterization+of+C-+and+N-terminal+catalytic+sites+of+angiotensin+I-converting+enzyme&doi=10.1021%2Fbi9928905"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fbi9928905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi9928905%26sid%3Dliteratum%253Aachs%26aulast%3DAraujo%26aufirst%3DM.%2BC.%26aulast%3DMelo%26aufirst%3DR.%2BL.%26aulast%3DCesari%26aufirst%3DM.%2BH.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DCarmona%26aufirst%3DA.%2BK.%26atitle%3DPeptidase%2520specificity%2520characterization%2520of%2520C-%2520and%2520N-terminal%2520catalytic%2520sites%2520of%2520angiotensin%2520I-converting%2520enzyme%26jtitle%3DBiochemistry%26date%3D2000%26volume%3D39%26spage%3D8519%26epage%3D8525%26doi%3D10.1021%2Fbi9928905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rousseau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauvet, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenfant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corvol, P.</span></span> <span> </span><span class="NLM_article-title">The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>270</i></span>,  <span class="NLM_fpage">3656</span>– <span class="NLM_lpage">3661</span>, <span class="refDoi"> DOI: 10.1074/jbc.270.8.3656</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1074%2Fjbc.270.8.3656" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=3656-3661&author=A.+Rousseauauthor=A.+Michaudauthor=M.+T.+Chauvetauthor=M.+Lenfantauthor=P.+Corvol&title=The+hemoregulatory+peptide+N-acetyl-Ser-Asp-Lys-Pro+is+a+natural+and+specific+substrate+of+the+N-terminal+active+site+of+human+angiotensin-converting+enzyme&doi=10.1074%2Fjbc.270.8.3656"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1074%2Fjbc.270.8.3656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.270.8.3656%26sid%3Dliteratum%253Aachs%26aulast%3DRousseau%26aufirst%3DA.%26aulast%3DMichaud%26aufirst%3DA.%26aulast%3DChauvet%26aufirst%3DM.%2BT.%26aulast%3DLenfant%26aufirst%3DM.%26aulast%3DCorvol%26aufirst%3DP.%26atitle%3DThe%2520hemoregulatory%2520peptide%2520N-acetyl-Ser-Asp-Lys-Pro%2520is%2520a%2520natural%2520and%2520specific%2520substrate%2520of%2520the%2520N-terminal%2520active%2520site%2520of%2520human%2520angiotensin-converting%2520enzyme%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D3656%26epage%3D3661%26doi%3D10.1074%2Fjbc.270.8.3656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soubrier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alhenc-Gelas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allegrini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">John, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tregear, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corvol, P.</span></span> <span> </span><span class="NLM_article-title">Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">9386</span>– <span class="NLM_lpage">9390</span>, <span class="refDoi"> DOI: 10.1073/pnas.85.24.9386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1073%2Fpnas.85.24.9386" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1988&pages=9386-9390&author=F.+Soubrierauthor=F.+Alhenc-Gelasauthor=C.+Hubertauthor=J.+Allegriniauthor=M.+Johnauthor=G.+Tregearauthor=P.+Corvol&title=Two+putative+active+centers+in+human+angiotensin+I-converting+enzyme+revealed+by+molecular+cloning&doi=10.1073%2Fpnas.85.24.9386"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.85.24.9386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.85.24.9386%26sid%3Dliteratum%253Aachs%26aulast%3DSoubrier%26aufirst%3DF.%26aulast%3DAlhenc-Gelas%26aufirst%3DF.%26aulast%3DHubert%26aufirst%3DC.%26aulast%3DAllegrini%26aufirst%3DJ.%26aulast%3DJohn%26aufirst%3DM.%26aulast%3DTregear%26aufirst%3DG.%26aulast%3DCorvol%26aufirst%3DP.%26atitle%3DTwo%2520putative%2520active%2520centers%2520in%2520human%2520angiotensin%2520I-converting%2520enzyme%2520revealed%2520by%2520molecular%2520cloning%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1988%26volume%3D85%26spage%3D9386%26epage%3D9390%26doi%3D10.1073%2Fpnas.85.24.9386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span>; <span class="NLM_string-name">Anthony, C. S.</span>; <span class="NLM_string-name">Danilov, S. M.</span></span> <span> </span><span class="NLM_article-title">Peptidyl-dipeptidase A/Angiotensin I-Converting Enzyme</span>. In  <i>Handbook of Proteolytic Enzymes</i>, <span class="NLM_edition">3rd</span> ed.; <span class="NLM_publisher-name">Elsevier</span>, <span class="NLM_year">2013</span>; Vol.  <span class="NLM_volume">1 and 2</span>, pp  <span class="NLM_fpage">480</span>– <span class="NLM_lpage">494</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1016%2FB978-0-12-382219-2.00098-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=480-494&author=E.+D.+Sturrock&author=C.+S.+Anthony&author=S.+M.+Danilov&title=Handbook+of+Proteolytic+Enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-382219-2.00098-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-382219-2.00098-3%26sid%3Dliteratum%253Aachs%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26atitle%3DPeptidyl-dipeptidase%2520A%252FAngiotensin%2520I-Converting%2520Enzyme%26btitle%3DHandbook%2520of%2520Proteolytic%2520Enzymes%26pub%3DElsevier%26date%3D2013%26volume%3D1%2520and%25202%26spage%3D480%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alhenc-Gelas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corvol, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clauser, E.</span></span> <span> </span><span class="NLM_article-title">The two homologous domains of human angiotensin I-converting enzyme are both catalytically active</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>266</i></span>,  <span class="NLM_fpage">9002</span>– <span class="NLM_lpage">9008</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1851160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADyaK3MXks1OntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1991&pages=9002-9008&author=L.+Weiauthor=F.+Alhenc-Gelasauthor=P.+Corvolauthor=E.+Clauser&title=The+two+homologous+domains+of+human+angiotensin+I-converting+enzyme+are+both+catalytically+active"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The two homologous domains of human angiotensin I-converting enzyme are both catalytically active</span></div><div class="casAuthors">Wei, Lei; Alhenc-Gelas, Francois; Corvol, Pierre; Clauser, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">266</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">9002-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Mol. cloning of human endothelial angiotensin I-covering enzyme (kinase II; EC 3.4.15.1) (ACE) has recently shown that the enzyme contains 2 large homol. domains (called here the N and C domains), each bearing a putative active site, identified by sequence comparisons with the active sites of other zinc metallopeptidases.  However, the previous expts. with zinc or competitive ACE inhibitors suggested a single active site in ACE.  To establish whether both domains of ACE are enzymically active, a series of ACE mutants, each contg. only 1 intact domain, were constructed by deletion or point mutations of putative crit. residues of the other domain, and expressed in heterologous Chinese hamster ovary cells.  Both domains are enzymically active and cleave the C-terminal dipeptide of hippuryl-His-Leu or angiotensin I.  Moreover, both domains have an abs. zinc requirement for activity, are activated by chloride and are sensitive to competitive ACE inhibitors, and appear to function independently.  However, the 2 domains display different catalytic consts. and different patterns of chloride activation.  At high chloride concns., the C domain hydrolyzes the 2 substrates tested faster than does the N domain.  His-361,365 and His-959,963 are established as essential residues in the N and C domains, resp., most likely involved in zinc binding, and Glu-362 in the N domain and Glu-960 in the C domain are essential catalytic residues.  These observations provide strong evidence that ACE possesses 2 independent catalytic domains and suggest that they may have different functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquqPiPJev2abVg90H21EOLACvtfcHk0lh8lEY5x0uIdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXks1OntLY%253D&md5=907f83aa628bc22968428d5d43d804ff</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DL.%26aulast%3DAlhenc-Gelas%26aufirst%3DF.%26aulast%3DCorvol%26aufirst%3DP.%26aulast%3DClauser%26aufirst%3DE.%26atitle%3DThe%2520two%2520homologous%2520domains%2520of%2520human%2520angiotensin%2520I-converting%2520enzyme%2520are%2520both%2520catalytically%2520active%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1991%26volume%3D266%26spage%3D9002%26epage%3D9008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steckelings, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artuc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wollschlager, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiehstutz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henz, B. M.</span></span> <span> </span><span class="NLM_article-title">Angiotensin-converting enzyme inhibitors as inducers of adverse cutaneous reactions</span>. <i>Acta Derm Venereol</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1080/000155501317140007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1080%2F000155501317140007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=321-325&author=U.+M.+Steckelingsauthor=M.+Artucauthor=T.+Wollschlagerauthor=S.+Wiehstutzauthor=B.+M.+Henz&title=Angiotensin-converting+enzyme+inhibitors+as+inducers+of+adverse+cutaneous+reactions&doi=10.1080%2F000155501317140007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1080%2F000155501317140007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F000155501317140007%26sid%3Dliteratum%253Aachs%26aulast%3DSteckelings%26aufirst%3DU.%2BM.%26aulast%3DArtuc%26aufirst%3DM.%26aulast%3DWollschlager%26aufirst%3DT.%26aulast%3DWiehstutz%26aufirst%3DS.%26aulast%3DHenz%26aufirst%3DB.%2BM.%26atitle%3DAngiotensin-converting%2520enzyme%2520inhibitors%2520as%2520inducers%2520of%2520adverse%2520cutaneous%2520reactions%26jtitle%3DActa%2520Derm%2520Venereol%26date%3D2001%26volume%3D81%26spage%3D321%26epage%3D325%26doi%3D10.1080%2F000155501317140007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weber, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messerli, F. H.</span></span> <span> </span><span class="NLM_article-title">Angiotensin-converting enzyme inhibitors and angioedema: estimating the risk</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1465</span>– <span class="NLM_lpage">1467</span>, <span class="refDoi"> DOI: 10.1161/HYPERTENSIONAHA.108.111393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1161%2FHYPERTENSIONAHA.108.111393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=18413486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVahurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1465-1467&author=M.+A.+Weberauthor=F.+H.+Messerli&title=Angiotensin-converting+enzyme+inhibitors+and+angioedema%3A+estimating+the+risk&doi=10.1161%2FHYPERTENSIONAHA.108.111393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Angiotensin-converting enzyme inhibitors and angioedema: estimating the risk</span></div><div class="casAuthors">Weber, Michael A.; Messerli, Franz H.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1465-1467</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvGFGj7rAMm7Vg90H21EOLACvtfcHk0lgqv44sX_8aqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVahurg%253D&md5=9c00260a5a4f6db0f679058a5db727e2</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1161%2FHYPERTENSIONAHA.108.111393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FHYPERTENSIONAHA.108.111393%26sid%3Dliteratum%253Aachs%26aulast%3DWeber%26aufirst%3DM.%2BA.%26aulast%3DMesserli%26aufirst%3DF.%2BH.%26atitle%3DAngiotensin-converting%2520enzyme%2520inhibitors%2520and%2520angioedema%253A%2520estimating%2520the%2520risk%26jtitle%3DHypertension%26date%3D2008%26volume%3D51%26spage%3D1465%26epage%3D1467%26doi%3D10.1161%2FHYPERTENSIONAHA.108.111393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuyer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubbe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamora, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span> <span> </span><span class="NLM_article-title">Fragment-based design for the development of N-domain-selective angiotensin-1-converting enzyme inhibitors</span>. <i>Clin. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">313</span>, <span class="refDoi"> DOI: 10.1042/CS20130403</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1042%2FCS20130403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=24015848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CktL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2014&pages=305-313&author=R.+G.+Douglasauthor=R.+K.+Sharmaauthor=G.+Masuyerauthor=L.+Lubbeauthor=I.+Zamoraauthor=K.+R.+Acharyaauthor=K.+Chibaleauthor=E.+D.+Sturrock&title=Fragment-based+design+for+the+development+of+N-domain-selective+angiotensin-1-converting+enzyme+inhibitors&doi=10.1042%2FCS20130403"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based design for the development of N-domain-selective angiotensin-1-converting enzyme inhibitors</span></div><div class="casAuthors">Douglas, Ross G.; Sharma, Rajni K.; Masuyer, Geoffrey; Lubbe, Lizelle; Zamora, Ismael; Acharya, K. Ravi; Chibale, Kelly; Sturrock, Edward D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">305-313</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1470-8736</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">ACE (angiotensin-1-converting enzyme) is a zinc metallopeptidase that plays a prominent role in blood pressure regulation and electrolyte homeostasis.  ACE consists of two homologous domains that despite similarities of sequence and topol. display differences in substrate processing and inhibitor binding.  The design of inhibitors that selectively inhibit the N-domain (N-selective) could be useful in treating conditions of tissue injury and fibrosis due to build-up of N-domain-specific substrate Ac-SDKP (N-acetyl-Ser-Asp-Lys-Pro).  Using a receptor-based SHOP (scaffold hopping) approach with N-selective inhibitor RXP407, a shortlist of scaffolds that consisted of modified RXP407 backbones with novel chemotypes was generated.  These scaffolds were selected on the basis of enhanced predicted interaction energies with N-domain residues that differed from their C-domain counterparts.  One scaffold was synthesized and inhibitory binding tested using a fluorogenic ACE assay.  A mol. incorporating a tetrazole moiety in the P2 position (compd. 33RE) displayed potent inhibition (Ki=11.21±0.74 nM) and was 927-fold more selective for the N-domain than the C-domain.  A crystal structure of compd. 33RE in complex with the N-domain revealed its mode of binding through arom. stacking with His388 and a direct hydrogen bond with the hydroxy group of the N-domain specific Tyr369.  This work further elucidates the mol. basis for N-domain selective inhibition and assists in the design of novel N-selective ACE inhibitors that could be employed in treatment of fibrosis disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra1vuAtVm_07Vg90H21EOLACvtfcHk0lgqv44sX_8aqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CktL3M&md5=b74b9a12946c6235f20d766eddea846f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1042%2FCS20130403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20130403%26sid%3Dliteratum%253Aachs%26aulast%3DDouglas%26aufirst%3DR.%2BG.%26aulast%3DSharma%26aufirst%3DR.%2BK.%26aulast%3DMasuyer%26aufirst%3DG.%26aulast%3DLubbe%26aufirst%3DL.%26aulast%3DZamora%26aufirst%3DI.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26aulast%3DChibale%26aufirst%3DK.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26atitle%3DFragment-based%2520design%2520for%2520the%2520development%2520of%2520N-domain-selective%2520angiotensin-1-converting%2520enzyme%2520inhibitors%26jtitle%3DClin.%2520Sci.%26date%3D2014%26volume%3D126%26spage%3D305%26epage%3D313%26doi%3D10.1042%2FCS20130403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nathisuwan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbert, R. L.</span></span> <span> </span><span class="NLM_article-title">A review of vasopeptidase inhibitors: a new modality in the treatment of hypertension and chronic heart failure</span>. <i>Pharmacotherapy</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.1592/phco.22.1.27.33502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1592%2Fphco.22.1.27.33502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=11794428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvVKksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=27-42&author=S.+Nathisuwanauthor=R.+L.+Talbert&title=A+review+of+vasopeptidase+inhibitors%3A+a+new+modality+in+the+treatment+of+hypertension+and+chronic+heart+failure&doi=10.1592%2Fphco.22.1.27.33502"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A review of vasopeptidase inhibitors: A new modality in the treatment of hypertension and chronic heart failure</span></div><div class="casAuthors">Nathisuwan, Surakit; Talbert, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacotherapy</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-42</span>CODEN:
                <span class="NLM_cas:coden">PHPYDQ</span>;
        ISSN:<span class="NLM_cas:issn">0277-0008</span>.
    
            (<span class="NLM_cas:orgname">Pharmacotherapy Publications</span>)
        </div><div class="casAbstract">A review.  Vasopeptidase inhibitors are a group of agents capable of inhibiting neutral endopeptidase and angiotensin-converting enzymes, which leads to potentiation of natriuretic peptide actions and suppression of the reninangiotensin-aldosterone system.  With this distinctively characteristic mechanism, these agents have emerged as a new drug class for management of hypertension and heart failure.  Several vasopeptidase inhibitors are under clin. investigation.  Omapatrilat is the most studied agent in this class.  Clin. studies of omapatrilat in hypertension have consistently shown the agent's effectiveness in a variety of patient populations.  In patients with heart failure, omapatrilat significantly improved neurohormonal and hemodynamic status.  Long-term effects of omapatrilat in patients with heart failure recently were compared with those of conventional therapy in a large phase II trial.  Results of the study appear promising.  Large clin. trials are ongoing, and addnl. information regarding safety and efficacy from these studies may help define the place in therapy for this agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdG44q7150ybVg90H21EOLACvtfcHk0lgqv44sX_8aqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvVKksw%253D%253D&md5=1cecd58c809de787d03181d29e65169c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1592%2Fphco.22.1.27.33502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1592%252Fphco.22.1.27.33502%26sid%3Dliteratum%253Aachs%26aulast%3DNathisuwan%26aufirst%3DS.%26aulast%3DTalbert%26aufirst%3DR.%2BL.%26atitle%3DA%2520review%2520of%2520vasopeptidase%2520inhibitors%253A%2520a%2520new%2520modality%2520in%2520the%2520treatment%2520of%2520hypertension%2520and%2520chronic%2520heart%2520failure%26jtitle%3DPharmacotherapy%26date%3D2002%26volume%3D22%26spage%3D27%26epage%3D42%26doi%3D10.1592%2Fphco.22.1.27.33502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nussberger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cugno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amstutz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cicardi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellacani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agostoni, A.</span></span> <span> </span><span class="NLM_article-title">Plasma bradykinin in angio-oedema</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>351</i></span>,  <span class="NLM_fpage">1693</span>– <span class="NLM_lpage">1697</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(97)09137-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1016%2FS0140-6736%2897%2909137-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=9734886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADyaK1cXkt1Sls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=1998&pages=1693-1697&author=J.+Nussbergerauthor=M.+Cugnoauthor=C.+Amstutzauthor=M.+Cicardiauthor=A.+Pellacaniauthor=A.+Agostoni&title=Plasma+bradykinin+in+angio-oedema&doi=10.1016%2FS0140-6736%2897%2909137-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma bradykinin in angio-edema</span></div><div class="casAuthors">Nussberger, Juerg; Cugno, Massimo; Amstutz, Catherine; Cicardi, Marco; Pellacani, Andrea; Agostoni, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">9117</span>),
    <span class="NLM_cas:pages">1693-1697</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Lancet Ltd.</span>)
        </div><div class="casAbstract">Bradykinin is believed to be the main mediator of symptoms in hereditary (HA) and acquired (AA) angio-edema due to C1 esterase inhibitor deficiency, as well as in angio-edema that complicates treatment with inhibitors of angiotensin-converting enzyme (ACE).  Difficulties in the measurement of kinin concns., however, have so far precluded the demonstration of an incontrovertible change in plasma bradykinin concns. in these disorders.  By developing a reliable assay we have been able to follow bradykinin concns. during attacks and during remission in HA and in AA, and also in a patient treated with an ACE-inhibitor.  Liq.-phase extn., high-performance liq. chromatog., and RIA were used for specific measurement of plasma bradykinin concns. in 22 patients with HA and in 22 healthy volunteers of similar age and sex distribution.  Four patients with AA and one hypertensive patient treated with the ACE inhibitor captopril were also studied.  Among the healthy volunteers plasma bradykinin concn. was inversely proportional to age.  The geometric mean plasma bradykinin concn. in the healthy volunteers was 2.2 fmol/mL (SD 2.2), compared with 3.9 fmol/mL (3.7) among patients with HA during remission (p=0.095).  Bradykinin was also high in the patients with AA (10.4 fmol/mL [1.6]).  During acute attacks of edema, in both HA and AA, plasma bradykinin rose to two to 12 times the upper limit of normal.  Infusion of C1-esterase inhibitor (the deficient factor in both HA and AA) immediately lowered bradykinin concns.  In the patient receiving the ACE-inhibitor captopril, bradykinin concn. was very high at 47 fmol/mL during an acute attack of angio-edema, but normal at 3.2 fmol/mL in remission after withdrawal of the drug.  A sensitive method for measurement of plasma bradykinin provided the means to show that concns. of this peptide decrease with age in healthy people.  Although the differences between patients in remission and healthy controls did not reach statistical significance, there were substantial rises in bradykinin during acute attacks of hereditary, acquired, or captopril-induced angio-edema.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb4Tr2-3qhp7Vg90H21EOLACvtfcHk0ljEhMs-V8iIaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkt1Sls74%253D&md5=16a3faac0fdb640549c75e1b93e2c3be</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2897%2909137-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252897%252909137-X%26sid%3Dliteratum%253Aachs%26aulast%3DNussberger%26aufirst%3DJ.%26aulast%3DCugno%26aufirst%3DM.%26aulast%3DAmstutz%26aufirst%3DC.%26aulast%3DCicardi%26aufirst%3DM.%26aulast%3DPellacani%26aufirst%3DA.%26aulast%3DAgostoni%26aufirst%3DA.%26atitle%3DPlasma%2520bradykinin%2520in%2520angio-oedema%26jtitle%3DLancet%26date%3D1998%26volume%3D351%26spage%3D1693%26epage%3D1697%26doi%3D10.1016%2FS0140-6736%2897%2909137-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cotton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuniasse, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazeux, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ianzer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Camargo, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of the C-domain of angiotensin I converting enzyme by bradykinin potentiating peptides</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">6065</span>– <span class="NLM_lpage">6071</span>, <span class="refDoi"> DOI: 10.1021/bi012121x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi012121x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=6065-6071&author=J.+Cottonauthor=M.+A.+Hayashiauthor=P.+Cuniasseauthor=G.+Vazeuxauthor=D.+Ianzerauthor=A.+C.+De+Camargoauthor=V.+Dive&title=Selective+inhibition+of+the+C-domain+of+angiotensin+I+converting+enzyme+by+bradykinin+potentiating+peptides&doi=10.1021%2Fbi012121x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fbi012121x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi012121x%26sid%3Dliteratum%253Aachs%26aulast%3DCotton%26aufirst%3DJ.%26aulast%3DHayashi%26aufirst%3DM.%2BA.%26aulast%3DCuniasse%26aufirst%3DP.%26aulast%3DVazeux%26aufirst%3DG.%26aulast%3DIanzer%26aufirst%3DD.%26aulast%3DDe%2BCamargo%26aufirst%3DA.%2BC.%26aulast%3DDive%26aufirst%3DV.%26atitle%3DSelective%2520inhibition%2520of%2520the%2520C-domain%2520of%2520angiotensin%2520I%2520converting%2520enzyme%2520by%2520bradykinin%2520potentiating%2520peptides%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D6065%26epage%3D6071%26doi%3D10.1021%2Fbi012121x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenzel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keshelava, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capecchi, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corvol, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernstein, K. E.</span></span> <span> </span><span class="NLM_article-title">Role of the N-terminal catalytic domain of angiotensin-converting enzyme investigated by targeted inactivation in mice</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">15946</span>– <span class="NLM_lpage">15953</span>, <span class="refDoi"> DOI: 10.1074/jbc.M400149200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1074%2Fjbc.M400149200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=15946-15953&author=S.+Fuchsauthor=H.+D.+Xiaoauthor=J.+M.+Coleauthor=J.+W.+Adamsauthor=K.+Frenzelauthor=A.+Michaudauthor=H.+Zhaoauthor=G.+Keshelavaauthor=M.+R.+Capecchiauthor=P.+Corvolauthor=K.+E.+Bernstein&title=Role+of+the+N-terminal+catalytic+domain+of+angiotensin-converting+enzyme+investigated+by+targeted+inactivation+in+mice&doi=10.1074%2Fjbc.M400149200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M400149200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M400149200%26sid%3Dliteratum%253Aachs%26aulast%3DFuchs%26aufirst%3DS.%26aulast%3DXiao%26aufirst%3DH.%2BD.%26aulast%3DCole%26aufirst%3DJ.%2BM.%26aulast%3DAdams%26aufirst%3DJ.%2BW.%26aulast%3DFrenzel%26aufirst%3DK.%26aulast%3DMichaud%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DKeshelava%26aufirst%3DG.%26aulast%3DCapecchi%26aufirst%3DM.%2BR.%26aulast%3DCorvol%26aufirst%3DP.%26aulast%3DBernstein%26aufirst%3DK.%2BE.%26atitle%3DRole%2520of%2520the%2520N-terminal%2520catalytic%2520domain%2520of%2520angiotensin-converting%2520enzyme%2520investigated%2520by%2520targeted%2520inactivation%2520in%2520mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D15946%26epage%3D15953%26doi%3D10.1074%2Fjbc.M400149200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louw, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span> <span> </span><span class="NLM_article-title">New ketomethylene inhibitor analogues: synthesis and assessment of structural determinants for N-domain selective inhibition of angiotensin-converting enzyme</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>393</i></span>,  <span class="NLM_fpage">485</span>– <span class="NLM_lpage">493</span>, <span class="refDoi"> DOI: 10.1515/hsz-2012-0127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1515%2Fhsz-2012-0127" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=2012&pages=485-493&author=R.+K.+Sharmaauthor=R.+G.+Douglasauthor=S.+Louwauthor=K.+Chibaleauthor=E.+D.+Sturrock&title=New+ketomethylene+inhibitor+analogues%3A+synthesis+and+assessment+of+structural+determinants+for+N-domain+selective+inhibition+of+angiotensin-converting+enzyme&doi=10.1515%2Fhsz-2012-0127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2012-0127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2012-0127%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DR.%2BK.%26aulast%3DDouglas%26aufirst%3DR.%2BG.%26aulast%3DLouw%26aufirst%3DS.%26aulast%3DChibale%26aufirst%3DK.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26atitle%3DNew%2520ketomethylene%2520inhibitor%2520analogues%253A%2520synthesis%2520and%2520assessment%2520of%2520structural%2520determinants%2520for%2520N-domain%2520selective%2520inhibition%2520of%2520angiotensin-converting%2520enzyme%26jtitle%3DBiol.%2520Chem.%26date%3D2012%26volume%3D393%26spage%3D485%26epage%3D493%26doi%3D10.1515%2Fhsz-2012-0127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erdos, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skidgel, R. A.</span></span> <span> </span><span class="NLM_article-title">Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1096/fasebj.3.2.2521610</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1096%2Ffasebj.3.2.2521610" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1989&pages=145-151&author=E.+G.+Erdosauthor=R.+A.+Skidgel&title=Neutral+endopeptidase+24.11+%28enkephalinase%29+and+related+regulators+of+peptide+hormones&doi=10.1096%2Ffasebj.3.2.2521610"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1096%2Ffasebj.3.2.2521610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffasebj.3.2.2521610%26sid%3Dliteratum%253Aachs%26aulast%3DErdos%26aufirst%3DE.%2BG.%26aulast%3DSkidgel%26aufirst%3DR.%2BA.%26atitle%3DNeutral%2520endopeptidase%252024.11%2520%2528enkephalinase%2529%2520and%2520related%2520regulators%2520of%2520peptide%2520hormones%26jtitle%3DFASEB%2520J.%26date%3D1989%26volume%3D3%26spage%3D145%26epage%3D151%26doi%3D10.1096%2Ffasebj.3.2.2521610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roques, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noble, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dauge, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournie-Zaluski, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, A.</span></span> <span> </span><span class="NLM_article-title">Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology</span>. <i>Pharmacol Rev.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">146</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1993&pages=87-146&author=B.+P.+Roquesauthor=F.+Nobleauthor=V.+Daugeauthor=M.+C.+Fournie-Zaluskiauthor=A.+Beaumont&title=Neutral+endopeptidase+24.11%3A+structure%2C+inhibition%2C+and+experimental+and+clinical+pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoques%26aufirst%3DB.%2BP.%26aulast%3DNoble%26aufirst%3DF.%26aulast%3DDauge%26aufirst%3DV.%26aulast%3DFournie-Zaluski%26aufirst%3DM.%2BC.%26aulast%3DBeaumont%26aufirst%3DA.%26atitle%3DNeutral%2520endopeptidase%252024.11%253A%2520structure%252C%2520inhibition%252C%2520and%2520experimental%2520and%2520clinical%2520pharmacology%26jtitle%3DPharmacol%2520Rev.%26date%3D1993%26volume%3D45%26spage%3D87%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gros, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souque, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danvy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plaquevent, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duhamel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duhamel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecomte, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bralet, J.</span></span> <span> </span><span class="NLM_article-title">Mixed inhibitors of angiotensin-converting enzyme (EC 3.4.15.1) and enkephalinase (EC 3.4.24.11): rational design, properties, and potential cardiovascular applications of glycopril and alatriopril</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">4210</span>– <span class="NLM_lpage">4214</span>, <span class="refDoi"> DOI: 10.1073/pnas.88.10.4210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1073%2Fpnas.88.10.4210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1851998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADyaK3MXks1CgsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=4210-4214&author=C.+Grosauthor=N.+Noelauthor=A.+Souqueauthor=J.+C.+Schwartzauthor=D.+Danvyauthor=J.+C.+Plaqueventauthor=L.+Duhamelauthor=P.+Duhamelauthor=J.+M.+Lecomteauthor=J.+Bralet&title=Mixed+inhibitors+of+angiotensin-converting+enzyme+%28EC+3.4.15.1%29+and+enkephalinase+%28EC+3.4.24.11%29%3A+rational+design%2C+properties%2C+and+potential+cardiovascular+applications+of+glycopril+and+alatriopril&doi=10.1073%2Fpnas.88.10.4210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Mixed inhibitors of angiotensin-converting enzyme (EC 3.4.15.1) and enkephalinase (EC 3.4.24.11):  rational design, properties, and potential cardiovascular applications of glycopril and alatriopril</span></div><div class="casAuthors">Gros, Claude; Noel, Nadine; Souque, Anny; Schwartz, Jean Charles; Danvy, Denis; Plaquevent, Jean Christophe; Duhamel, Lucette; Duhamel, Pierre; Lecomte, Jeanne Marie; Bralet, Jean</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4210-14</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Angiotensin-converting enzyme (ACE) and enkephalinase, two cell surface metallopeptidases, are responsible for angiotensin II formation and atrial natriuretic factor (ANF) degrdn., resp., and thereby play a crit. role in the metab. of hormonal peptides exerting essentially opposite actions in cardiovascular regulations.  To affect simultaneously both hormonal systems by a single mol. structure, glycoprilat and alatrioprilat [(S)-N-[3-(3,4-methylenedioxyphenyl)-2-(mercaptomethyl)-1-oxopropyl]glycine and -alanine, resp.] were designed.  In vitro the two compds. inhibit both ACE and enkephalinase activities with similar, nanomolar potencies, and in vivo, glycopril and alatriopril, the corresponding diester prodrugs, occupy the two enzyme mols. in lung at similar low dosages (0.2-0.5 mg/kg of body wt., per os).  The high potency of these compds. is attributable to interaction of the methylenedioxy group with the S1 subsite of ACE and of the arom. ring with the S1 subsite of enkephalinase.  In rodents, low doses of these mixed inhibitors exert typical actions of ACE inhibitors i.e., prevention of angiotensin I-induced hypertension, as well as of enkephalinase inhibitors i.e., protection from 125I-ANF degrdn. or enhancement of diuresis and natriuresis following acute extracellular vol. expansion.  In view of the known counterbalanced physiol. actions of the two hormone peptides, whose metab. is controlled by ACE and enkephalinase, mixed inhibitors of the two peptidases show promise for the treatment of various cardiovascular and salt-retention disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLpFAjkhE92rVg90H21EOLACvtfcHk0lhMSDuskZ6Gjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXks1CgsbY%253D&md5=995e5d82e074b67c125d100e2704346f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.88.10.4210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.88.10.4210%26sid%3Dliteratum%253Aachs%26aulast%3DGros%26aufirst%3DC.%26aulast%3DNoel%26aufirst%3DN.%26aulast%3DSouque%26aufirst%3DA.%26aulast%3DSchwartz%26aufirst%3DJ.%2BC.%26aulast%3DDanvy%26aufirst%3DD.%26aulast%3DPlaquevent%26aufirst%3DJ.%2BC.%26aulast%3DDuhamel%26aufirst%3DL.%26aulast%3DDuhamel%26aufirst%3DP.%26aulast%3DLecomte%26aufirst%3DJ.%2BM.%26aulast%3DBralet%26aufirst%3DJ.%26atitle%3DMixed%2520inhibitors%2520of%2520angiotensin-converting%2520enzyme%2520%2528EC%25203.4.15.1%2529%2520and%2520enkephalinase%2520%2528EC%25203.4.24.11%2529%253A%2520rational%2520design%252C%2520properties%252C%2520and%2520potential%2520cardiovascular%2520applications%2520of%2520glycopril%2520and%2520alatriopril%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1991%26volume%3D88%26spage%3D4210%26epage%3D4214%26doi%3D10.1073%2Fpnas.88.10.4210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robl, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryono, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpkins, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cimarusti, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dejneka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusarchyk, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratton, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misra, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bednarz, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asaad, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abboa-Offei, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathers, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seymour, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trippodo, N. C.</span></span> <span> </span><span class="NLM_article-title">Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1570</span>– <span class="NLM_lpage">1577</span>, <span class="refDoi"> DOI: 10.1021/jm970041e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970041e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADyaK2sXjtFSjtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1570-1577&author=J.+A.+Roblauthor=C.+Q.+Sunauthor=J.+Stevensonauthor=D.+E.+Ryonoauthor=L.+M.+Simpkinsauthor=M.+P.+Cimarustiauthor=T.+Dejnekaauthor=W.+A.+Slusarchykauthor=S.+Chaoauthor=L.+Strattonauthor=R.+N.+Misraauthor=M.+S.+Bednarzauthor=M.+M.+Asaadauthor=H.+S.+Cheungauthor=B.+E.+Abboa-Offeiauthor=P.+L.+Smithauthor=P.+D.+Mathersauthor=M.+Foxauthor=T.+R.+Schaefferauthor=A.+A.+Seymourauthor=N.+C.+Trippodo&title=Dual+metalloprotease+inhibitors%3A+mercaptoacetyl-based+fused+heterocyclic+dipeptide+mimetics+as+inhibitors+of+angiotensin-converting+enzyme+and+neutral+endopeptidase&doi=10.1021%2Fjm970041e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Metalloprotease Inhibitors: Mercaptoacetyl-Based Fused Heterocyclic Dipeptide Mimetics as Inhibitors of Angiotensin-Converting Enzyme and Neutral Endopeptidase</span></div><div class="casAuthors">Robl, Jeffrey A.; Sun, Chong-Qing; Stevenson, Jay; Ryono, Denis E.; Simpkins, Ligaya M.; Cimarusti, Maria P.; Dejneka, Tamara; Slusarchyk, William A.; Chao, Sam; Stratton, Leslie; Misra, Raj N.; Bednarz, Mark S.; Asaad, Magdi M.; Cheung, Hong Son; Abboa-Offei, Benoni E.; Smith, Patricia L.; Mathers, Parker D.; Fox, Maxine; Schaeffer, Thomas R.; Seymour, Andrea A.; Trippodo, Nick C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1570-1577</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 7,6- and 7,5-fused bicyclic thiazepinones and oxazepinones were generated and incorporated as conformationally restricted dipeptide surrogates in mercaptoacyl dipeptides.  These compds. are potent inhibitors of angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP) both in vitro and in vivo.  Compd. 1a, a 7,6-fused bicyclic thiazepinone, demonstrated excellent blood pressure lowering in a variety of animal models characterized by various levels of plasma renin activity and significantly potentiated urinary sodium, ANP, and cGMP excretion in a cynomolgus monkey assay.  On the basis of its potency and duration of action, compd. 1a (BMS-186716) was advanced into clin. development for the treatment of hypertension and congestive heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpA1AhNVtyuOrVg90H21EOLACvtfcHk0lhMSDuskZ6Gjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtFSjtbY%253D&md5=e255086829b24dd59c25c1991ba04264</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm970041e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970041e%26sid%3Dliteratum%253Aachs%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DSun%26aufirst%3DC.%2BQ.%26aulast%3DStevenson%26aufirst%3DJ.%26aulast%3DRyono%26aufirst%3DD.%2BE.%26aulast%3DSimpkins%26aufirst%3DL.%2BM.%26aulast%3DCimarusti%26aufirst%3DM.%2BP.%26aulast%3DDejneka%26aufirst%3DT.%26aulast%3DSlusarchyk%26aufirst%3DW.%2BA.%26aulast%3DChao%26aufirst%3DS.%26aulast%3DStratton%26aufirst%3DL.%26aulast%3DMisra%26aufirst%3DR.%2BN.%26aulast%3DBednarz%26aufirst%3DM.%2BS.%26aulast%3DAsaad%26aufirst%3DM.%2BM.%26aulast%3DCheung%26aufirst%3DH.%2BS.%26aulast%3DAbboa-Offei%26aufirst%3DB.%2BE.%26aulast%3DSmith%26aufirst%3DP.%2BL.%26aulast%3DMathers%26aufirst%3DP.%2BD.%26aulast%3DFox%26aufirst%3DM.%26aulast%3DSchaeffer%26aufirst%3DT.%2BR.%26aulast%3DSeymour%26aufirst%3DA.%2BA.%26aulast%3DTrippodo%26aufirst%3DN.%2BC.%26atitle%3DDual%2520metalloprotease%2520inhibitors%253A%2520mercaptoacetyl-based%2520fused%2520heterocyclic%2520dipeptide%2520mimetics%2520as%2520inhibitors%2520of%2520angiotensin-converting%2520enzyme%2520and%2520neutral%2520endopeptidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1570%26epage%3D1577%26doi%3D10.1021%2Fjm970041e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azizi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massien, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corvol, P.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo inhibition of the 2 active sites of ACE by omapatrilat, a vasopeptidase inhibitor</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1226</span>– <span class="NLM_lpage">1231</span>, <span class="refDoi"> DOI: 10.1161/01.HYP.35.6.1226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1161%2F01.HYP.35.6.1226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10856268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksVCntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2000&pages=1226-1231&author=M.+Aziziauthor=C.+Massienauthor=A.+Michaudauthor=P.+Corvol&title=In+vitro+and+in+vivo+inhibition+of+the+2+active+sites+of+ACE+by+omapatrilat%2C+a+vasopeptidase+inhibitor&doi=10.1161%2F01.HYP.35.6.1226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo inhibition of the 2 active sites of ACE by omapatrilat, a vasopeptidase inhibitor</span></div><div class="casAuthors">Azizi, Michel; Massien, Christine; Michaud, Annie; Corvol, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1226-1231</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The vasopeptidase inhibitor omapatrilat inhibits both neutral endopeptidase and angiotensin-converting enzyme (ACE).  The in vitro and in vivo inhibitory potency of omapatrilat and the specific ACE inhibitor fosinopril toward the 2 active sites of ACE (called N- and C-domains) was investigated with the use of 3 substrates: angiotensin I, which is equally cleaved by the 2 ACE domains; hippuryl-histidyl-leucine, specific synthetic substrate of the C-domain in high-salt conditions; and a newly synthesized specific substrate of the N-domain designed by acetylating the lysine residue of AcSDKP.  In vitro, omapatrilat was 5 times more potent than fosinoprilat in inhibiting angiotensin I hydrolysis.  Omapatrilat inhibited similarly both N- and C-domain hydrolysis, whereas fosinoprilat was slightly more specific for the N-domain.  The in vivo selective inhibitory potency of single oral doses of 10 mg omapatrilat and 20 mg fosinopril were investigated in a double-blind, placebo-controlled, cross-over study in 9 mildly sodium-depleted normotensive subjects.  In accordance with the in vitro results, fosinopril appeared to be more specific for the N-domain than the C-domain in vivo, since plasma and urine AcSDKP concns. were significantly higher than those obsd. with omapatrilat.  This study shows that it is possible to assess sep. in vitro and in vivo the selectivity of ACE or ACE/neutral endopeptidase inhibitors.  A differential selectivity may explain some peculiar properties obsd. with some ACE inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpEX7zuaqkurVg90H21EOLACvtfcHk0ljabJd9oIohmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksVCntr0%253D&md5=961802b4e2984e1d80acb5e49dbac749</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1161%2F01.HYP.35.6.1226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.HYP.35.6.1226%26sid%3Dliteratum%253Aachs%26aulast%3DAzizi%26aufirst%3DM.%26aulast%3DMassien%26aufirst%3DC.%26aulast%3DMichaud%26aufirst%3DA.%26aulast%3DCorvol%26aufirst%3DP.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520inhibition%2520of%2520the%25202%2520active%2520sites%2520of%2520ACE%2520by%2520omapatrilat%252C%2520a%2520vasopeptidase%2520inhibitor%26jtitle%3DHypertension%26date%3D2000%26volume%3D35%26spage%3D1226%26epage%3D1231%26doi%3D10.1161%2F01.HYP.35.6.1226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fryer, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segreti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banfor, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widomski, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backes, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballaron, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevillyan, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhart, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Geldern, T. W.</span></span> <span> </span><span class="NLM_article-title">Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>153</i></span>,  <span class="NLM_fpage">947</span>– <span class="NLM_lpage">955</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0707641</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1038%2Fsj.bjp.0707641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=18084312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD1cXislWis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=947-955&author=R.+M.+Fryerauthor=J.+Segretiauthor=P.+N.+Banforauthor=D.+L.+Widomskiauthor=B.+J.+Backesauthor=C.+W.+Linauthor=S.+J.+Ballaronauthor=B.+F.+Coxauthor=J.+M.+Trevillyanauthor=G.+A.+Reinhartauthor=T.+W.+von+Geldern&title=Effect+of+bradykinin+metabolism+inhibitors+on+evoked+hypotension+in+rats%3A+rank+efficacy+of+enzymes+associated+with+bradykinin-mediated+angioedema&doi=10.1038%2Fsj.bjp.0707641"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema</span></div><div class="casAuthors">Fryer, R. M.; Segreti, J.; Banfor, P. N.; Widomski, D. L.; Backes, B. J.; Lin, C. W.; Ballaron, S. J.; Cox, B. F.; Trevillyan, J. M.; Reinhart, G. A.; von Geldern, T. W.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">947-955</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhibition of bradykinin metabolizing enzymes (BMEs) can cause acute angioedema, as demonstrated in a recent clin. trial in patients administered the antihypertensive, omapatrilat.  However, the relative contribution of specific BMEs to this effect is unclear and confounded by the lack of a predictive pre-clin. model of angioedema.  Rats were instrumented to record blood pressure and heart rate; inhibitors were infused for 35 min and bradykinin was infused during the last 5 min to elicit hypotension, as a functional marker of circulating bradykinin and relative angioedema risk.  In the presence of omapatrilat, bradykinin produced dose-dependent hypotension, an effect abolished by B2 blockade.  In the presence of lisinopril (ACE inhibitor), but not candoxatril (NEP inhibitor) or apstatin (APP inhibitor), bradykinin also elicited hypotension.  Lisinopril-mediated hypotension was unchanged with concomitant blockade of NEP or NEP/DPPIV (candoxatril + A-899301).  However, hypotension was enhanced upon concomitant blockade of APP and further intensified in the presence of NEP inhibition to values not different from omapatrilat alone.  We demonstrated that bradykinin is degraded in vivo with an enzyme rank-efficacy of ACE>APP»NEP or DPPIV.  These results suggest the effects of omapatrilat are mediated by inhibition of three BMEs, ACE/APP/NEP.  However, dual inhibition of ACE/NEP or ACE/NEP/DPPIV elicits no increased risk of angioedema compared to ACE inhibition alone.  Thus, novel BME inhibitors must display no activity against APP to avoid angioedema risk due to high prevalence of ACE inhibitor therapy in patients with diabetes and cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHe-dQxhoWF7Vg90H21EOLACvtfcHk0ljabJd9oIohmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXislWis7Y%253D&md5=e3067cd71575b8f32a623ef6a0303569</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707641%26sid%3Dliteratum%253Aachs%26aulast%3DFryer%26aufirst%3DR.%2BM.%26aulast%3DSegreti%26aufirst%3DJ.%26aulast%3DBanfor%26aufirst%3DP.%2BN.%26aulast%3DWidomski%26aufirst%3DD.%2BL.%26aulast%3DBackes%26aufirst%3DB.%2BJ.%26aulast%3DLin%26aufirst%3DC.%2BW.%26aulast%3DBallaron%26aufirst%3DS.%2BJ.%26aulast%3DCox%26aufirst%3DB.%2BF.%26aulast%3DTrevillyan%26aufirst%3DJ.%2BM.%26aulast%3DReinhart%26aufirst%3DG.%2BA.%26aulast%3Dvon%2BGeldern%26aufirst%3DT.%2BW.%26atitle%3DEffect%2520of%2520bradykinin%2520metabolism%2520inhibitors%2520on%2520evoked%2520hypotension%2520in%2520rats%253A%2520rank%2520efficacy%2520of%2520enzymes%2520associated%2520with%2520bradykinin-mediated%2520angioedema%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3D947%26epage%3D955%26doi%3D10.1038%2Fsj.bjp.0707641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kostis, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmieder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, E.</span></span> <span> </span><span class="NLM_article-title">Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial</span>. <i>Am. J. Hypertens.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">103</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1016/j.amjhyper.2003.09.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1016%2Fj.amjhyper.2003.09.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=14751650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvF2gtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=103-111&author=J.+B.+Kostisauthor=M.+Packerauthor=H.+R.+Blackauthor=R.+Schmiederauthor=D.+Henryauthor=E.+Levy&title=Omapatrilat+and+enalapril+in+patients+with+hypertension%3A+the+Omapatrilat+Cardiovascular+Treatment+vs.+Enalapril+%28OCTAVE%29+trial&doi=10.1016%2Fj.amjhyper.2003.09.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial</span></div><div class="casAuthors">Kostis, John B.; Packer, Milton; Black, Henry R.; Schmieder, Roland; Henry, David; Levy, Elliott</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Hypertension</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">103-111</span>CODEN:
                <span class="NLM_cas:coden">AJHYE6</span>;
        ISSN:<span class="NLM_cas:issn">0895-7061</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Recent reports suggest that existing antihypertensive agents may not have sufficient efficacy to control blood pressure (BP) in many patients.  Omapatrilat, an agent under development, has been shown to have significantly greater antihypertensive efficacy than existing agents, but may also carry increased risk of angioedema.  We compared the efficacy and safety of omapatrilat to a representative angiotensin-converting enzyme (ACE) inhibitor, enalapril.  The Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial is a multicenter, randomized, double-blind, active-controlled, 24-wk trial in 25,302 patients with untreated or uncontrolled hypertension conducted in 3298 office-based sites in 12 countries.  Subjects were randomized to omapatrilat 10 mg or enalapril 5 mg as initial therapy for hypertension (group 1, n = 9292), replacement for existing antihypertensive therapy (group 2, n = 11,224), or in addn. to existing antihypertensive therapy (group 3, n = 4751).  Study drug was force-titrated at week 2 and electively titrated at weeks 4 and 6 to a max. of omapatrilat 80 mg or enalapril 40 mg once daily.  At weeks 8 and 16, adjunctive antihypertensive medications were added electively to achieve target BP.  Omapatrilat reduced systolic BP 3.6 mm Hg more than enalapril at week 8, and was assocd. with less use of adjunctive antihypertensive therapy by week 24 (19% v 27%; P < 0.001 for both comparisons).  Subjects randomized to omapatrilat were more likely to reach BP target, regardless of demographics or comorbid conditions and whether omapatrilat was used as initial therapy, replacement for existing therapy, or in addn. to existing therapy.  Angioedema was more frequent with omapatrilat than enalapril (2.17% v 0.68%).  Two omapatrilat-treated subjects experienced angioedema with airway compromise, which was successfully treated.  Omapatrilat provided broadly superior antihypertensive efficacy when used in a setting resembling clin. practice.  Angioedema was more common than with enalapril but life-threatening angioedema was rare.  The risk-benefit profile for omapatrilat in clin. use therefore appears likely to be favorable in appropriate patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPTjmO9Y1hr7Vg90H21EOLACvtfcHk0ljabJd9oIohmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvF2gtw%253D%253D&md5=a783f9aa5c8d243ac3c077b601918535</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.amjhyper.2003.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjhyper.2003.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DKostis%26aufirst%3DJ.%2BB.%26aulast%3DPacker%26aufirst%3DM.%26aulast%3DBlack%26aufirst%3DH.%2BR.%26aulast%3DSchmieder%26aufirst%3DR.%26aulast%3DHenry%26aufirst%3DD.%26aulast%3DLevy%26aufirst%3DE.%26atitle%3DOmapatrilat%2520and%2520enalapril%2520in%2520patients%2520with%2520hypertension%253A%2520the%2520Omapatrilat%2520Cardiovascular%2520Treatment%2520vs.%2520Enalapril%2520%2528OCTAVE%2529%2520trial%26jtitle%3DAm.%2520J.%2520Hypertens.%26date%3D2004%26volume%3D17%26spage%3D103%26epage%3D111%26doi%3D10.1016%2Fj.amjhyper.2003.09.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Natesh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwager, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K. R.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the human angiotensin-converting enzyme-lisinopril complex</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>421</i></span>,  <span class="NLM_fpage">551</span>– <span class="NLM_lpage">554</span>, <span class="refDoi"> DOI: 10.1038/nature01370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1038%2Fnature01370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=12540854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntFSqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2003&pages=551-554&author=R.+Nateshauthor=S.+L.+Schwagerauthor=E.+D.+Sturrockauthor=K.+R.+Acharya&title=Crystal+structure+of+the+human+angiotensin-converting+enzyme-lisinopril+complex&doi=10.1038%2Fnature01370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the human angiotensin-converting enzyme-lisinopril complex</span></div><div class="casAuthors">Natesh, Ramanathan; Schwager, Sylva L. U.; Sturrock, Edward D.; Acharya, K. Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">421</span>
        (<span class="NLM_cas:issue">6922</span>),
    <span class="NLM_cas:pages">551-554</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Angiotensin-converting enzyme (ACE) has a crit. role in cardiovascular function by cleaving the carboxy terminal His-Leu dipeptide from angiotensin I to produce a potent vasopressor octapeptide, angiotensin II.  Inhibitors of ACE are a first line of therapy for hypertension, heart failure, myocardial infarction and diabetic nephropathy.  Notably, these inhibitors were developed without knowledge of the structure of human ACE, but were instead designed on the basis of an assumed mechanistic homol. with carboxypeptidase A.  Here we present the x-ray structure of human testicular ACE and its complex with one of the most widely used inhibitors, lisinopril (N2-[(S)-1-carboxy-3-phenylpropyl]-l-lysyl-l-proline; also known as Prinivil or Zestril), at 2.0 Å resoln.  Anal. of the three-dimensional structure of ACE shows that it bears little similarity to that of carboxypeptidase A, but instead resembles neurolysin and Pyrococcus furiosus carboxypeptidase-zinc metallopeptidases with no detectable sequence similarity to ACE.  The structure provides an opportunity to design domain-selective ACE inhibitors that may exhibit new pharmacol. profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxHYbWU8PmP7Vg90H21EOLACvtfcHk0ljabJd9oIohmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntFSqtg%253D%253D&md5=84f2f474ac20541b0352691128782b1d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnature01370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01370%26sid%3Dliteratum%253Aachs%26aulast%3DNatesh%26aufirst%3DR.%26aulast%3DSchwager%26aufirst%3DS.%2BL.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520angiotensin-converting%2520enzyme-lisinopril%2520complex%26jtitle%3DNature%26date%3D2003%26volume%3D421%26spage%3D551%26epage%3D554%26doi%3D10.1038%2Fnature01370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cozier, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwager, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K. R.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of sampatrilat and sampatrilat-Asp in complex with human ACE - a molecular basis for domain selectivity</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">1477</span>– <span class="NLM_lpage">1490</span>, <span class="refDoi"> DOI: 10.1111/febs.14421</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1111%2Ffebs.14421" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=29476645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktV2nur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2018&pages=1477-1490&author=G.+E.+Cozierauthor=S.+L.+Schwagerauthor=R.+K.+Sharmaauthor=K.+Chibaleauthor=E.+D.+Sturrockauthor=K.+R.+Acharya&title=Crystal+structures+of+sampatrilat+and+sampatrilat-Asp+in+complex+with+human+ACE+-+a+molecular+basis+for+domain+selectivity&doi=10.1111%2Ffebs.14421"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of sampatrilat and sampatrilat-Asp in complex with human ACE - a molecular basis for domain selectivity</span></div><div class="casAuthors">Cozier, Gyles E.; Schwager, Sylva L.; Sharma, Rajni K.; Chibale, Kelly; Sturrock, Edward D.; Acharya, K. Ravi</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1477-1490</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Angiotensin-1-converting enzyme (ACE) is a zinc metallopeptidase that consists of two homologous catalytic domains (known as nACE and cACE) with different substrate specificities.  Based on kinetic studies it was previously reported that sampatrilat, a tight-binding inhibitor of ACE, Ki = 13.8 nM and 171.9 nM for cACE and nACE resp. [Sharma et al., Journal of Chem. Information and Modeling (2016), 56, 2486-2494], was 12.4-fold more selective for cACE.  In addn., sampatrilat-Asp (samAsp), in which an aspartate group replaces the sampatrilat lysine, was found to be a nonspecific and lower micromolar affinity inhibitor.  Here, we report a detailed three-dimensional structural anal. of sampatrilat and samAsp binding to ACE using high-resoln. crystal structures elucidated by X-ray crystallog., which provides a mol. basis for differences in inhibitor affinity and selectivity for nACE and cACE.  The structures show that the specificity of sampatrilat can be explained by increased hydrophobic interactions and a H-bond from Glu403 of cACE with the lysine side chain of sampatrilat that are not obsd. in nACE.  In addn., the structures clearly show a significantly greater no. of hydrophilic and hydrophobic interactions with sampatrilat compared to samAsp in both cACE and nACE consistent with the difference in affinities.  Our findings provide new exptl. insights into ligand binding at the active site pockets that are important for the design of highly specific domain selective inhibitors of ACE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgO5eB50LzpbVg90H21EOLACvtfcHk0ligjWMHES1fHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktV2nur8%253D&md5=407be458962d79e4fa0e512e01bb7e04</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1111%2Ffebs.14421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.14421%26sid%3Dliteratum%253Aachs%26aulast%3DCozier%26aufirst%3DG.%2BE.%26aulast%3DSchwager%26aufirst%3DS.%2BL.%26aulast%3DSharma%26aufirst%3DR.%2BK.%26aulast%3DChibale%26aufirst%3DK.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26atitle%3DCrystal%2520structures%2520of%2520sampatrilat%2520and%2520sampatrilat-Asp%2520in%2520complex%2520with%2520human%2520ACE%2520-%2520a%2520molecular%2520basis%2520for%2520domain%2520selectivity%26jtitle%3DFEBS%2520J.%26date%3D2018%26volume%3D285%26spage%3D1477%26epage%3D1490%26doi%3D10.1111%2Ffebs.14421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larmuth, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuyer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwager, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span> <span> </span><span class="NLM_article-title">Kinetic and structural characterization of amyloid-beta peptide hydrolysis by human angiotensin-1-converting enzyme</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">1060</span>– <span class="NLM_lpage">1076</span>, <span class="refDoi"> DOI: 10.1111/febs.13647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1111%2Ffebs.13647" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2016&pages=1060-1076&author=K.+M.+Larmuthauthor=G.+Masuyerauthor=R.+G.+Douglasauthor=S.+L.+Schwagerauthor=K.+R.+Acharyaauthor=E.+D.+Sturrock&title=Kinetic+and+structural+characterization+of+amyloid-beta+peptide+hydrolysis+by+human+angiotensin-1-converting+enzyme&doi=10.1111%2Ffebs.13647"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1111%2Ffebs.13647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.13647%26sid%3Dliteratum%253Aachs%26aulast%3DLarmuth%26aufirst%3DK.%2BM.%26aulast%3DMasuyer%26aufirst%3DG.%26aulast%3DDouglas%26aufirst%3DR.%2BG.%26aulast%3DSchwager%26aufirst%3DS.%2BL.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26atitle%3DKinetic%2520and%2520structural%2520characterization%2520of%2520amyloid-beta%2520peptide%2520hydrolysis%2520by%2520human%2520angiotensin-1-converting%2520enzyme%26jtitle%3DFEBS%2520J.%26date%3D2016%26volume%3D283%26spage%3D1060%26epage%3D1076%26doi%3D10.1111%2Ffebs.13647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akif, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuyer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingham, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaac, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K. R.</span></span> <span> </span><span class="NLM_article-title">Structural basis of peptide recognition by the angiotensin-1 converting enzyme homologue AnCE from Drosophila melanogaster</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">4525</span>– <span class="NLM_lpage">4534</span>, <span class="refDoi"> DOI: 10.1111/febs.12038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1111%2Ffebs.12038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=23082758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslKrtLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2012&pages=4525-4534&author=M.+Akifauthor=G.+Masuyerauthor=R.+J.+Binghamauthor=E.+D.+Sturrockauthor=R.+E.+Isaacauthor=K.+R.+Acharya&title=Structural+basis+of+peptide+recognition+by+the+angiotensin-1+converting+enzyme+homologue+AnCE+from+Drosophila+melanogaster&doi=10.1111%2Ffebs.12038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of peptide recognition by the angiotensin-1 converting enzyme homologue AnCE from Drosophila melanogaster</span></div><div class="casAuthors">Akif, Mohd; Masuyer, Geoffrey; Bingham, Richard J.; Sturrock, Edward D.; Isaac, R. Elwyn; Acharya, K. Ravi</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4525-4534</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Human somatic angiotensin-1 converting enzyme (ACE) is a zinc-dependent exopeptidase, that catalyzes the conversion of the decapeptide angiotensin I to the octapeptide angiotensin II, by removing a C-terminal dipeptide.  It is the principal component of the renin-angiotensin-aldosterone system that regulates blood pressure.  Hence it is an important therapeutic target for the treatment of hypertension and cardiovascular disorders.  Here, we report the structures of an ACE homolog from Drosophila melanogaster (AnCE; a proven structural model for the more complex human ACE) co-crystd. with mammalian peptide substrates (bradykinin, Thr6-bradykinin, angiotensin I, and a snake venom peptide inhibitor, bradykinin-potentiating peptide-b).  The structures detd. at 2-Å resoln. illustrate that both angiotensin II (the cleaved product of angiotensin I by AnCE) and bradykinin-potentiating peptide-b bind in an analogous fashion at the active site of AnCE, but also exhibit significant differences.  In addn., the binding of Arg-Pro-Pro, the cleavage product of bradykinin and Thr6- bradykinin, provides addnl. detail of the general peptide binding in AnCE.  Thus the new structures of AnCE complexes presented here improves our understanding of the binding of peptides and the mechanism by which peptides inhibit this family of enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1E5hdVAxySLVg90H21EOLACvtfcHk0ligjWMHES1fHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslKrtLbL&md5=0f8d7e8f1ff891560717214e2c7b6858</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12038%26sid%3Dliteratum%253Aachs%26aulast%3DAkif%26aufirst%3DM.%26aulast%3DMasuyer%26aufirst%3DG.%26aulast%3DBingham%26aufirst%3DR.%2BJ.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26aulast%3DIsaac%26aufirst%3DR.%2BE.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26atitle%3DStructural%2520basis%2520of%2520peptide%2520recognition%2520by%2520the%2520angiotensin-1%2520converting%2520enzyme%2520homologue%2520AnCE%2520from%2520Drosophila%2520melanogaster%26jtitle%3DFEBS%2520J.%26date%3D2012%26volume%3D279%26spage%3D4525%26epage%3D4534%26doi%3D10.1111%2Ffebs.12038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yiotakis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassiliou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiracek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazeux, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauvet, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuniasse, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corvol, P.</span></span> <span> </span><span class="NLM_article-title">RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">4330</span>– <span class="NLM_lpage">4335</span>, <span class="refDoi"> DOI: 10.1073/pnas.96.8.4330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1073%2Fpnas.96.8.4330" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=4330-4335&author=V.+Diveauthor=J.+Cottonauthor=A.+Yiotakisauthor=A.+Michaudauthor=S.+Vassiliouauthor=J.+Jiracekauthor=G.+Vazeuxauthor=M.+T.+Chauvetauthor=P.+Cuniasseauthor=P.+Corvol&title=RXP+407%2C+a+phosphinic+peptide%2C+is+a+potent+inhibitor+of+angiotensin+I+converting+enzyme+able+to+differentiate+between+its+two+active+sites&doi=10.1073%2Fpnas.96.8.4330"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.8.4330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.8.4330%26sid%3Dliteratum%253Aachs%26aulast%3DDive%26aufirst%3DV.%26aulast%3DCotton%26aufirst%3DJ.%26aulast%3DYiotakis%26aufirst%3DA.%26aulast%3DMichaud%26aufirst%3DA.%26aulast%3DVassiliou%26aufirst%3DS.%26aulast%3DJiracek%26aufirst%3DJ.%26aulast%3DVazeux%26aufirst%3DG.%26aulast%3DChauvet%26aufirst%3DM.%2BT.%26aulast%3DCuniasse%26aufirst%3DP.%26aulast%3DCorvol%26aufirst%3DP.%26atitle%3DRXP%2520407%252C%2520a%2520phosphinic%2520peptide%252C%2520is%2520a%2520potent%2520inhibitor%2520of%2520angiotensin%2520I%2520converting%2520enzyme%2520able%2520to%2520differentiate%2520between%2520its%2520two%2520active%2520sites%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D4330%26epage%3D4335%26doi%3D10.1073%2Fpnas.96.8.4330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akif, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwager, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarny, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K. R.</span></span> <span> </span><span class="NLM_article-title">Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>436</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1042/BJ20102123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1042%2FBJ20102123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=21352096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsFGntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2011&pages=53-59&author=M.+Akifauthor=S.+L.+Schwagerauthor=C.+S.+Anthonyauthor=B.+Czarnyauthor=F.+Beauauthor=V.+Diveauthor=E.+D.+Sturrockauthor=K.+R.+Acharya&title=Novel+mechanism+of+inhibition+of+human+angiotensin-I-converting+enzyme+%28ACE%29+by+a+highly+specific+phosphinic+tripeptide&doi=10.1042%2FBJ20102123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide</span></div><div class="casAuthors">Akif, Mohd.; Schwager, Sylva L.; Anthony, Colin S.; Czarny, Bertrand; Beau, Fabrice; Dive, Vincent; Sturrock, Edward D.; Acharya, K. Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">436</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-59</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Human ACE (angiotensin-I-converting enzyme) has long been regarded as an excellent target for the treatment of hypertension and related cardiovascular diseases.  Highly potent inhibitors have been developed and are extensively used in the clinic.  To develop inhibitors with higher therapeutic efficacy and reduced side effects, recent efforts have been directed towards the discovery of compds. able to simultaneously block more than one zinc metallopeptidase (apart from ACE) involved in blood pressure regulation in humans, such as neprilysin and ECE-1 (endothelin-converting enzyme-1).  In the present paper, we show the first structures of testis ACE [C-ACE, which is identical with the C-domain of somatic ACE and the dominant domain responsible for blood pressure regulation, at 1.97Å (1 Å=0.1 nm)] and the N-domain of somatic ACE (N-ACE, at 2.15Å) in complex with a highly potent and selective dual ACE/ECE-1 inhibitor.  The structural determinants revealed unique features of the binding of two mols. of the dual inhibitor in the active site of C-ACE.  In both structures, the first mol. is positioned in the obligatory binding site and has a bulky bicyclic P1' residue with the unusual R configuration which, surprisingly, is accommodated by the large S2' pocket.  In the C-ACE complex, the isoxazole Ph group of the second mol. makes strong pi-pi stacking interactions with the amino benzoyl group of the first mol. locking them in a hand-shake' conformation.  These features, for the first time, highlight the unusual architecture and flexibility of the active site of C-ACE, which could be further utilized for structure-based design of new C-ACE or vasopeptidase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzDrSwHKC1kbVg90H21EOLACvtfcHk0lgW4z7bj_t1cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsFGntbo%253D&md5=9f596a4891cc2645c711efe630b2bc81</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1042%2FBJ20102123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20102123%26sid%3Dliteratum%253Aachs%26aulast%3DAkif%26aufirst%3DM.%26aulast%3DSchwager%26aufirst%3DS.%2BL.%26aulast%3DAnthony%26aufirst%3DC.%2BS.%26aulast%3DCzarny%26aufirst%3DB.%26aulast%3DBeau%26aufirst%3DF.%26aulast%3DDive%26aufirst%3DV.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26atitle%3DNovel%2520mechanism%2520of%2520inhibition%2520of%2520human%2520angiotensin-I-converting%2520enzyme%2520%2528ACE%2529%2520by%2520a%2520highly%2520specific%2520phosphinic%2520tripeptide%26jtitle%3DBiochem.%2520J.%26date%3D2011%26volume%3D436%26spage%3D53%26epage%3D59%26doi%3D10.1042%2FBJ20102123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masuyer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwager, S. L. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaac, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K. R.</span></span> <span> </span><span class="NLM_article-title">Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">717</span>, <span class="refDoi"> DOI: 10.1038/srep00717</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1038%2Fsrep00717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=23056909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1GksrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=717&author=G.+Masuyerauthor=S.+L.+U.+Schwagerauthor=E.+D.+Sturrockauthor=R.+E.+Isaacauthor=K.+R.+Acharya&title=Molecular+recognition+and+regulation+of+human+angiotensin-I+converting+enzyme+%28ACE%29+activity+by+natural+inhibitory+peptides&doi=10.1038%2Fsrep00717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides</span></div><div class="casAuthors">Masuyer, Geoffrey; Schwager, Sylva L. U.; Sturrock, Edward D.; Isaac, R. Elwyn; Acharya, K. Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">717/1-717/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Angiotensin-I converting enzyme (ACE), a two-domain dipeptidylcarboxypeptidase, is a key regulator of blood pressure as a result of its crit. role in the renin-angiotensin-aldosterone and kallikrein-kinin systems.  Hence it is an important drug target in the treatment of cardiovascular diseases.  ACE is primarily known for its ability to cleave angiotensin I (Ang I) to the vasoactive octapeptide angiotensin II (Ang II), but is also able to cleave a no. of other substrates including the vasodilator bradykinin and N-acetyl-Ser-Asp-Lys-Pro (Ac-SDKP), a physiol. modulator of hematopoiesis.  For the first time we provide a detailed biochem. and structural basis for the domain selectivity of the natural peptide inhibitors of ACE, bradykinin potentiating peptide b and Ang II.  Moreover, Ang II showed selective competitive inhibition of the carboxy-terminal domain of human somatic ACE providing evidence for a regulatory role in the human renin-angiotensin system (RAS).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV83_WWdRH57Vg90H21EOLACvtfcHk0lgW4z7bj_t1cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1GksrzF&md5=fbc1f0bafbe17a5f7fddb71ed18fe31d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fsrep00717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep00717%26sid%3Dliteratum%253Aachs%26aulast%3DMasuyer%26aufirst%3DG.%26aulast%3DSchwager%26aufirst%3DS.%2BL.%2BU.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26aulast%3DIsaac%26aufirst%3DR.%2BE.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26atitle%3DMolecular%2520recognition%2520and%2520regulation%2520of%2520human%2520angiotensin-I%2520converting%2520enzyme%2520%2528ACE%2529%2520activity%2520by%2520natural%2520inhibitory%2520peptides%26jtitle%3DSci.%2520Rep.%26date%3D2012%26volume%3D2%26spage%3D717%26doi%3D10.1038%2Fsrep00717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehlers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span> <span> </span><span class="NLM_article-title">Vasopeptidase inhibition - Solving the cardiovascular puzzle?</span>. <i>Drugs Future</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">33</span>, <span class="refDoi"> DOI: 10.1358/dof.2011.036.01.1537940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1358%2Fdof.2011.036.01.1537940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmslyku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=33&author=R.+Douglasauthor=M.+Ehlersauthor=E.+D.+Sturrock&title=Vasopeptidase+inhibition+-+Solving+the+cardiovascular+puzzle%3F&doi=10.1358%2Fdof.2011.036.01.1537940"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Vasopeptidase inhibition - solving the cardiovascular puzzle?</span></div><div class="casAuthors">Douglas, R. G.; Ehlers, M. R. W.; Sturrock, E. D.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-43</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  The therapeutic blockade of the renin-angiotensin-aldosterone system (RAAS) using angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers, aldosterone receptor antagonists and, more recently, renin inhibitors has been a mainstay for the treatment of hypertension, the main risk factor for cardiovascular disease.  Blood pressure and fluid homeostasis are regulated by the interconnected pathways of the RAAS, the endothelin system, the natriuretic peptide system and the kallikrein-kinin system.  The simultaneous modulation of several neurohumoral mediators has been an attractive approach that has received much attention.  The dual ACE/neutral endopeptidase (NEP) and triple ACE/NEP/endothelin-converting enzyme (ECE) inhibitors are the most celebrated vasopeptidase inhibitors, but their progress to the clinic has been stalled by kinin-mediated adverse effects.  NEP/ECE and ACE/ECE inhibitors and compds. targeting the angiotensin receptor and NEP are other attractive options that have been investigated.  In this review, we discuss the systems that regulate the concns. of vasoactive peptides, the current therapies and the mol. basis for the design and action of vasopeptidase inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrenr-odqPbGLVg90H21EOLACvtfcHk0lgW4z7bj_t1cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmslyku7o%253D&md5=026daed9c19adf0ffd94ea28651e2bfe</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1358%2Fdof.2011.036.01.1537940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2011.036.01.1537940%26sid%3Dliteratum%253Aachs%26aulast%3DDouglas%26aufirst%3DR.%26aulast%3DEhlers%26aufirst%3DM.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26atitle%3DVasopeptidase%2520inhibition%2520-%2520Solving%2520the%2520cardiovascular%2520puzzle%253F%26jtitle%3DDrugs%2520Future%26date%3D2011%26volume%3D36%26spage%3D33%26doi%3D10.1358%2Fdof.2011.036.01.1537940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watermeyer, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroger, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sewell, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span> <span> </span><span class="NLM_article-title">Probing the basis of domain-dependent inhibition using novel ketone inhibitors of Angiotensin-converting enzyme</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">5942</span>– <span class="NLM_lpage">5950</span>, <span class="refDoi"> DOI: 10.1021/bi8002605</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi8002605" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsVKltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=5942-5950&author=J.+M.+Watermeyerauthor=W.+L.+Krogerauthor=H.+G.+O%E2%80%99Neillauthor=B.+T.+Sewellauthor=E.+D.+Sturrock&title=Probing+the+basis+of+domain-dependent+inhibition+using+novel+ketone+inhibitors+of+Angiotensin-converting+enzyme&doi=10.1021%2Fbi8002605"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the basis of domain-dependent inhibition using novel ketone inhibitors of angiotensin-converting enzyme</span></div><div class="casAuthors">Watermeyer, Jean M.; Kroeger, Wendy L.; O'Neill, Hester G.; Sewell, B. Trevor; Sturrock, Edward D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5942-5950</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human angiotensin-converting enzyme (ACE) has two homologous domains, the N and C domains, with differing substrate preferences.  X-ray crystal structures of the C and N domains complexed with various inhibitors have allowed identification of active site residues that might be important for the mol. basis of this selectivity.  However, it is unclear to what extent the different residues contribute to substrate domain selectivity.  Here, cocrystal structures of human testis ACE, equiv. to the C domain, have been detd. with two novel C domain-selective ketomethylene inhibitors, (5S)-5-[(N-benzoyl)amino]-4-oxo-6-phenylhexanoyl-L-tryptophan (kAW) and (5S)-5-[(N-benzoyl)amino]-4-oxo-6-phenylhexanoyl-L-phenylalanine (kAF).  The ketone groups of both inhibitors bind to the zinc ion as a hydrated geminal diolate, demonstrating the ability of the active site to catalyze the formation of the transition state.  Moreover, active site residues involved in inhibitor binding have been mutated to their N domain counterparts, and the effect of the mutations on inhibitor binding has been detd.  The C domain selectivity of these inhibitors was found to result from interactions between bulky hydrophobic side chain moieties and C domain-specific residues F391, V518, E376, and V380 (numbering of testis ACE).  Mutation of these residues decreased the affinity for the inhibitors 4-20-fold.  T282, V379, E403, D453, and S516 did not contribute individually to C domain-selective inhibitor binding.  Further domain-selective inhibitor design should focus on increasing both the affinity and selectivity of the side chain moieties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpizYhFPo2WMbVg90H21EOLACvtfcHk0lgJpvTnoCcBdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsVKltrs%253D&md5=62f38e6cfa609f11d467cb39df05ac93</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fbi8002605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi8002605%26sid%3Dliteratum%253Aachs%26aulast%3DWatermeyer%26aufirst%3DJ.%2BM.%26aulast%3DKroger%26aufirst%3DW.%2BL.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DH.%2BG.%26aulast%3DSewell%26aufirst%3DB.%2BT.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26atitle%3DProbing%2520the%2520basis%2520of%2520domain-dependent%2520inhibition%2520using%2520novel%2520ketone%2520inhibitors%2520of%2520Angiotensin-converting%2520enzyme%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D5942%26epage%3D5950%26doi%3D10.1021%2Fbi8002605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watermeyer, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroger, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sewell, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span> <span> </span><span class="NLM_article-title">Characterization of domain-selective inhibitor binding in angiotensin-converting enzyme using a novel derivative of lisinopril</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>428</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1042/BJ20100056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1042%2FBJ20100056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=20233165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1Cmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=428&publication_year=2010&pages=67-74&author=J.+M.+Watermeyerauthor=W.+L.+Krogerauthor=H.+G.+O%E2%80%99Neillauthor=B.+T.+Sewellauthor=E.+D.+Sturrock&title=Characterization+of+domain-selective+inhibitor+binding+in+angiotensin-converting+enzyme+using+a+novel+derivative+of+lisinopril&doi=10.1042%2FBJ20100056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of domain-selective inhibitor binding in angiotensin-converting enzyme using a novel derivative of lisinopril</span></div><div class="casAuthors">Watermeyer, Jean M.; Kroeger, Wendy L.; O'Neill, Hester G.; Sewell, B. Trevor; Sturrock, Edward D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">428</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-74</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Human ACE (angiotensin-converting enzyme) (EC 3.4.15.1) is an important drug target because of its role in the regulation of blood pressure via the renin-angiotensin-aldosterone system.  Somatic ACE comprises two homologous domains, the differing substrate preferences of which present a new avenue for domain-selective inhibitor design.  LisW-S, a C-domain-selective deriv. of the drug lisinopril, was co-crystd. with human testis ACE and a crystal structure was detd. using X-ray crystallog. to a resoln. of 2.30 Å (1 Å=0.1 nm).  In this structure, lisW-S is seen to have a similar binding mode to its parent compd. lisinopril, but the P2' tryptophan moiety takes a different conformation to that seen in other inhibitors having a tryptophan residue in this position.  The domain-specific interactions of this inhibitor was examd. further by mutating C-domain-specific active-site residues to their N domain equiv., then assessing the effect of the mutation on inhibition by lisW-S using a fluorescence-based assay.  Kinetics anal. shows a 258-fold domain-selectivity that is largely due to the co-operative effect of C-domain-specific residues in the S2' subsite.  The high affinity and selectivity of this inhibitor make it a good lead candidate for cardiovascular drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV_1gE3mSs_LVg90H21EOLACvtfcHk0lgJpvTnoCcBdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1Cmtr8%253D&md5=1957d1bed6004296c886e8a8088c256c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1042%2FBJ20100056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20100056%26sid%3Dliteratum%253Aachs%26aulast%3DWatermeyer%26aufirst%3DJ.%2BM.%26aulast%3DKroger%26aufirst%3DW.%2BL.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DH.%2BG.%26aulast%3DSewell%26aufirst%3DB.%2BT.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26atitle%3DCharacterization%2520of%2520domain-selective%2520inhibitor%2520binding%2520in%2520angiotensin-converting%2520enzyme%2520using%2520a%2520novel%2520derivative%2520of%2520lisinopril%26jtitle%3DBiochem.%2520J.%26date%3D2010%26volume%3D428%26spage%3D67%26epage%3D74%26doi%3D10.1042%2FBJ20100056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kroger, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span> <span> </span><span class="NLM_article-title">Investigating the domain specificity of phosphinic inhibitors RXPA380 and RXP407 in angiotensin-converting enzyme</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">8405</span>– <span class="NLM_lpage">8412</span>, <span class="refDoi"> DOI: 10.1021/bi9011226</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi9011226" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=8405-8412&author=W.+L.+Krogerauthor=R.+G.+Douglasauthor=H.+G.+O%E2%80%99Neillauthor=V.+Diveauthor=E.+D.+Sturrock&title=Investigating+the+domain+specificity+of+phosphinic+inhibitors+RXPA380+and+RXP407+in+angiotensin-converting+enzyme&doi=10.1021%2Fbi9011226"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fbi9011226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi9011226%26sid%3Dliteratum%253Aachs%26aulast%3DKroger%26aufirst%3DW.%2BL.%26aulast%3DDouglas%26aufirst%3DR.%2BG.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DH.%2BG.%26aulast%3DDive%26aufirst%3DV.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26atitle%3DInvestigating%2520the%2520domain%2520specificity%2520of%2520phosphinic%2520inhibitors%2520RXPA380%2520and%2520RXP407%2520in%2520angiotensin-converting%2520enzyme%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D8405%26epage%3D8412%26doi%3D10.1021%2Fbi9011226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fienberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozier, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span> <span> </span><span class="NLM_article-title">The design and development of a potent and selective novel diprolyl derivative that binds to the N-domain of angiotensin-I converting enzyme</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">344</span>– <span class="NLM_lpage">359</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01478</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01478" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=344-359&author=S.+Fienbergauthor=G.+E.+Cozierauthor=K.+R.+Acharyaauthor=K.+Chibaleauthor=E.+D.+Sturrock&title=The+design+and+development+of+a+potent+and+selective+novel+diprolyl+derivative+that+binds+to+the+N-domain+of+angiotensin-I+converting+enzyme&doi=10.1021%2Facs.jmedchem.7b01478"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01478%26sid%3Dliteratum%253Aachs%26aulast%3DFienberg%26aufirst%3DS.%26aulast%3DCozier%26aufirst%3DG.%2BE.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26aulast%3DChibale%26aufirst%3DK.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26atitle%3DThe%2520design%2520and%2520development%2520of%2520a%2520potent%2520and%2520selective%2520novel%2520diprolyl%2520derivative%2520that%2520binds%2520to%2520the%2520N-domain%2520of%2520angiotensin-I%2520converting%2520enzyme%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D344%26epage%3D359%26doi%3D10.1021%2Facs.jmedchem.7b01478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazin, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dack, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeves, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringer, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strang, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, C. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of heteroarylalanine diacids as potent and selective neutral endopeptidase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3404</span>– <span class="NLM_lpage">3406</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.03.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1016%2Fj.bmcl.2011.03.109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=21515054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsVOgurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3404-3406&author=M.+S.+Glossopauthor=R.+J.+Bazinauthor=K.+N.+Dackauthor=D.+N.+Foxauthor=G.+A.+MacDonaldauthor=M.+Millsauthor=D.+R.+Owenauthor=C.+Phillipsauthor=K.+A.+Reevesauthor=T.+J.+Ringerauthor=R.+S.+Strangauthor=C.+A.+Watson&title=Synthesis+and+evaluation+of+heteroarylalanine+diacids+as+potent+and+selective+neutral+endopeptidase+inhibitors&doi=10.1016%2Fj.bmcl.2011.03.109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of heteroarylalanine diacids as potent and selective neutral endopeptidase inhibitors</span></div><div class="casAuthors">Glossop, Melanie S.; Bazin, Richard J.; Dack, Kevin N.; Fox, David N. A.; MacDonald, Graeme A.; Mills, Mark; Owen, Dafydd R.; Phillips, Chris; Reeves, Keith A.; Ringer, Tracy J.; Strang, Ross S.; Watson, Christine A. L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3404-3406</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Heteroarylalanine derivs. 4 were designed as potential inhibitors of neutral endopeptidase (NEP EC 3.4.24.11).  Selectivity over other zinc metalloproteinases was explored through occupation of the S2' subsite within NEP.  Structural optimization led to the identification of 5-Ph oxazole (I), a potent and selective NEP inhibitor.  A crystal structure of the inhibitor bound complex is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG2Cx7Omr7KrVg90H21EOLACvtfcHk0lg-p2hV-ZjPCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsVOgurY%253D&md5=afebcffffd6a63edbb1278696dbdc7e1</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.03.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.03.109%26sid%3Dliteratum%253Aachs%26aulast%3DGlossop%26aufirst%3DM.%2BS.%26aulast%3DBazin%26aufirst%3DR.%2BJ.%26aulast%3DDack%26aufirst%3DK.%2BN.%26aulast%3DFox%26aufirst%3DD.%2BN.%26aulast%3DMacDonald%26aufirst%3DG.%2BA.%26aulast%3DMills%26aufirst%3DM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DPhillips%26aufirst%3DC.%26aulast%3DReeves%26aufirst%3DK.%2BA.%26aulast%3DRinger%26aufirst%3DT.%2BJ.%26aulast%3DStrang%26aufirst%3DR.%2BS.%26aulast%3DWatson%26aufirst%3DC.%2BA.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520heteroarylalanine%2520diacids%2520as%2520potent%2520and%2520selective%2520neutral%2520endopeptidase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3404%26epage%3D3406%26doi%3D10.1016%2Fj.bmcl.2011.03.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oefner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, G. E.</span></span> <span> </span><span class="NLM_article-title">Structure of human neutral endopeptidase (Neprilysin) complexed with phosphoramidon</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>296</i></span>,  <span class="NLM_fpage">341</span>– <span class="NLM_lpage">349</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1999.3492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1006%2Fjmbi.1999.3492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10669592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD3cXps1GqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2000&pages=341-349&author=C.+Oefnerauthor=A.+D%E2%80%99Arcyauthor=M.+Hennigauthor=F.+K.+Winklerauthor=G.+E.+Dale&title=Structure+of+human+neutral+endopeptidase+%28Neprilysin%29+complexed+with+phosphoramidon&doi=10.1006%2Fjmbi.1999.3492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human neutral endopeptidase (neprilysin) complexed with phosphoramidon</span></div><div class="casAuthors">Oefner, Christian; D'Arcy, Allan; Hennig, Michael; Winkler, Fritz K.; Dale, Glenn E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">341-349</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Neprilysin (EC 3.4.24.11; neutral endopeptidase) (I) is a mammalian type II integral membrane Zn-contg. endopeptidase, which degrades and inactivates a no. of bioactive peptides.  The range of substrates cleaved by I in vitro includes the enkephalins, substance P, endothelin, bradykinin, and atrial natriuretic factor.  Due to the physiol. importance of I in the modulation of nociceptive and pressor responses there is considerable interest in inhibitors of this enzyme as novel analgesics and anti-hypertensive agents.  Here, the authors describe the crystal structure of the extracellular domain (residues 52-749) of human I complexed with the generic metalloproteinase inhibitor, phosphoramidon (II), at 2.1 Å resoln.  The structure revealed 2 multiply connected folding domains which embraced a large central cavity contg. the active site.  II was bound to one side of this cavity and its binding mode provided a detailed understanding of the ligand-binding and specificity determinants.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCc0rfNE03ULVg90H21EOLACvtfcHk0lg-p2hV-ZjPCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXps1GqsA%253D%253D&md5=82d113a6b2e0349fd738bd62e6e59f9a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1999.3492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1999.3492%26sid%3Dliteratum%253Aachs%26aulast%3DOefner%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DA.%26aulast%3DHennig%26aufirst%3DM.%26aulast%3DWinkler%26aufirst%3DF.%2BK.%26aulast%3DDale%26aufirst%3DG.%2BE.%26atitle%3DStructure%2520of%2520human%2520neutral%2520endopeptidase%2520%2528Neprilysin%2529%2520complexed%2520with%2520phosphoramidon%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2000%26volume%3D296%26spage%3D341%26epage%3D349%26doi%3D10.1006%2Fjmbi.1999.3492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oefner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, G. E.</span></span> <span> </span><span class="NLM_article-title">Structural studies of a bifunctional inhibitor of neprilysin and DPP-IV</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">975</span>– <span class="NLM_lpage">981</span>, <span class="refDoi"> DOI: 10.1107/S0907444907036281</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1107%2FS0907444907036281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=17704566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1aks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2007&pages=975-981&author=C.+Oefnerauthor=S.+Pierauauthor=H.+Schulzauthor=G.+E.+Dale&title=Structural+studies+of+a+bifunctional+inhibitor+of+neprilysin+and+DPP-IV&doi=10.1107%2FS0907444907036281"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Structural studies of a bifunctional inhibitor of neprilysin and DPP-IV</span></div><div class="casAuthors">Oefner, Christian; Pierau, Sabine; Schulz, Henk; Dale, Glenn E.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">975-981</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Neutral endopeptidase (NEP) is the major enzyme involved in the metabolic inactivation of a no. of bioactive peptides including the enkephalins, substance P, endothelin, bradykinin and atrial natriuretic factor, as well as the incretin hormone glucagon-like peptide 1 (GLP-1), which is a potent stimulator of insulin secretion.  The activity of GLP-1 is also rapidly abolished by the serine protease dipeptidyl peptidase IV (DPP-IV), which led to an elevated interest in inhibitors of this enzyme for the treatment of type II diabetes.  A dual NEP/DPP-IV inhibitor concept is proposed, offering an alternative strategy for the treatment of type 2 diabetes.  Here, the synthesis and crystal structures of the sol. extracellular domain of human NEP (residues 52-749) complexed with the NEP, competitive and potent dual NEP/DPP-IV inhibitor MCB3937 are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqq5V_VbcNwrVg90H21EOLACvtfcHk0liEy25-55L5zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1aks7o%253D&md5=6fa2f31ff0e25cc4d6cbb91bf59b6109</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1107%2FS0907444907036281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444907036281%26sid%3Dliteratum%253Aachs%26aulast%3DOefner%26aufirst%3DC.%26aulast%3DPierau%26aufirst%3DS.%26aulast%3DSchulz%26aufirst%3DH.%26aulast%3DDale%26aufirst%3DG.%2BE.%26atitle%3DStructural%2520studies%2520of%2520a%2520bifunctional%2520inhibitor%2520of%2520neprilysin%2520and%2520DPP-IV%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2007%26volume%3D63%26spage%3D975%26epage%3D981%26doi%3D10.1107%2FS0907444907036281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oefner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roques, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournie-Zaluski, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, G. E.</span></span> <span> </span><span class="NLM_article-title">Structural analysis of neprilysin with various specific and potent inhibitors</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1107/S0907444903027410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1107%2FS0907444903027410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=14747736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD2cXms1Gjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=392-396&author=C.+Oefnerauthor=B.+P.+Roquesauthor=M.+C.+Fournie-Zaluskiauthor=G.+E.+Dale&title=Structural+analysis+of+neprilysin+with+various+specific+and+potent+inhibitors&doi=10.1107%2FS0907444903027410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Structural analysis of neprilysin with various specific and potent inhibitors</span></div><div class="casAuthors">Oefner, Christian; Roques, Bernard P.; Fournie-Zaluski, Marie Claude; Dale, Glenn E.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">392-396</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Neutral endopeptidase (NEP) is the major enzyme involved in the metabolic inactivation of a no. of bioactive peptides including the enkephalins, substance P, endothelin, bradykinin, and atrial natriuretic factor.  Owing to the physiol. importance of NEP in the modulation of nociceptive and pressor responses, there is considerable interest in inhibitors of this enzyme as novel analgesics and antihypertensive agents.  Here, the crystal structures of the sol. extracellular domain of human NEP (residues 52-749) complexed with various potent and competitive inhibitors are described.  The structures unambiguously reveal the binding mode of the different zinc-chelating groups and the subsite specificity of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_5u7pq3mc2bVg90H21EOLACvtfcHk0liEy25-55L5zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXms1Gjuw%253D%253D&md5=e4a4aaaa854fedd851d83fa3615e8e53</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1107%2FS0907444903027410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444903027410%26sid%3Dliteratum%253Aachs%26aulast%3DOefner%26aufirst%3DC.%26aulast%3DRoques%26aufirst%3DB.%2BP.%26aulast%3DFournie-Zaluski%26aufirst%3DM.%2BC.%26aulast%3DDale%26aufirst%3DG.%2BE.%26atitle%3DStructural%2520analysis%2520of%2520neprilysin%2520with%2520various%2520specific%2520and%2520potent%2520inhibitors%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D392%26epage%3D396%26doi%3D10.1107%2FS0907444903027410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sahli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum-Kaelin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aebi, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böhm, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oefner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, G. E.</span></span> <span> </span><span class="NLM_article-title">Second-generation inhibitors for the metalloprotease neprilysin based on bicyclic heteroaromatic scaffolds: Synthesis, biological activity, and X-ray crystal-structure analysis</span>. <i>Helv. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">731</span>– <span class="NLM_lpage">750</span>, <span class="refDoi"> DOI: 10.1002/hlca.200590051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1002%2Fhlca.200590051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFSmsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2005&pages=731-750&author=S.+Sahliauthor=B.+Frankauthor=W.+B.+Schweizerauthor=F.+Diederichauthor=D.+Blum-Kaelinauthor=J.+D.+Aebiauthor=H.+B%C3%B6hmauthor=C.+Oefnerauthor=G.+E.+Dale&title=Second-generation+inhibitors+for+the+metalloprotease+neprilysin+based+on+bicyclic+heteroaromatic+scaffolds%3A+Synthesis%2C+biological+activity%2C+and+X-ray+crystal-structure+analysis&doi=10.1002%2Fhlca.200590051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Second-generation inhibitors for the metalloprotease neprilysin based on bicyclic heteroaromatic scaffolds: Synthesis, biological activity, and X-ray crystal-structure analysis</span></div><div class="casAuthors">Sahli, Stefan; Frank, Brian; Schweizer, W. Bernd; Diederich, Francois; Blum-Kaelin, Denise; Aebi, Johannes D.; Boehm, Hans-Joachim; Oefner, Christian; Dale, Glenn E.</div><div class="citationInfo"><span class="NLM_cas:title">Helvetica Chimica Acta</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">731-750</span>CODEN:
                <span class="NLM_cas:coden">HCACAV</span>;
        ISSN:<span class="NLM_cas:issn">0018-019X</span>.
    
            (<span class="NLM_cas:orgname">Verlag Helvetica Chimica Acta</span>)
        </div><div class="casAbstract">A new class of nonpeptidic inhibitors of the ZnII-dependent metalloprotease neprilysin with IC50 values in the nanomolar activity range (0.034-0.30 μM) were developed based on structure-based de novo design.  The inhibitors I (X = CH, N; R1 = H, Me; R2 = H, Ph; R3 = H, PhCH2) feature benzimidazole or imidazo[4,5-c]pyridine moieties as central scaffolds to undergo H-bonding to Asn542 and Arg717 and to engage in favorable π-π stacking interactions with the imidazole ring of His711.  The platform is decorated with a thiol vector to coordinate to the ZnII ion and an aryl residue to occupy the hydrophobic S1' pocket, but lack a substituent for binding in the S2' pocket, which remains closed by the side chains of Phe106 and Arg110 when not occupied.  The enantioselective syntheses of optically active I (X = CH, N; R1 = R3 = H; R2 = H, Ph) were accomplished using Evans auxiliaries.  The inhibitors with an imidazo[4,5-c]pyridine core are ca. 8 times more active than those with a benzimidazole core.  The predicted binding mode was established by X-ray anal. of the complex of neprilysin with (+)-I (X = N; R1 = R2 = R3 = H) at 2.25-Å resoln.  The ligand coordinates with its sulfanyl residue to the ZnII ion, and the benzyl residue occupies the S1' pocket.  The 1H-imidazole moiety of the central scaffold forms the required H-bonds to the side chains of Asn542 and Arg717.  The heterobicyclic platform addnl. undergoes π-π stacking with the side chain of His711 as well as edge-to-face-type interactions with the side chain of Trp693.  According to the X-ray anal., the substantial advantage in biol. activity of the imidazopyridine inhibitors over the benzimidazole ligands arises from favorable interactions of the pyridine N-atom in the former with the side chain of Arg102.  Unexpectedly, replacement of the Ph group pointing into the deep S1' pocket by a biphenyl group does not enhance the binding affinity for this class of inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTE2Tw27MeUrVg90H21EOLACvtfcHk0liEy25-55L5zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFSmsrc%253D&md5=7c0b5c22602e76531023fffce5b0d3fe</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fhlca.200590051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhlca.200590051%26sid%3Dliteratum%253Aachs%26aulast%3DSahli%26aufirst%3DS.%26aulast%3DFrank%26aufirst%3DB.%26aulast%3DSchweizer%26aufirst%3DW.%2BB.%26aulast%3DDiederich%26aufirst%3DF.%26aulast%3DBlum-Kaelin%26aufirst%3DD.%26aulast%3DAebi%26aufirst%3DJ.%2BD.%26aulast%3DB%25C3%25B6hm%26aufirst%3DH.%26aulast%3DOefner%26aufirst%3DC.%26aulast%3DDale%26aufirst%3DG.%2BE.%26atitle%3DSecond-generation%2520inhibitors%2520for%2520the%2520metalloprotease%2520neprilysin%2520based%2520on%2520bicyclic%2520heteroaromatic%2520scaffolds%253A%2520Synthesis%252C%2520biological%2520activity%252C%2520and%2520X-ray%2520crystal-structure%2520analysis%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D2005%26volume%3D88%26spage%3D731%26epage%3D750%26doi%3D10.1002%2Fhlca.200590051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dimitropoulos, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papakyriakou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalkas, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spyroulias, G. A.</span></span> <span> </span><span class="NLM_article-title">A computational approach to the study of the binding mode of dual ACE/NEP inhibitors</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">388</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1021/ci9005047</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci9005047" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFyhsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=388-396&author=N.+Dimitropoulosauthor=A.+Papakyriakouauthor=G.+A.+Dalkasauthor=E.+D.+Sturrockauthor=G.+A.+Spyroulias&title=A+computational+approach+to+the+study+of+the+binding+mode+of+dual+ACE%2FNEP+inhibitors&doi=10.1021%2Fci9005047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A Computational Approach to the Study of the Binding Mode of Dual ACE/NEP Inhibitors</span></div><div class="casAuthors">Dimitropoulos, Nikolaos; Papakyriakou, Athanasios; Dalkas, Georgios A.; Sturrock, Edward D.; Spyroulias, Georgios A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">388-396</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Combined blockade of the renin-angiotensin-aldosterone system (RAAS) is an attractive therapeutic strategy for the treatment of cardiovascular diseases.  Vasopeptidase inhibitors are a group of compds. capable of inhibiting more than one enzyme, which leads to potentiation of natriuretic peptide actions and suppression of the RAAS.  In this study, mol. modeling has been used to elucidate key structural features that govern the binding and/or selectivity of a single compd. toward the zinc catalytic sites of the N- and C-domains of the angiotensin-converting enzyme (ACE) and the neutral endopeptidase (NEP).  Eleven dual inhibitors were categorized in three classes, according to their zinc binding groups.  Anal. of their docked conformers revealed the mol. environment of the catalytic sites and the specific interactions between the inhibitors and amino acid residues that are important for selectivity and cooperativity.  In addn., inhibitors were predicted to bind to the C-domain of the ACE with greater affinity than the N-domain, with an av. difference in the free energy of binding ∼2-3 kcal mol-1.  Residues that were identified to actively participate in the binding and stabilizing of the enzyme-inhibitor complexes were analyzed in a consensus way for both the ACE and the NEP.  These at.-level insights into enzyme-ligand binding can be used to drive new structure-based drug design processes in the quest for more selective and effective vasopeptidase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlmtVNKnY-CbVg90H21EOLACvtfcHk0lirPXrXZlb3mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFyhsLg%253D&md5=b88dadb9dc6da855a31264c038e51212</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fci9005047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci9005047%26sid%3Dliteratum%253Aachs%26aulast%3DDimitropoulos%26aufirst%3DN.%26aulast%3DPapakyriakou%26aufirst%3DA.%26aulast%3DDalkas%26aufirst%3DG.%2BA.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26aulast%3DSpyroulias%26aufirst%3DG.%2BA.%26atitle%3DA%2520computational%2520approach%2520to%2520the%2520study%2520of%2520the%2520binding%2520mode%2520of%2520dual%2520ACE%252FNEP%2520inhibitors%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D388%26epage%3D396%26doi%3D10.1021%2Fci9005047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corradi, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwager, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redelinghuys, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiadis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span> <span> </span><span class="NLM_article-title">The N domain of human angiotensin-I-converting enzyme: the role of N-glycosylation and the crystal structure in complex with an N domain-specific phosphinic inhibitor, RXP407</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">35685</span>– <span class="NLM_lpage">35693</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.167866</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1074%2Fjbc.M110.167866" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=35685-35693&author=C.+S.+Anthonyauthor=H.+R.+Corradiauthor=S.+L.+Schwagerauthor=P.+Redelinghuysauthor=D.+Georgiadisauthor=V.+Diveauthor=K.+R.+Acharyaauthor=E.+D.+Sturrock&title=The+N+domain+of+human+angiotensin-I-converting+enzyme%3A+the+role+of+N-glycosylation+and+the+crystal+structure+in+complex+with+an+N+domain-specific+phosphinic+inhibitor%2C+RXP407&doi=10.1074%2Fjbc.M110.167866"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.167866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.167866%26sid%3Dliteratum%253Aachs%26aulast%3DAnthony%26aufirst%3DC.%2BS.%26aulast%3DCorradi%26aufirst%3DH.%2BR.%26aulast%3DSchwager%26aufirst%3DS.%2BL.%26aulast%3DRedelinghuys%26aufirst%3DP.%26aulast%3DGeorgiadis%26aufirst%3DD.%26aulast%3DDive%26aufirst%3DV.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26atitle%3DThe%2520N%2520domain%2520of%2520human%2520angiotensin-I-converting%2520enzyme%253A%2520the%2520role%2520of%2520N-glycosylation%2520and%2520the%2520crystal%2520structure%2520in%2520complex%2520with%2520an%2520N%2520domain-specific%2520phosphinic%2520inhibitor%252C%2520RXP407%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D35685%26epage%3D35693%26doi%3D10.1074%2Fjbc.M110.167866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redelinghuys, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwager, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehlers, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papageorgiou, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natesh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span> <span> </span><span class="NLM_article-title">Deglycosylation, processing and crystallization of human testis angiotensin-converting enzyme</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>371</i></span>,  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">442</span>, <span class="refDoi"> DOI: 10.1042/bj20021842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1042%2Fbj20021842" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=437-442&author=K.+Gordonauthor=P.+Redelinghuysauthor=S.+L.+Schwagerauthor=M.+R.+Ehlersauthor=A.+C.+Papageorgiouauthor=R.+Nateshauthor=K.+R.+Acharyaauthor=E.+D.+Sturrock&title=Deglycosylation%2C+processing+and+crystallization+of+human+testis+angiotensin-converting+enzyme&doi=10.1042%2Fbj20021842"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1042%2Fbj20021842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021842%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DK.%26aulast%3DRedelinghuys%26aufirst%3DP.%26aulast%3DSchwager%26aufirst%3DS.%2BL.%26aulast%3DEhlers%26aufirst%3DM.%2BR.%26aulast%3DPapageorgiou%26aufirst%3DA.%2BC.%26aulast%3DNatesh%26aufirst%3DR.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26atitle%3DDeglycosylation%252C%2520processing%2520and%2520crystallization%2520of%2520human%2520testis%2520angiotensin-converting%2520enzyme%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26spage%3D437%26epage%3D442%26doi%3D10.1042%2Fbj20021842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waterman, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gildea, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkhurst, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brewster, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauter, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, G.</span></span> <span> </span><span class="NLM_article-title">Diffraction-geometry refinement in the DIALS framework</span>. <i>Acta Crystallogr. D Struct Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">558</span>– <span class="NLM_lpage">575</span>, <span class="refDoi"> DOI: 10.1107/S2059798316002187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1107%2FS2059798316002187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=27050135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsFSkurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2016&pages=558-575&author=D.+G.+Watermanauthor=G.+Winterauthor=R.+J.+Gildeaauthor=J.+M.+Parkhurstauthor=A.+S.+Brewsterauthor=N.+K.+Sauterauthor=G.+Evans&title=Diffraction-geometry+refinement+in+the+DIALS+framework&doi=10.1107%2FS2059798316002187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Diffraction-geometry refinement in the DIALS framework</span></div><div class="casAuthors">Waterman, David G.; Winter, Graeme; Gildea, Richard J.; Parkhurst, James M.; Brewster, Aaron S.; Sauter, Nicholas K.; Evans, Gwyndaf</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Structural Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">558-575</span>CODEN:
                <span class="NLM_cas:coden">ACSDAD</span>;
        ISSN:<span class="NLM_cas:issn">2059-7983</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Rapid data collection and modern computing resources provide the opportunity to revisit the task of optimizing the model of diffraction geometry prior to integration.  A comprehensive description is given of new software that builds upon established methods by performing a single global refinement procedure, utilizing a smoothly varying model of the crystal lattice where appropriate.  This global refinement technique extends to multiple data sets, providing useful constraints to handle the problem of correlated parameters, particularly for small wedges of data.  Examples of advanced uses of the software are given and the design is explained in detail, with particular emphasis on the flexibility and extensibility it entails.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowmCZHkbbl6bVg90H21EOLACvtfcHk0lirPXrXZlb3mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsFSkurs%253D&md5=0041260941cd2e0581c8a1db0b5add97</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS2059798316002187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2059798316002187%26sid%3Dliteratum%253Aachs%26aulast%3DWaterman%26aufirst%3DD.%2BG.%26aulast%3DWinter%26aufirst%3DG.%26aulast%3DGildea%26aufirst%3DR.%2BJ.%26aulast%3DParkhurst%26aufirst%3DJ.%2BM.%26aulast%3DBrewster%26aufirst%3DA.%2BS.%26aulast%3DSauter%26aufirst%3DN.%2BK.%26aulast%3DEvans%26aufirst%3DG.%26atitle%3DDiffraction-geometry%2520refinement%2520in%2520the%2520DIALS%2520framework%26jtitle%3DActa%2520Crystallogr.%2520D%2520Struct%2520Biol.%26date%3D2016%26volume%3D72%26spage%3D558%26epage%3D575%26doi%3D10.1107%2FS2059798316002187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span> <span> </span><span class="NLM_article-title">How good are my data and what is the resolution?</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1204</span>– <span class="NLM_lpage">1214</span>, <span class="refDoi"> DOI: 10.1107/S0907444913000061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1107%2FS0907444913000061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=23793146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVejsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1204-1214&author=P.+R.+Evansauthor=G.+N.+Murshudov&title=How+good+are+my+data+and+what+is+the+resolution%3F&doi=10.1107%2FS0907444913000061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">How good are my data and what is the resolution?</span></div><div class="casAuthors">Evans, Philip R.; Murshudov, Garib N.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1204-1214</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Following integration of the obsd. diffraction spots, the process of  data redn.' initially aims to det. the point-group symmetry of the data and the likely space group.  This can be performed with the program POINTLESS.  The scaling program then puts all the measurements on a common scale, avs. measurements of symmetry-related reflections (using the symmetry detd. previously) and produces many statistics that provide the first important measures of data quality.  A new scaling program, AIMLESS, implements scaling models similar to those in SCALA but adds some addnl. analyses.  From the analyses, a no. of decisions can be made about the quality of the data and whether some measurements should be discarded.  The effective  resoln.' of a data set is a difficult and possibly contentious question (particularly with referees of papers) and this is discussed in the light of tests comparing the data-processing statistics with trials of refinement against obsd. and simulated data, and automated model-building and comparison of maps calcd. with different resoln. limits.  These trials show that adding weak high-resoln. data beyond the commonly used limits may make some improvement and does no harm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreOyPAR8GLBrVg90H21EOLACvtfcHk0lirPXrXZlb3mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVejsL8%253D&md5=3f649426c21e9d423f94ef8d7c568233</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS0907444913000061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444913000061%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26atitle%3DHow%2520good%2520are%2520my%2520data%2520and%2520what%2520is%2520the%2520resolution%253F%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26spage%3D1204%26epage%3D1214%26doi%3D10.1107%2FS0907444913000061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Collaborative
Computational Project, Number 4</span> <span> </span><span class="NLM_article-title">The CCP4 suite: programs for protein crystallography</span>. <i>Acta Crystallogr. D, Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">760</span>– <span class="NLM_lpage">763</span>, <span class="refDoi"> DOI: 10.1107/S0907444994003112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1107%2FS0907444994003112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=15299374" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=760-763&author=Collaborative%0AComputational+Project%2C+Number+4&title=The+CCP4+suite%3A+programs+for+protein+crystallography&doi=10.1107%2FS0907444994003112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1107%2FS0907444994003112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444994003112%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DThe%2520CCP4%2520suite%253A%2520programs%2520for%2520protein%2520crystallography%26jtitle%3DActa%2520Crystallogr.%2520D%252C%2520Biol.%2520Crystallogr.%26date%3D1994%26volume%3D50%26spage%3D760%26epage%3D763%26doi%3D10.1107%2FS0907444994003112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0ljikx0Fv5psOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E. J.</span></span> <span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1107/S0907444996012255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=15299926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method&doi=10.1107%2FS0907444996012255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0ljikx0Fv5psOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26spage%3D240%26epage%3D255%26doi%3D10.1107%2FS0907444996012255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkoczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeffner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span> <span> </span><span class="NLM_article-title">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.+W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+Python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0ljikx0Fv5psOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.%2BW.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2126</span>– <span class="NLM_lpage">2132</span>, <span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lg0l35vMfm-qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendall, W. B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keedy, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Immormino, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span> <span> </span><span class="NLM_article-title">MolProbity: all-atom structure validation for macromolecular crystallography</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">12</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1107/S0907444909042073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1107%2FS0907444909042073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=20057044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Kktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=12-21&author=V.+B.+Chenauthor=W.+B.+Arendallauthor=J.+J.+Headdauthor=D.+A.+Keedyauthor=R.+M.+Immorminoauthor=G.+J.+Kapralauthor=L.+W.+Murrayauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=MolProbity%3A+all-atom+structure+validation+for+macromolecular+crystallography&doi=10.1107%2FS0907444909042073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">MolProbity: all-atom structure validation for macromolecular crystallography</span></div><div class="casAuthors">Chen, Vincent B.; Arendall, W. Bryan, III; Headd, Jeffrey J.; Keedy, Daniel A.; Immormino, Robert M.; Kapral, Gary J.; Murray, Laura W.; Richardson, Jane S.; Richardson, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-21</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">MolProbity is a structure-validation web service that provides broad-spectrum solidly based evaluation of model quality at both the global and local levels for both proteins and nucleic acids.  It relies heavily on the power and sensitivity provided by optimized hydrogen placement and all-atom contact anal., complemented by updated versions of covalent-geometry and torsion-angle criteria.  Some of the local corrections can be performed automatically in MolProbity and all of the diagnostics are presented in chart and graphical forms that help guide manual rebuilding.  X-ray crystallog. provides a wealth of biol. important mol. data in the form of at. three-dimensional structures of proteins, nucleic acids and increasingly large complexes in multiple forms and states.  Advances in automation, in everything from crystn. to data collection to phasing to model building to refinement, have made solving a structure using crystallog. easier than ever.  However, despite these improvements, local errors that can affect biol. interpretation are widespread at low resoln. and even high-resoln. structures nearly all contain at least a few local errors such as Ramachandran outliers, flipped branched protein side chains and incorrect sugar puckers.  It is crit. both for the crystallographer and for the end user that there are easy and reliable methods to diagnose and correct these sorts of errors in structures.  MolProbity is the authors' contribution to helping solve this problem and this article reviews its general capabilities, reports on recent enhancements and usage, and presents evidence that the resulting improvements are now beneficially affecting the global database.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIjgsh59dO-7Vg90H21EOLACvtfcHk0lg0l35vMfm-qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Kktg%253D%253D&md5=b5fc7574f43f01dd6e43c3663ca4f779</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1107%2FS0907444909042073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909042073%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DArendall%26aufirst%3DW.%2BB.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DKeedy%26aufirst%3DD.%2BA.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DMurray%26aufirst%3DL.%2BW.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DMolProbity%253A%2520all-atom%2520structure%2520validation%2520for%2520macromolecular%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D12%26epage%3D21%26doi%3D10.1107%2FS0907444909042073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McNicholas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potterton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noble, M. E.</span></span> <span> </span><span class="NLM_article-title">Presenting your structures: the CCP4mg molecular-graphics software</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">386</span>– <span class="NLM_lpage">394</span>, <span class="refDoi"> DOI: 10.1107/S0907444911007281</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1107%2FS0907444911007281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=21460457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=386-394&author=S.+McNicholasauthor=E.+Pottertonauthor=K.+S.+Wilsonauthor=M.+E.+Noble&title=Presenting+your+structures%3A+the+CCP4mg+molecular-graphics+software&doi=10.1107%2FS0907444911007281"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Presenting your structures: The CCP4mg molecular-graphics software</span></div><div class="casAuthors">McNicholas, S.; Potterton, E.; Wilson, K. S.; Noble, M. E. M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">386-394</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">CCP4mg is a mol.-graphics program that is designed to give rapid access to both straightforward and complex static and dynamic representations of macromol. structures.  It has recently been updated with a new interface that provides more sophisticated atom-selection options and a wizard to facilitate the generation of complex scenes.  These scenes may contain a mixt. of coordinate-derived and abstr. graphical objects, including text objects, arbitrary vectors, geometric objects and imported images, which can enhance a picture and eliminate the need for subsequent editing.  Scene descriptions can be saved to file and transferred to other mols.  Here, the substantially enhanced version 2 of the program, with a new underlying GUI toolkit, is described.  A built-in rendering module produces publication-quality images.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdtflrxrILlbVg90H21EOLACvtfcHk0lg0l35vMfm-qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqurw%253D&md5=d96403a39bc723a66f11a730f81f76c3</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1107%2FS0907444911007281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911007281%26sid%3Dliteratum%253Aachs%26aulast%3DMcNicholas%26aufirst%3DS.%26aulast%3DPotterton%26aufirst%3DE.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26aulast%3DNoble%26aufirst%3DM.%2BE.%26atitle%3DPresenting%2520your%2520structures%253A%2520the%2520CCP4mg%2520molecular-graphics%2520software%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D386%26epage%3D394%26doi%3D10.1107%2FS0907444911007281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span> <i>The PyMOL Molecular
Graphics System</i>, <span class="NLM_edition">version
2.0</span>; <span class="NLM_publisher-name">Schrodinger, LLC</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+The+PyMOL+Molecular%0AGraphics+System%2C+version%0A2.0%3B+Schrodinger%2C+LLC%2C+2018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520PyMOL%2520Molecular%250AGraphics%2520System%26pub%3DSchrodinger%252C%2520LLC%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laskowski, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swindells, M. B.</span></span> <span> </span><span class="NLM_article-title">LigPlot+: multiple ligand-protein interaction diagrams for drug discovery</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2778</span>– <span class="NLM_lpage">2786</span>, <span class="refDoi"> DOI: 10.1021/ci200227u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci200227u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1KjtrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=2778-2786&author=R.+A.+Laskowskiauthor=M.+B.+Swindells&title=LigPlot%2B%3A+multiple+ligand-protein+interaction+diagrams+for+drug+discovery&doi=10.1021%2Fci200227u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery</span></div><div class="casAuthors">Laskowski, Roman A.; Swindells, Mark B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2778-2786</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe a graphical system for automatically generating multiple 2D diagrams of ligand-protein interactions from 3D coordinates.  The diagrams portray the hydrogen-bond interaction patterns and hydrophobic contacts between the ligand(s) and the main-chain or side-chain elements of the protein.  The system is able to plot, in the same orientation, related sets of ligand-protein interactions.  This facilitates popular research tasks, such as analyzing a series of small mols. binding to the same protein target, a single ligand binding to homologous proteins, or the completely general case where both protein and ligand change.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYuWvYH7Nel7Vg90H21EOLACvtfcHk0lgiJUglFl-PMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1KjtrzP&md5=576e59ad4f0c4304d01c6c80301ecf39</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fci200227u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200227u%26sid%3Dliteratum%253Aachs%26aulast%3DLaskowski%26aufirst%3DR.%2BA.%26aulast%3DSwindells%26aufirst%3DM.%2BB.%26atitle%3DLigPlot%252B%253A%2520multiple%2520ligand-protein%2520interaction%2520diagrams%2520for%2520drug%2520discovery%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26spage%3D2778%26epage%3D2786%26doi%3D10.1021%2Fci200227u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruswitz, F.</span></span> <span> </span><span class="NLM_article-title">HOLLOW: generating accurate representations of channel and interior surfaces in molecular structures</span>. <i>BMC Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">49</span>, <span class="refDoi"> DOI: 10.1186/1472-6807-8-49</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1186%2F1472-6807-8-49" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=19014592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FitFKisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=49&author=B.+K.+Hoauthor=F.+Gruswitz&title=HOLLOW%3A+generating+accurate+representations+of+channel+and+interior+surfaces+in+molecular+structures&doi=10.1186%2F1472-6807-8-49"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">HOLLOW: generating accurate representations of channel and interior surfaces in molecular structures</span></div><div class="casAuthors">Ho Bosco K; Gruswitz Franz</div><div class="citationInfo"><span class="NLM_cas:title">BMC structural biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">49</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  An accurate rendering of interior surfaces can facilitate the analysis of mechanisms at atomic-level detail, such as the transport of substrates in the ammonia channel.  In molecular viewers, one must remove the exterior surface that obscures the channel surface by clipping the viewing plane or manually selecting the channel residues in order to display a partial surface.  Neither method is entirely satisfactory, as unwanted additional pieces of surfaces are always generated.  RESULTS:  To cleanly visualize a channel surface, we present HOLLOW, a program that generates a "casting" of the interior volume of the protein as dummy atoms.  We show that the molecular surface of the dummy atoms closely approximates the channel surface, where this complementary surface of the protein channel can be displayed without superfluous surfaces.  CONCLUSION:  The use of HOLLOW significantly simplifies the generation of channel surfaces, and other interior surfaces of protein structures.  HOLLOW is written in PYTHON and is available at http://hollow.sourceforge.net.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtLhsJjctkvyCEBeYuoi7AfW6udTcc2eaYNjPIs6f9wrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FitFKisQ%253D%253D&md5=3bb9c4ca98489d16571ca4d7ee5751c2</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1186%2F1472-6807-8-49&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1472-6807-8-49%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DB.%2BK.%26aulast%3DGruswitz%26aufirst%3DF.%26atitle%3DHOLLOW%253A%2520generating%2520accurate%2520representations%2520of%2520channel%2520and%2520interior%2520surfaces%2520in%2520molecular%2520structures%26jtitle%3DBMC%2520Struct.%2520Biol.%26date%3D2008%26volume%3D8%26spage%3D49%26doi%3D10.1186%2F1472-6807-8-49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dolinsky, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCammon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, N. A.</span></span> <span> </span><span class="NLM_article-title">PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">W665</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1093/nar/gkh381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1093%2Fnar%2Fgkh381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=15215472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFKmsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=W665-667&author=T.+J.+Dolinskyauthor=J.+E.+Nielsenauthor=J.+A.+McCammonauthor=N.+A.+Baker&title=PDB2PQR%3A+an+automated+pipeline+for+the+setup+of+Poisson-Boltzmann+electrostatics+calculations&doi=10.1093%2Fnar%2Fgkh381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">PDB2PQR: An automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations</span></div><div class="casAuthors">Dolinsky, Todd J.; Nielsen, Jens E.; McCammon, J. Andrew; Baker, Nathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">Web Server</span>),
    <span class="NLM_cas:pages">W665-W667</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Continuum solvation models, such as Poisson-Boltzmann and Generalized Born methods, have become increasingly popular tools for investigating the influence of electrostatics on biomol. structure, energetics and dynamics.  However, the use of such methods requires accurate and complete structural data as well as force field parameters such as at. charges and radii.  Unfortunately, the limiting step in continuum electrostatics calcns. is often the addn. of missing at. coordinates to mol. structures from the Protein Data Bank and the assignment of parameters to biomol. structures.  To address this problem, we have developed the PDB2PQR web service (http://agave.wustl.edu/pdb2pqr/).  This server automates many of the common tasks of prepg. structures for continuum electrostatics calcns., including adding a limited no. of missing heavy atoms to biomol. structures, estg. titrn. states and protonating biomols. in a manner consistent with favorable hydrogen bonding, assigning charge and radius parameters from a variety of force fields, and finally generating "PQR" output compatible with several popular computational biol. packages.  This service is intended to facilitate the setup and execution of electrostatics calcns. for both experts and non-experts and thereby broaden the accessibility to the biol. community of continuum electrostatics analyses of biomol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-GebFAmzzkrVg90H21EOLACvtfcHk0lgiJUglFl-PMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFKmsbY%253D&md5=678d2d58f5cb2c1dd862e2d71cf9dbe1</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkh381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkh381%26sid%3Dliteratum%253Aachs%26aulast%3DDolinsky%26aufirst%3DT.%2BJ.%26aulast%3DNielsen%26aufirst%3DJ.%2BE.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26aulast%3DBaker%26aufirst%3DN.%2BA.%26atitle%3DPDB2PQR%253A%2520an%2520automated%2520pipeline%2520for%2520the%2520setup%2520of%2520Poisson-Boltzmann%2520electrostatics%2520calculations%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2004%26volume%3D32%26spage%3DW665%26epage%3D667%26doi%3D10.1093%2Fnar%2Fgkh381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baker, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sept, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holst, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCammon, J. A.</span></span> <span> </span><span class="NLM_article-title">Electrostatics of nanosystems: application to microtubules and the ribosome</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">10037</span>– <span class="NLM_lpage">10041</span>, <span class="refDoi"> DOI: 10.1073/pnas.181342398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1073%2Fpnas.181342398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=11517324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvFWisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=10037-10041&author=N.+A.+Bakerauthor=D.+Septauthor=S.+Josephauthor=M.+J.+Holstauthor=J.+A.+McCammon&title=Electrostatics+of+nanosystems%3A+application+to+microtubules+and+the+ribosome&doi=10.1073%2Fpnas.181342398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Electrostatics of nanosystems: application to microtubules and the ribosome</span></div><div class="casAuthors">Baker, Nathan A.; Sept, David; Joseph, Simpson; Holst, Michael J.; McCammon, J. Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">10037-10041</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Evaluation of the electrostatic properties of biomols. has become a std. practice in mol. biophysics.  Foremost among the models used to elucidate the electrostatic potential is the Poisson-Boltzmann equation; however, existing methods for solving this equation have limited the scope of accurate electrostatic calcns. to relatively small biomol. systems.  Here we present the application of numerical methods to enable the trivially parallel soln. of the Poisson-Boltzmann equation for supramol. structures that are orders of magnitude larger in size.  As a demonstration of this methodol., electrostatic potentials have been calcd. for large microtubule and ribosome structures.  The results point to the likely role of electrostatics in a variety of activities of these structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA_CAlhE0uX7Vg90H21EOLACvtfcHk0ljtOWd1C5eKiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvFWisbc%253D&md5=1b861999ef12c6972e82e8ada0f387cb</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1073%2Fpnas.181342398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.181342398%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DN.%2BA.%26aulast%3DSept%26aufirst%3DD.%26aulast%3DJoseph%26aufirst%3DS.%26aulast%3DHolst%26aufirst%3DM.%2BJ.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26atitle%3DElectrostatics%2520of%2520nanosystems%253A%2520application%2520to%2520microtubules%2520and%2520the%2520ribosome%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26spage%3D10037%26epage%3D10041%26doi%3D10.1073%2Fpnas.181342398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 10 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Lukas Roth, Michael P. Gotsbacher, <span class="NLM_string-name hlFld-ContribAuthor">Rachel Codd</span>. </span><span class="cited-content_cbyCitation_article-title">Immobilized Metal Affinity Chromatography as a Drug Discovery Platform for Metalloenzyme Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 12116-12127. <a href="https://doi.org/10.1021/acs.jmedchem.0c01541" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01541</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01541%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DImmobilized%252BMetal%252BAffinity%252BChromatography%252Bas%252Ba%252BDrug%252BDiscovery%252BPlatform%252Bfor%252BMetalloenzyme%252BInhibitors%26aulast%3DRoth%26aufirst%3DLukas%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03092020%26date%3D02102020%26date%3D17092020%26volume%3D63%26issue%3D20%26spage%3D12116%26epage%3D12127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Urvashi Sharma, Gyles E. Cozier, Edward D. Sturrock, <span class="NLM_string-name hlFld-ContribAuthor">K. Ravi Acharya</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Basis for Omapatrilat and Sampatrilat Binding to Neprilysin—Implications for Dual Inhibitor Design with Angiotensin-Converting Enzyme. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (10)
                                     , 5488-5500. <a href="https://doi.org/10.1021/acs.jmedchem.0c00441" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00441</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00441%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMolecular%252BBasis%252Bfor%252BOmapatrilat%252Band%252BSampatrilat%252BBinding%252Bto%252BNeprilysin%2525E2%252580%252594Implications%252Bfor%252BDual%252BInhibitor%252BDesign%252Bwith%252BAngiotensin-Converting%252BEnzyme%26aulast%3DSharma%26aufirst%3DUrvashi%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16032020%26date%3D08052020%26date%3D27042020%26volume%3D63%26issue%3D10%26spage%3D5488%26epage%3D5500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rhéure  Alves-Lopes</span>, <span class="hlFld-ContribAuthor ">Augusto C.  Montezano</span>, <span class="hlFld-ContribAuthor ">Karla B.  Neves</span>, <span class="hlFld-ContribAuthor ">Adam  Harvey</span>, <span class="hlFld-ContribAuthor ">Francisco J.  Rios</span>, <span class="hlFld-ContribAuthor ">Dominik S.  Skiba</span>, <span class="hlFld-ContribAuthor ">Lauren B.  Arendse</span>, <span class="hlFld-ContribAuthor ">Tomasz J.  Guzik</span>, <span class="hlFld-ContribAuthor ">Delyth  Graham</span>, <span class="hlFld-ContribAuthor ">Marko  Poglitsch</span>, <span class="hlFld-ContribAuthor ">Edward  Sturrock</span>, <span class="hlFld-ContribAuthor ">Rhian M.  Touyz</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin): A Potential New Therapy for Hypertension. </span><span class="cited-content_cbyCitation_journal-name">Hypertension</span><span> <strong>2021,</strong> <em>4 </em><a href="https://doi.org/10.1161/HYPERTENSIONAHA.121.17041" title="DOI URL">https://doi.org/10.1161/HYPERTENSIONAHA.121.17041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1161/HYPERTENSIONAHA.121.17041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1161%2FHYPERTENSIONAHA.121.17041%26sid%3Dliteratum%253Aachs%26jtitle%3DHypertension%26atitle%3DSelective%252BInhibition%252Bof%252Bthe%252BC-Domain%252Bof%252BACE%252B%252528Angiotensin-Converting%252BEnzyme%252529%252BCombined%252BWith%252BInhibition%252Bof%252BNEP%252B%252528Neprilysin%252529%25253A%252BA%252BPotential%252BNew%252BTherapy%252Bfor%252BHypertension%26aulast%3DAlves-Lopes%26aufirst%3DRh%25C3%25A9ure%26date%3D2021%26date%3D2021%26volume%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gyles E.  Cozier</span>, <span class="hlFld-ContribAuthor ">Lizelle  Lubbe</span>, <span class="hlFld-ContribAuthor ">Edward D.  Sturrock</span>, <span class="hlFld-ContribAuthor ">K. Ravi  Acharya</span>. </span><span class="cited-content_cbyCitation_article-title">Angiotensin‐converting enzyme open for business: structural insights into the subdomain dynamics. </span><span class="cited-content_cbyCitation_journal-name">The FEBS Journal</span><span> <strong>2021,</strong> <em>288 </em>
                                    (7)
                                     , 2238-2256. <a href="https://doi.org/10.1111/febs.15601" title="DOI URL">https://doi.org/10.1111/febs.15601</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/febs.15601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Ffebs.15601%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FEBS%2520Journal%26atitle%3DAngiotensin%2525E2%252580%252590converting%252Benzyme%252Bopen%252Bfor%252Bbusiness%25253A%252Bstructural%252Binsights%252Binto%252Bthe%252Bsubdomain%252Bdynamics%26aulast%3DCozier%26aufirst%3DGyles%2BE.%26date%3D2021%26date%3D2020%26volume%3D288%26issue%3D7%26spage%3D2238%26epage%3D2256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lizelle  Lubbe</span>, <span class="hlFld-ContribAuthor ">Gyles E.  Cozier</span>, <span class="hlFld-ContribAuthor ">Delia  Oosthuizen</span>, <span class="hlFld-ContribAuthor ">K. Ravi  Acharya</span>, <span class="hlFld-ContribAuthor ">Edward D.  Sturrock</span>. </span><span class="cited-content_cbyCitation_article-title">ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV. </span><span class="cited-content_cbyCitation_journal-name">Clinical Science</span><span> <strong>2020,</strong> <em>134 </em>
                                    (21)
                                     , 2851-2871. <a href="https://doi.org/10.1042/CS20200899" title="DOI URL">https://doi.org/10.1042/CS20200899</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/CS20200899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FCS20200899%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Science%26atitle%3DACE2%252Band%252BACE%25253A%252Bstructure-based%252Binsights%252Binto%252Bmechanism%25252C%252Bregulation%252Band%252Breceptor%252Brecognition%252Bby%252BSARS-CoV%26aulast%3DLubbe%26aufirst%3DLizelle%26date%3D2020%26date%3D2020%26volume%3D134%26issue%3D21%26spage%3D2851%26epage%3D2871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gyles E.  Cozier</span>, <span class="hlFld-ContribAuthor ">Lizelle  Lubbe</span>, <span class="hlFld-ContribAuthor ">Edward D.  Sturrock</span>, <span class="hlFld-ContribAuthor ">K. Ravi  Acharya</span>. </span><span class="cited-content_cbyCitation_article-title">ACE-domain selectivity extends beyond direct interacting residues at the active site. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2020,</strong> <em>477 </em>
                                    (7)
                                     , 1241-1259. <a href="https://doi.org/10.1042/BCJ20200060" title="DOI URL">https://doi.org/10.1042/BCJ20200060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BCJ20200060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBCJ20200060%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DACE-domain%252Bselectivity%252Bextends%252Bbeyond%252Bdirect%252Binteracting%252Bresidues%252Bat%252Bthe%252Bactive%252Bsite%26aulast%3DCozier%26aufirst%3DGyles%2BE.%26date%3D2020%26date%3D2020%26volume%3D477%26issue%3D7%26spage%3D1241%26epage%3D1259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Itsuki  Fukunaga</span>, <span class="hlFld-ContribAuthor ">Ryusuke  Sawada</span>, <span class="hlFld-ContribAuthor ">Tomokazu  Shibata</span>, <span class="hlFld-ContribAuthor ">Kazuma  Kaitoh</span>, <span class="hlFld-ContribAuthor ">Yukie  Sakai</span>, <span class="hlFld-ContribAuthor ">Yoshihiro  Yamanishi</span>. </span><span class="cited-content_cbyCitation_article-title">Prediction of the Health Effects of Food Peptides and Elucidation of the Mode‐of‐action Using Multi‐task Graph Convolutional Neural Network. </span><span class="cited-content_cbyCitation_journal-name">Molecular Informatics</span><span> <strong>2020,</strong> <em>39 </em>
                                    (1-2)
                                     , 1900134. <a href="https://doi.org/10.1002/minf.201900134" title="DOI URL">https://doi.org/10.1002/minf.201900134</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/minf.201900134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fminf.201900134%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Informatics%26atitle%3DPrediction%252Bof%252Bthe%252BHealth%252BEffects%252Bof%252BFood%252BPeptides%252Band%252BElucidation%252Bof%252Bthe%252BMode%2525E2%252580%252590of%2525E2%252580%252590action%252BUsing%252BMulti%2525E2%252580%252590task%252BGraph%252BConvolutional%252BNeural%252BNetwork%26aulast%3DFukunaga%26aufirst%3DItsuki%26date%3D2020%26date%3D2019%26volume%3D39%26issue%3D1-2%26spage%3D1900134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lauren B.  Arendse</span>, <span class="hlFld-ContribAuthor ">A. H. Jan  Danser</span>, <span class="hlFld-ContribAuthor ">Marko  Poglitsch</span>, <span class="hlFld-ContribAuthor ">Rhian M.  Touyz</span>, <span class="hlFld-ContribAuthor ">John C.  Burnett</span>, <span class="hlFld-ContribAuthor ">Catherine  Llorens-Cortes</span>, <span class="hlFld-ContribAuthor ">Mario R.  Ehlers</span>, <span class="hlFld-ContribAuthor ">Edward D.  Sturrock</span>, . </span><span class="cited-content_cbyCitation_article-title">Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2019,</strong> <em>71 </em>
                                    (4)
                                     , 539-570. <a href="https://doi.org/10.1124/pr.118.017129" title="DOI URL">https://doi.org/10.1124/pr.118.017129</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pr.118.017129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpr.118.017129%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DNovel%252BTherapeutic%252BApproaches%252BTargeting%252Bthe%252BRenin-Angiotensin%252BSystem%252Band%252BAssociated%252BPeptides%252Bin%252BHypertension%252Band%252BHeart%252BFailure%26aulast%3DArendse%26aufirst%3DLauren%2BB.%26date%3D2019%26date%3D2019%26volume%3D71%26issue%3D4%26spage%3D539%26epage%3D570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mája  Polakovičová</span>, <span class="hlFld-ContribAuthor ">Josef  Jampílek</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in Structural Biology of ACE and Development of Domain Selective ACE-inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry</span><span> <strong>2019,</strong> <em>15 </em>
                                    (6)
                                     , 574-587. <a href="https://doi.org/10.2174/1573406415666190514081132" title="DOI URL">https://doi.org/10.2174/1573406415666190514081132</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1573406415666190514081132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1573406415666190514081132%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%26atitle%3DAdvances%252Bin%252BStructural%252BBiology%252Bof%252BACE%252Band%252BDevelopment%252Bof%252BDomain%252BSelective%252BACE-inhibitors%26aulast%3DPolakovi%25C4%258Dov%25C3%25A1%26aufirst%3DM%25C3%25A1ja%26date%3D2019%26volume%3D15%26issue%3D6%26spage%3D574%26epage%3D587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hemant P.  Yennawar</span>, <span class="hlFld-ContribAuthor ">Samuel D.  Peterson</span>, <span class="hlFld-ContribAuthor ">Lee J.  Silverberg</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structures of two isomeric 2-aryl-3-phenyl-1,3-thiazepan-4-ones. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section E Crystallographic Communications</span><span> <strong>2019,</strong> <em>75 </em>
                                    (8)
                                     , 1270-1273. <a href="https://doi.org/10.1107/S2056989019010429" title="DOI URL">https://doi.org/10.1107/S2056989019010429</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S2056989019010429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS2056989019010429%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520E%2520Crystallographic%2520Communications%26atitle%3DCrystal%252Bstructures%252Bof%252Btwo%252Bisomeric%252B2-aryl-3-phenyl-1%25252C3-thiazepan-4-ones%26aulast%3DYennawar%26aufirst%3DHemant%2BP.%26date%3D2019%26date%3D2019%26volume%3D75%26issue%3D8%26spage%3D1270%26epage%3D1273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/medium/jm-2018-013098_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01309&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/medium/jm-2018-013098_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of omapatrilat, phosphinic tripeptide FII, BPPb, and angiotensin II, with the PDB atom numbering for omapatrilat indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01309&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/medium/jm-2018-013098_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic representation of omapatrilat bound to the ACE domains. A–D are overlaid with the final 2m<i>F</i><sub>o</sub> – D<i>F</i><sub>c</sub> (blue, contoured at 1σ level) electron density map and the m<i>F</i><sub>o</sub> – D<i>F</i><sub>c</sub> (green, contoured at 3σ level) electron density omit map for (A) omapatrilat–nACE, (B) omapatrilat–cACE (molecule 1), (C) omapatrilat–cACE (molecule 2), and (D) omapatrilat–cACE (molecule 3) complexes. The zinc ion is shown as a lilac sphere with the coordinating side chains shown as sticks. α-Helices and β-strands are shown in rose and dark cyan, respectively. (E,F) Omapatrilat molecules 2 and 3, respectively, overlaid with polder maps.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01309&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/medium/jm-2018-013098_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Ligplot representation of the binding site interactions of (A) omapatrilat–nACE chain A, (B) omapatrilat–nACE chain B, (C) omapatrilat–cACE (molecule 1), (D) omapatrilat–cACE (molecule 2 conformation A and molecule 3), and (E) omapatrilat–cACE (molecule 2 conformation B). H-bond/electrostatic interactions are shown in green, hydrophobic interactions in red, and water molecules as cyan spheres. Residues solely involved in hydrophobic interactions are represented by red, semicircular symbols.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01309&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/medium/jm-2018-013098_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Schematic representation of (A) omapatrilat–cACE (molecule 1), (B) omapatrilat–cACE (molecule 2), and (C) omapatrilat–cACE (molecule 3) binding sites showing the interactions involved with the three omapatrilat molecules. The zinc ion and water molecules are shown as lilac and red spheres, respectively, and the coordinating side chains shown as sticks. α-Helices and β-strands are shown in rose and dark cyan, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01309&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/medium/jm-2018-013098_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Two views showing the binding cavity (transparent green surface) of omapatrilat–cACE complex structure indicating how the omapatrilat molecules occupy most of the nonprime cavity. The zinc atom is shown as lilac sphere, omapatrilat molecules as sticks, α-helices as rose cylinders, and β-strands in dark cyan.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01309&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/medium/jm-2018-013098_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Comparison of the location inside the binding cavity for ligands that interact beyond the S<sub>2</sub> subsite. (A) Omapatrilat–cACE, (B) phosphinic tripeptide–cACE, (C) BPPb–cACE, (D) Angiotensin II–cACE (for clarity only one conformation is shown), and (E) BPPb–AnCE. Proteins are depicted as an internal surface colored by electrostatic potential, ligands and the zinc binding residues are shown as sticks with zinc ions shown as lilac spheres. NB: There was no zinc ion bound in the BPPb–cACE crystal structure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01309&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/medium/jm-2018-013098_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Two views of the overlay of ligands to show binding orientations that extend beyond the S<sub>2</sub> subsite. Omapatrilat, BPPb, angiotensin II, and phosphinic tripeptide from cACE complexes are shown as magenta, light-blue, green, and lime sticks, respectively, and BPPb from AnCE complex is shown as orange sticks.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01309&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/medium/jm-2018-013098_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Inhibition of nACE and cACE activity by omapatrilat. (A,B) IC<sub>50</sub> log plots (variable slope) and (C,D) Morrison plots generated using the same data (Et unconstrained). Enzyme and inhibitor were incubated at 22 °C for 15 min, and reactions were initiated by the addition of Z-FHL substrate (nACE <i>K</i><sub>m</sub> 600 μM; cACE <i>K</i><sub>m</sub> 60 μM). Reactions were carried out in triplicate, and assays were carried out at different substrate concentrations (nACE, final Z-FHL concentrations 0.3 and 1.2 mM; cACE, final Z-FHL concentrations 0.15, 0.3, and 1.2 mM). The final enzyme concentration in each reaction was 4 and 2 nM for nACE and cACE, respectively, which corresponded well with the enzyme concentration (Et) determined by the Morrison equation. IC<sub>50</sub> and <i>K</i><sub>i</sub> values are average values at all substrate concentrations ± standard deviation of the mean.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01309&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/medium/jm-2018-013098_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. (A) Omapatrilat dimerization monitored by HPLC. The sample was analyzed using a Poroshell 120 EC-C 18 column on the Agilent 1260 infinity HPLC system. 10 μL of sample was injected onto the column at the indicated time points. Conditions: A, 1% ACN, 0.1% TFA; B, 95% ACN, 0.1% TFA; 0–100% B over 10 min; 0.5 mL/min, 214 nm. Peaks corresponding to the monomer and dimer were observed at 7.8 and 9.1 min, respectively. (B,C) Inhibition of nACE and cACE activity by omapatrilat dimer: IC<sub>50</sub> log plots for inhibition of the ACE mediated turnover of (B) Z-FHL (final concentration 500 μM, nACE <i>K</i><sub>m</sub> 600 μM, cACE <i>K</i><sub>m</sub> 60 μM) and (C) MCA-MCA-RPPGFSAFK(Dnp)-OH (final concentration 5 μM, nACE <i>K</i><sub>m</sub> 3.6, cACE <i>K</i><sub>m</sub> 2.4 μM) substrates. Enzyme and inhibitor were preincubated at 22 °C for 15 min, and reactions were initiated by the addition of substrate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01309&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/medium/jm-2018-013098_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Predicted binding pose for omapatrilat in the active-site of NEP. Omapatrilat (cyan) was docked into NEP PDB structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R1H">1R1H</a> (green) using Schrödinger’s XP Glide. (A) Close up of the omapatrilat binding site with polar contacts indicated by dotted lines and the catalytic Zn<sup>2+</sup> ion shown in purple. (B) Predicted binding pose for omapatrilat (green) in the active-site of NEP, aligned to the nACE- and cACE-omapatrilat structures, with omapatrilat shown in yellow and magenta, respectively. Domain specific ACE active-site residues important for conferring domain selectivity are shown as sticks with nACE specific residues in orange and cACE specific residues in cyan.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-22/acs.jmedchem.8b01309/20181127/images/large/jm-2018-013098_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01309&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70525" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70525" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 57 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riordan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehlers, M. R.</span></span> <span> </span><span class="NLM_article-title">Ace revisited: a new target for structure-based drug design</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">891</span>– <span class="NLM_lpage">902</span>, <span class="refDoi"> DOI: 10.1038/nrd1227</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1038%2Fnrd1227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=14668810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1agu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=891-902&author=K.+R.+Acharyaauthor=E.+D.+Sturrockauthor=J.+F.+Riordanauthor=M.+R.+Ehlers&title=Ace+revisited%3A+a+new+target+for+structure-based+drug+design&doi=10.1038%2Fnrd1227"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">ACE revisited: A new target for structure-based drug design</span></div><div class="casAuthors">Acharya, K. Ravi; Sturrock, Edward D.; Rirodan, James F.; Ehlers, Mario R. W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">891-902</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Current-generation angiotensin-coverting enzyme (ACE) inhibitors are widely used for cardiovascular diseases, including high blood pressure, heart failure, heart attack and kidney failure, and have combined annual sales in excess of US $6 billion.  However, the use of these ACE inhibitors, which were developed in the late 1970s and early 1980s, is hampered by common side effects.  Moreover, we now know that ACE actually consists of two parts (called the N- and C-domains) that have different functions.  Therefore, the design of specific domain-selective ACE inhibitors is expected to produce next-generation drugs that might be safer and more effective.  Here we discuss the structural features of current inhibitors and outline how next-generation ACE inhibitors could be designed by using the three-dimensional mol. structure of human testis ACE.  The ACE structure provides a unique opportunity for rational drug design, based on a combination of in silico modeling using existing inhibitors as scaffolds and iterative lead optimization to drive the synthetic chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq00n8hyDan07Vg90H21EOLACvtfcHk0ljEwJJp4JEqKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1agu78%253D&md5=cf5e5ee0b4126287dc1cdef5f605ed58</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd1227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1227%26sid%3Dliteratum%253Aachs%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26aulast%3DRiordan%26aufirst%3DJ.%2BF.%26aulast%3DEhlers%26aufirst%3DM.%2BR.%26atitle%3DAce%2520revisited%253A%2520a%2520new%2520target%2520for%2520structure-based%2520drug%2520design%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D891%26epage%3D902%26doi%3D10.1038%2Fnrd1227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skeggs, L. T.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahn, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shumway, N. P.</span></span> <span> </span><span class="NLM_article-title">The preparation and function of the hypertensin-converting enzyme</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">1956</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">299</span>, <span class="refDoi"> DOI: 10.1084/jem.103.3.295</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1084%2Fjem.103.3.295" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=13295487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADyaG28Xot1Ohtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1956&pages=295-299&author=L.+T.+Skeggsauthor=J.+R.+Kahnauthor=N.+P.+Shumway&title=The+preparation+and+function+of+the+hypertensin-converting+enzyme&doi=10.1084%2Fjem.103.3.295"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation and function of the hypertensin-converting enzyme</span></div><div class="casAuthors">Skeggs, Leonard T., Jr.; Kahn, Joseph R.; Shumway, Norman P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">1956</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">295-9</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    </div><div class="casAbstract">On perfusing isolated rat kidneys with purified hypertensin I (I) and II (II), II was found to result in large and sustained elevations in the perfusion pressure, whereas similar doses, or doses increased 12 times, of I were completely without effect.  The enzyme converting I to II was isolated from horse plasma in a semipurified form by means of (NH4)2SO4 fractionation, dialysis, and isoelec. pptn.  The soln. was chilled to 0-1°, the pH adjusted to 5.2 with concd. NaOAc buffer pH 4.0.  A light-green ppt. formed, and was dissolved in 0.05M Na phosphate buffer at pH 7.8.  The soln. was pale green and free of hypertensinase.  The yield of enzyme was 5.5 g./10 gal. of horse blood.  It was stable at pH 4, but was entirely destroyed at pH 3 and a temp. of 25°.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlp_RChQQYk7Vg90H21EOLACvtfcHk0ljEwJJp4JEqKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG28Xot1Ohtg%253D%253D&md5=ffff296cc37181d4e4721e22b20a69e4</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1084%2Fjem.103.3.295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.103.3.295%26sid%3Dliteratum%253Aachs%26aulast%3DSkeggs%26aufirst%3DL.%2BT.%26aulast%3DKahn%26aufirst%3DJ.%2BR.%26aulast%3DShumway%26aufirst%3DN.%2BP.%26atitle%3DThe%2520preparation%2520and%2520function%2520of%2520the%2520hypertensin-converting%2520enzyme%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1956%26volume%3D103%26spage%3D295%26epage%3D299%26doi%3D10.1084%2Fjem.103.3.295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdos, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, Y.</span></span> <span> </span><span class="NLM_article-title">A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin</span>. <i>Biochim. Biophys. Acta, Protein Struct.</i> <span class="NLM_year" style="font-weight: bold;">1970</span>,  <span class="NLM_volume"><i>214</i></span>,  <span class="NLM_fpage">374</span>– <span class="NLM_lpage">376</span>, <span class="refDoi"> DOI: 10.1016/0005-2795(70)90017-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1016%2F0005-2795%2870%2990017-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=4322742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADyaE3cXkvFCrtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=214&publication_year=1970&pages=374-376&author=H.+Y.+Yangauthor=E.+G.+Erdosauthor=Y.+Levin&title=A+dipeptidyl+carboxypeptidase+that+converts+angiotensin+I+and+inactivates+bradykinin&doi=10.1016%2F0005-2795%2870%2990017-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin</span></div><div class="casAuthors">Yang, Hsiu-Ying Tsai; Erdos, Ervin G.; Levin, Yehuda</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Protein Structure</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">214</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">374-6</span>CODEN:
                <span class="NLM_cas:coden">BBPTBH</span>;
        ISSN:<span class="NLM_cas:issn">0005-2795</span>.
    </div><div class="casAbstract">Kininase II (dipeptidyl carboxypeptidase), 200-fold purified from swine plasma, inactivated the hypotensive peptide bradykinin and converted angiotensin I into the hypertensive angiotensin II; these reactions were inhibited by dipeptide split products and the B-chain of insulin.  When tert-butyloxycarbonyl-Phe(NO2)-Phe-Gly was used as the substrate for the enzyme, having an optimum pH of 7.4 in 0.1M Tris buffer, the enzyme activity was increased by the addn. of NaCl, but was inhibited by o-phenanthroline and EDTA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5yLY-yEGOlrVg90H21EOLACvtfcHk0ljEwJJp4JEqKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3cXkvFCrtrg%253D&md5=0454518853a0788c5dd54812589835a2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2F0005-2795%2870%2990017-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0005-2795%252870%252990017-6%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%2BY.%26aulast%3DErdos%26aufirst%3DE.%2BG.%26aulast%3DLevin%26aufirst%3DY.%26atitle%3DA%2520dipeptidyl%2520carboxypeptidase%2520that%2520converts%2520angiotensin%2520I%2520and%2520inactivates%2520bradykinin%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Protein%2520Struct.%26date%3D1970%26volume%3D214%26spage%3D374%26epage%3D376%26doi%3D10.1016%2F0005-2795%2870%2990017-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Araujo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melo, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cesari, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juliano, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juliano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmona, A. K.</span></span> <span> </span><span class="NLM_article-title">Peptidase specificity characterization of C- and N-terminal catalytic sites of angiotensin I-converting enzyme</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">8519</span>– <span class="NLM_lpage">8525</span>, <span class="refDoi"> DOI: 10.1021/bi9928905</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi9928905" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=8519-8525&author=M.+C.+Araujoauthor=R.+L.+Meloauthor=M.+H.+Cesariauthor=M.+A.+Julianoauthor=L.+Julianoauthor=A.+K.+Carmona&title=Peptidase+specificity+characterization+of+C-+and+N-terminal+catalytic+sites+of+angiotensin+I-converting+enzyme&doi=10.1021%2Fbi9928905"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fbi9928905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi9928905%26sid%3Dliteratum%253Aachs%26aulast%3DAraujo%26aufirst%3DM.%2BC.%26aulast%3DMelo%26aufirst%3DR.%2BL.%26aulast%3DCesari%26aufirst%3DM.%2BH.%26aulast%3DJuliano%26aufirst%3DM.%2BA.%26aulast%3DJuliano%26aufirst%3DL.%26aulast%3DCarmona%26aufirst%3DA.%2BK.%26atitle%3DPeptidase%2520specificity%2520characterization%2520of%2520C-%2520and%2520N-terminal%2520catalytic%2520sites%2520of%2520angiotensin%2520I-converting%2520enzyme%26jtitle%3DBiochemistry%26date%3D2000%26volume%3D39%26spage%3D8519%26epage%3D8525%26doi%3D10.1021%2Fbi9928905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rousseau, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauvet, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenfant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corvol, P.</span></span> <span> </span><span class="NLM_article-title">The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>270</i></span>,  <span class="NLM_fpage">3656</span>– <span class="NLM_lpage">3661</span>, <span class="refDoi"> DOI: 10.1074/jbc.270.8.3656</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1074%2Fjbc.270.8.3656" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=3656-3661&author=A.+Rousseauauthor=A.+Michaudauthor=M.+T.+Chauvetauthor=M.+Lenfantauthor=P.+Corvol&title=The+hemoregulatory+peptide+N-acetyl-Ser-Asp-Lys-Pro+is+a+natural+and+specific+substrate+of+the+N-terminal+active+site+of+human+angiotensin-converting+enzyme&doi=10.1074%2Fjbc.270.8.3656"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1074%2Fjbc.270.8.3656&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.270.8.3656%26sid%3Dliteratum%253Aachs%26aulast%3DRousseau%26aufirst%3DA.%26aulast%3DMichaud%26aufirst%3DA.%26aulast%3DChauvet%26aufirst%3DM.%2BT.%26aulast%3DLenfant%26aufirst%3DM.%26aulast%3DCorvol%26aufirst%3DP.%26atitle%3DThe%2520hemoregulatory%2520peptide%2520N-acetyl-Ser-Asp-Lys-Pro%2520is%2520a%2520natural%2520and%2520specific%2520substrate%2520of%2520the%2520N-terminal%2520active%2520site%2520of%2520human%2520angiotensin-converting%2520enzyme%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D3656%26epage%3D3661%26doi%3D10.1074%2Fjbc.270.8.3656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soubrier, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alhenc-Gelas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allegrini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">John, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tregear, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corvol, P.</span></span> <span> </span><span class="NLM_article-title">Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">9386</span>– <span class="NLM_lpage">9390</span>, <span class="refDoi"> DOI: 10.1073/pnas.85.24.9386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1073%2Fpnas.85.24.9386" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=1988&pages=9386-9390&author=F.+Soubrierauthor=F.+Alhenc-Gelasauthor=C.+Hubertauthor=J.+Allegriniauthor=M.+Johnauthor=G.+Tregearauthor=P.+Corvol&title=Two+putative+active+centers+in+human+angiotensin+I-converting+enzyme+revealed+by+molecular+cloning&doi=10.1073%2Fpnas.85.24.9386"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.85.24.9386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.85.24.9386%26sid%3Dliteratum%253Aachs%26aulast%3DSoubrier%26aufirst%3DF.%26aulast%3DAlhenc-Gelas%26aufirst%3DF.%26aulast%3DHubert%26aufirst%3DC.%26aulast%3DAllegrini%26aufirst%3DJ.%26aulast%3DJohn%26aufirst%3DM.%26aulast%3DTregear%26aufirst%3DG.%26aulast%3DCorvol%26aufirst%3DP.%26atitle%3DTwo%2520putative%2520active%2520centers%2520in%2520human%2520angiotensin%2520I-converting%2520enzyme%2520revealed%2520by%2520molecular%2520cloning%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1988%26volume%3D85%26spage%3D9386%26epage%3D9390%26doi%3D10.1073%2Fpnas.85.24.9386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span>; <span class="NLM_string-name">Anthony, C. S.</span>; <span class="NLM_string-name">Danilov, S. M.</span></span> <span> </span><span class="NLM_article-title">Peptidyl-dipeptidase A/Angiotensin I-Converting Enzyme</span>. In  <i>Handbook of Proteolytic Enzymes</i>, <span class="NLM_edition">3rd</span> ed.; <span class="NLM_publisher-name">Elsevier</span>, <span class="NLM_year">2013</span>; Vol.  <span class="NLM_volume">1 and 2</span>, pp  <span class="NLM_fpage">480</span>– <span class="NLM_lpage">494</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1016%2FB978-0-12-382219-2.00098-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=480-494&author=E.+D.+Sturrock&author=C.+S.+Anthony&author=S.+M.+Danilov&title=Handbook+of+Proteolytic+Enzymes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-382219-2.00098-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-382219-2.00098-3%26sid%3Dliteratum%253Aachs%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26atitle%3DPeptidyl-dipeptidase%2520A%252FAngiotensin%2520I-Converting%2520Enzyme%26btitle%3DHandbook%2520of%2520Proteolytic%2520Enzymes%26pub%3DElsevier%26date%3D2013%26volume%3D1%2520and%25202%26spage%3D480%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alhenc-Gelas, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corvol, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clauser, E.</span></span> <span> </span><span class="NLM_article-title">The two homologous domains of human angiotensin I-converting enzyme are both catalytically active</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>266</i></span>,  <span class="NLM_fpage">9002</span>– <span class="NLM_lpage">9008</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1851160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADyaK3MXks1OntLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1991&pages=9002-9008&author=L.+Weiauthor=F.+Alhenc-Gelasauthor=P.+Corvolauthor=E.+Clauser&title=The+two+homologous+domains+of+human+angiotensin+I-converting+enzyme+are+both+catalytically+active"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The two homologous domains of human angiotensin I-converting enzyme are both catalytically active</span></div><div class="casAuthors">Wei, Lei; Alhenc-Gelas, Francois; Corvol, Pierre; Clauser, Eric</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">266</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">9002-8</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">Mol. cloning of human endothelial angiotensin I-covering enzyme (kinase II; EC 3.4.15.1) (ACE) has recently shown that the enzyme contains 2 large homol. domains (called here the N and C domains), each bearing a putative active site, identified by sequence comparisons with the active sites of other zinc metallopeptidases.  However, the previous expts. with zinc or competitive ACE inhibitors suggested a single active site in ACE.  To establish whether both domains of ACE are enzymically active, a series of ACE mutants, each contg. only 1 intact domain, were constructed by deletion or point mutations of putative crit. residues of the other domain, and expressed in heterologous Chinese hamster ovary cells.  Both domains are enzymically active and cleave the C-terminal dipeptide of hippuryl-His-Leu or angiotensin I.  Moreover, both domains have an abs. zinc requirement for activity, are activated by chloride and are sensitive to competitive ACE inhibitors, and appear to function independently.  However, the 2 domains display different catalytic consts. and different patterns of chloride activation.  At high chloride concns., the C domain hydrolyzes the 2 substrates tested faster than does the N domain.  His-361,365 and His-959,963 are established as essential residues in the N and C domains, resp., most likely involved in zinc binding, and Glu-362 in the N domain and Glu-960 in the C domain are essential catalytic residues.  These observations provide strong evidence that ACE possesses 2 independent catalytic domains and suggest that they may have different functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquqPiPJev2abVg90H21EOLACvtfcHk0lhmLDtoGeSpQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXks1OntLY%253D&md5=907f83aa628bc22968428d5d43d804ff</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DL.%26aulast%3DAlhenc-Gelas%26aufirst%3DF.%26aulast%3DCorvol%26aufirst%3DP.%26aulast%3DClauser%26aufirst%3DE.%26atitle%3DThe%2520two%2520homologous%2520domains%2520of%2520human%2520angiotensin%2520I-converting%2520enzyme%2520are%2520both%2520catalytically%2520active%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1991%26volume%3D266%26spage%3D9002%26epage%3D9008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Steckelings, U. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artuc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wollschlager, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiehstutz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henz, B. M.</span></span> <span> </span><span class="NLM_article-title">Angiotensin-converting enzyme inhibitors as inducers of adverse cutaneous reactions</span>. <i>Acta Derm Venereol</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1080/000155501317140007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1080%2F000155501317140007" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=321-325&author=U.+M.+Steckelingsauthor=M.+Artucauthor=T.+Wollschlagerauthor=S.+Wiehstutzauthor=B.+M.+Henz&title=Angiotensin-converting+enzyme+inhibitors+as+inducers+of+adverse+cutaneous+reactions&doi=10.1080%2F000155501317140007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1080%2F000155501317140007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F000155501317140007%26sid%3Dliteratum%253Aachs%26aulast%3DSteckelings%26aufirst%3DU.%2BM.%26aulast%3DArtuc%26aufirst%3DM.%26aulast%3DWollschlager%26aufirst%3DT.%26aulast%3DWiehstutz%26aufirst%3DS.%26aulast%3DHenz%26aufirst%3DB.%2BM.%26atitle%3DAngiotensin-converting%2520enzyme%2520inhibitors%2520as%2520inducers%2520of%2520adverse%2520cutaneous%2520reactions%26jtitle%3DActa%2520Derm%2520Venereol%26date%3D2001%26volume%3D81%26spage%3D321%26epage%3D325%26doi%3D10.1080%2F000155501317140007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weber, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messerli, F. H.</span></span> <span> </span><span class="NLM_article-title">Angiotensin-converting enzyme inhibitors and angioedema: estimating the risk</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1465</span>– <span class="NLM_lpage">1467</span>, <span class="refDoi"> DOI: 10.1161/HYPERTENSIONAHA.108.111393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1161%2FHYPERTENSIONAHA.108.111393" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=18413486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptVahurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1465-1467&author=M.+A.+Weberauthor=F.+H.+Messerli&title=Angiotensin-converting+enzyme+inhibitors+and+angioedema%3A+estimating+the+risk&doi=10.1161%2FHYPERTENSIONAHA.108.111393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Angiotensin-converting enzyme inhibitors and angioedema: estimating the risk</span></div><div class="casAuthors">Weber, Michael A.; Messerli, Franz H.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1465-1467</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvGFGj7rAMm7Vg90H21EOLACvtfcHk0lhmLDtoGeSpQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptVahurg%253D&md5=9c00260a5a4f6db0f679058a5db727e2</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1161%2FHYPERTENSIONAHA.108.111393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FHYPERTENSIONAHA.108.111393%26sid%3Dliteratum%253Aachs%26aulast%3DWeber%26aufirst%3DM.%2BA.%26aulast%3DMesserli%26aufirst%3DF.%2BH.%26atitle%3DAngiotensin-converting%2520enzyme%2520inhibitors%2520and%2520angioedema%253A%2520estimating%2520the%2520risk%26jtitle%3DHypertension%26date%3D2008%26volume%3D51%26spage%3D1465%26epage%3D1467%26doi%3D10.1161%2FHYPERTENSIONAHA.108.111393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuyer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubbe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamora, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span> <span> </span><span class="NLM_article-title">Fragment-based design for the development of N-domain-selective angiotensin-1-converting enzyme inhibitors</span>. <i>Clin. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>126</i></span>,  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">313</span>, <span class="refDoi"> DOI: 10.1042/CS20130403</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1042%2FCS20130403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=24015848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1CktL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2014&pages=305-313&author=R.+G.+Douglasauthor=R.+K.+Sharmaauthor=G.+Masuyerauthor=L.+Lubbeauthor=I.+Zamoraauthor=K.+R.+Acharyaauthor=K.+Chibaleauthor=E.+D.+Sturrock&title=Fragment-based+design+for+the+development+of+N-domain-selective+angiotensin-1-converting+enzyme+inhibitors&doi=10.1042%2FCS20130403"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-based design for the development of N-domain-selective angiotensin-1-converting enzyme inhibitors</span></div><div class="casAuthors">Douglas, Ross G.; Sharma, Rajni K.; Masuyer, Geoffrey; Lubbe, Lizelle; Zamora, Ismael; Acharya, K. Ravi; Chibale, Kelly; Sturrock, Edward D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">305-313</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1470-8736</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">ACE (angiotensin-1-converting enzyme) is a zinc metallopeptidase that plays a prominent role in blood pressure regulation and electrolyte homeostasis.  ACE consists of two homologous domains that despite similarities of sequence and topol. display differences in substrate processing and inhibitor binding.  The design of inhibitors that selectively inhibit the N-domain (N-selective) could be useful in treating conditions of tissue injury and fibrosis due to build-up of N-domain-specific substrate Ac-SDKP (N-acetyl-Ser-Asp-Lys-Pro).  Using a receptor-based SHOP (scaffold hopping) approach with N-selective inhibitor RXP407, a shortlist of scaffolds that consisted of modified RXP407 backbones with novel chemotypes was generated.  These scaffolds were selected on the basis of enhanced predicted interaction energies with N-domain residues that differed from their C-domain counterparts.  One scaffold was synthesized and inhibitory binding tested using a fluorogenic ACE assay.  A mol. incorporating a tetrazole moiety in the P2 position (compd. 33RE) displayed potent inhibition (Ki=11.21±0.74 nM) and was 927-fold more selective for the N-domain than the C-domain.  A crystal structure of compd. 33RE in complex with the N-domain revealed its mode of binding through arom. stacking with His388 and a direct hydrogen bond with the hydroxy group of the N-domain specific Tyr369.  This work further elucidates the mol. basis for N-domain selective inhibition and assists in the design of novel N-selective ACE inhibitors that could be employed in treatment of fibrosis disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra1vuAtVm_07Vg90H21EOLACvtfcHk0lgaFwXSWer0tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1CktL3M&md5=b74b9a12946c6235f20d766eddea846f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1042%2FCS20130403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20130403%26sid%3Dliteratum%253Aachs%26aulast%3DDouglas%26aufirst%3DR.%2BG.%26aulast%3DSharma%26aufirst%3DR.%2BK.%26aulast%3DMasuyer%26aufirst%3DG.%26aulast%3DLubbe%26aufirst%3DL.%26aulast%3DZamora%26aufirst%3DI.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26aulast%3DChibale%26aufirst%3DK.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26atitle%3DFragment-based%2520design%2520for%2520the%2520development%2520of%2520N-domain-selective%2520angiotensin-1-converting%2520enzyme%2520inhibitors%26jtitle%3DClin.%2520Sci.%26date%3D2014%26volume%3D126%26spage%3D305%26epage%3D313%26doi%3D10.1042%2FCS20130403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nathisuwan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbert, R. L.</span></span> <span> </span><span class="NLM_article-title">A review of vasopeptidase inhibitors: a new modality in the treatment of hypertension and chronic heart failure</span>. <i>Pharmacotherapy</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.1592/phco.22.1.27.33502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1592%2Fphco.22.1.27.33502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=11794428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvVKksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=27-42&author=S.+Nathisuwanauthor=R.+L.+Talbert&title=A+review+of+vasopeptidase+inhibitors%3A+a+new+modality+in+the+treatment+of+hypertension+and+chronic+heart+failure&doi=10.1592%2Fphco.22.1.27.33502"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A review of vasopeptidase inhibitors: A new modality in the treatment of hypertension and chronic heart failure</span></div><div class="casAuthors">Nathisuwan, Surakit; Talbert, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacotherapy</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">27-42</span>CODEN:
                <span class="NLM_cas:coden">PHPYDQ</span>;
        ISSN:<span class="NLM_cas:issn">0277-0008</span>.
    
            (<span class="NLM_cas:orgname">Pharmacotherapy Publications</span>)
        </div><div class="casAbstract">A review.  Vasopeptidase inhibitors are a group of agents capable of inhibiting neutral endopeptidase and angiotensin-converting enzymes, which leads to potentiation of natriuretic peptide actions and suppression of the reninangiotensin-aldosterone system.  With this distinctively characteristic mechanism, these agents have emerged as a new drug class for management of hypertension and heart failure.  Several vasopeptidase inhibitors are under clin. investigation.  Omapatrilat is the most studied agent in this class.  Clin. studies of omapatrilat in hypertension have consistently shown the agent's effectiveness in a variety of patient populations.  In patients with heart failure, omapatrilat significantly improved neurohormonal and hemodynamic status.  Long-term effects of omapatrilat in patients with heart failure recently were compared with those of conventional therapy in a large phase II trial.  Results of the study appear promising.  Large clin. trials are ongoing, and addnl. information regarding safety and efficacy from these studies may help define the place in therapy for this agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdG44q7150ybVg90H21EOLACvtfcHk0lgaFwXSWer0tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvVKksw%253D%253D&md5=1cecd58c809de787d03181d29e65169c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1592%2Fphco.22.1.27.33502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1592%252Fphco.22.1.27.33502%26sid%3Dliteratum%253Aachs%26aulast%3DNathisuwan%26aufirst%3DS.%26aulast%3DTalbert%26aufirst%3DR.%2BL.%26atitle%3DA%2520review%2520of%2520vasopeptidase%2520inhibitors%253A%2520a%2520new%2520modality%2520in%2520the%2520treatment%2520of%2520hypertension%2520and%2520chronic%2520heart%2520failure%26jtitle%3DPharmacotherapy%26date%3D2002%26volume%3D22%26spage%3D27%26epage%3D42%26doi%3D10.1592%2Fphco.22.1.27.33502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nussberger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cugno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amstutz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cicardi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pellacani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agostoni, A.</span></span> <span> </span><span class="NLM_article-title">Plasma bradykinin in angio-oedema</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>351</i></span>,  <span class="NLM_fpage">1693</span>– <span class="NLM_lpage">1697</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(97)09137-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1016%2FS0140-6736%2897%2909137-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=9734886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADyaK1cXkt1Sls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=1998&pages=1693-1697&author=J.+Nussbergerauthor=M.+Cugnoauthor=C.+Amstutzauthor=M.+Cicardiauthor=A.+Pellacaniauthor=A.+Agostoni&title=Plasma+bradykinin+in+angio-oedema&doi=10.1016%2FS0140-6736%2897%2909137-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Plasma bradykinin in angio-edema</span></div><div class="casAuthors">Nussberger, Juerg; Cugno, Massimo; Amstutz, Catherine; Cicardi, Marco; Pellacani, Andrea; Agostoni, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">9117</span>),
    <span class="NLM_cas:pages">1693-1697</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Lancet Ltd.</span>)
        </div><div class="casAbstract">Bradykinin is believed to be the main mediator of symptoms in hereditary (HA) and acquired (AA) angio-edema due to C1 esterase inhibitor deficiency, as well as in angio-edema that complicates treatment with inhibitors of angiotensin-converting enzyme (ACE).  Difficulties in the measurement of kinin concns., however, have so far precluded the demonstration of an incontrovertible change in plasma bradykinin concns. in these disorders.  By developing a reliable assay we have been able to follow bradykinin concns. during attacks and during remission in HA and in AA, and also in a patient treated with an ACE-inhibitor.  Liq.-phase extn., high-performance liq. chromatog., and RIA were used for specific measurement of plasma bradykinin concns. in 22 patients with HA and in 22 healthy volunteers of similar age and sex distribution.  Four patients with AA and one hypertensive patient treated with the ACE inhibitor captopril were also studied.  Among the healthy volunteers plasma bradykinin concn. was inversely proportional to age.  The geometric mean plasma bradykinin concn. in the healthy volunteers was 2.2 fmol/mL (SD 2.2), compared with 3.9 fmol/mL (3.7) among patients with HA during remission (p=0.095).  Bradykinin was also high in the patients with AA (10.4 fmol/mL [1.6]).  During acute attacks of edema, in both HA and AA, plasma bradykinin rose to two to 12 times the upper limit of normal.  Infusion of C1-esterase inhibitor (the deficient factor in both HA and AA) immediately lowered bradykinin concns.  In the patient receiving the ACE-inhibitor captopril, bradykinin concn. was very high at 47 fmol/mL during an acute attack of angio-edema, but normal at 3.2 fmol/mL in remission after withdrawal of the drug.  A sensitive method for measurement of plasma bradykinin provided the means to show that concns. of this peptide decrease with age in healthy people.  Although the differences between patients in remission and healthy controls did not reach statistical significance, there were substantial rises in bradykinin during acute attacks of hereditary, acquired, or captopril-induced angio-edema.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb4Tr2-3qhp7Vg90H21EOLACvtfcHk0lgaFwXSWer0tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkt1Sls74%253D&md5=16a3faac0fdb640549c75e1b93e2c3be</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2897%2909137-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252897%252909137-X%26sid%3Dliteratum%253Aachs%26aulast%3DNussberger%26aufirst%3DJ.%26aulast%3DCugno%26aufirst%3DM.%26aulast%3DAmstutz%26aufirst%3DC.%26aulast%3DCicardi%26aufirst%3DM.%26aulast%3DPellacani%26aufirst%3DA.%26aulast%3DAgostoni%26aufirst%3DA.%26atitle%3DPlasma%2520bradykinin%2520in%2520angio-oedema%26jtitle%3DLancet%26date%3D1998%26volume%3D351%26spage%3D1693%26epage%3D1697%26doi%3D10.1016%2FS0140-6736%2897%2909137-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cotton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuniasse, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazeux, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ianzer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Camargo, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of the C-domain of angiotensin I converting enzyme by bradykinin potentiating peptides</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">6065</span>– <span class="NLM_lpage">6071</span>, <span class="refDoi"> DOI: 10.1021/bi012121x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi012121x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=6065-6071&author=J.+Cottonauthor=M.+A.+Hayashiauthor=P.+Cuniasseauthor=G.+Vazeuxauthor=D.+Ianzerauthor=A.+C.+De+Camargoauthor=V.+Dive&title=Selective+inhibition+of+the+C-domain+of+angiotensin+I+converting+enzyme+by+bradykinin+potentiating+peptides&doi=10.1021%2Fbi012121x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fbi012121x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi012121x%26sid%3Dliteratum%253Aachs%26aulast%3DCotton%26aufirst%3DJ.%26aulast%3DHayashi%26aufirst%3DM.%2BA.%26aulast%3DCuniasse%26aufirst%3DP.%26aulast%3DVazeux%26aufirst%3DG.%26aulast%3DIanzer%26aufirst%3DD.%26aulast%3DDe%2BCamargo%26aufirst%3DA.%2BC.%26aulast%3DDive%26aufirst%3DV.%26atitle%3DSelective%2520inhibition%2520of%2520the%2520C-domain%2520of%2520angiotensin%2520I%2520converting%2520enzyme%2520by%2520bradykinin%2520potentiating%2520peptides%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D6065%26epage%3D6071%26doi%3D10.1021%2Fbi012121x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenzel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keshelava, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capecchi, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corvol, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernstein, K. E.</span></span> <span> </span><span class="NLM_article-title">Role of the N-terminal catalytic domain of angiotensin-converting enzyme investigated by targeted inactivation in mice</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">15946</span>– <span class="NLM_lpage">15953</span>, <span class="refDoi"> DOI: 10.1074/jbc.M400149200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1074%2Fjbc.M400149200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=15946-15953&author=S.+Fuchsauthor=H.+D.+Xiaoauthor=J.+M.+Coleauthor=J.+W.+Adamsauthor=K.+Frenzelauthor=A.+Michaudauthor=H.+Zhaoauthor=G.+Keshelavaauthor=M.+R.+Capecchiauthor=P.+Corvolauthor=K.+E.+Bernstein&title=Role+of+the+N-terminal+catalytic+domain+of+angiotensin-converting+enzyme+investigated+by+targeted+inactivation+in+mice&doi=10.1074%2Fjbc.M400149200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M400149200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M400149200%26sid%3Dliteratum%253Aachs%26aulast%3DFuchs%26aufirst%3DS.%26aulast%3DXiao%26aufirst%3DH.%2BD.%26aulast%3DCole%26aufirst%3DJ.%2BM.%26aulast%3DAdams%26aufirst%3DJ.%2BW.%26aulast%3DFrenzel%26aufirst%3DK.%26aulast%3DMichaud%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DKeshelava%26aufirst%3DG.%26aulast%3DCapecchi%26aufirst%3DM.%2BR.%26aulast%3DCorvol%26aufirst%3DP.%26aulast%3DBernstein%26aufirst%3DK.%2BE.%26atitle%3DRole%2520of%2520the%2520N-terminal%2520catalytic%2520domain%2520of%2520angiotensin-converting%2520enzyme%2520investigated%2520by%2520targeted%2520inactivation%2520in%2520mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D15946%26epage%3D15953%26doi%3D10.1074%2Fjbc.M400149200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louw, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span> <span> </span><span class="NLM_article-title">New ketomethylene inhibitor analogues: synthesis and assessment of structural determinants for N-domain selective inhibition of angiotensin-converting enzyme</span>. <i>Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>393</i></span>,  <span class="NLM_fpage">485</span>– <span class="NLM_lpage">493</span>, <span class="refDoi"> DOI: 10.1515/hsz-2012-0127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1515%2Fhsz-2012-0127" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=393&publication_year=2012&pages=485-493&author=R.+K.+Sharmaauthor=R.+G.+Douglasauthor=S.+Louwauthor=K.+Chibaleauthor=E.+D.+Sturrock&title=New+ketomethylene+inhibitor+analogues%3A+synthesis+and+assessment+of+structural+determinants+for+N-domain+selective+inhibition+of+angiotensin-converting+enzyme&doi=10.1515%2Fhsz-2012-0127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1515%2Fhsz-2012-0127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Fhsz-2012-0127%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DR.%2BK.%26aulast%3DDouglas%26aufirst%3DR.%2BG.%26aulast%3DLouw%26aufirst%3DS.%26aulast%3DChibale%26aufirst%3DK.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26atitle%3DNew%2520ketomethylene%2520inhibitor%2520analogues%253A%2520synthesis%2520and%2520assessment%2520of%2520structural%2520determinants%2520for%2520N-domain%2520selective%2520inhibition%2520of%2520angiotensin-converting%2520enzyme%26jtitle%3DBiol.%2520Chem.%26date%3D2012%26volume%3D393%26spage%3D485%26epage%3D493%26doi%3D10.1515%2Fhsz-2012-0127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erdos, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skidgel, R. A.</span></span> <span> </span><span class="NLM_article-title">Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones</span>. <i>FASEB J.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1096/fasebj.3.2.2521610</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1096%2Ffasebj.3.2.2521610" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1989&pages=145-151&author=E.+G.+Erdosauthor=R.+A.+Skidgel&title=Neutral+endopeptidase+24.11+%28enkephalinase%29+and+related+regulators+of+peptide+hormones&doi=10.1096%2Ffasebj.3.2.2521610"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1096%2Ffasebj.3.2.2521610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffasebj.3.2.2521610%26sid%3Dliteratum%253Aachs%26aulast%3DErdos%26aufirst%3DE.%2BG.%26aulast%3DSkidgel%26aufirst%3DR.%2BA.%26atitle%3DNeutral%2520endopeptidase%252024.11%2520%2528enkephalinase%2529%2520and%2520related%2520regulators%2520of%2520peptide%2520hormones%26jtitle%3DFASEB%2520J.%26date%3D1989%26volume%3D3%26spage%3D145%26epage%3D151%26doi%3D10.1096%2Ffasebj.3.2.2521610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roques, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noble, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dauge, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournie-Zaluski, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, A.</span></span> <span> </span><span class="NLM_article-title">Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology</span>. <i>Pharmacol Rev.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">87</span>– <span class="NLM_lpage">146</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1993&pages=87-146&author=B.+P.+Roquesauthor=F.+Nobleauthor=V.+Daugeauthor=M.+C.+Fournie-Zaluskiauthor=A.+Beaumont&title=Neutral+endopeptidase+24.11%3A+structure%2C+inhibition%2C+and+experimental+and+clinical+pharmacology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRoques%26aufirst%3DB.%2BP.%26aulast%3DNoble%26aufirst%3DF.%26aulast%3DDauge%26aufirst%3DV.%26aulast%3DFournie-Zaluski%26aufirst%3DM.%2BC.%26aulast%3DBeaumont%26aufirst%3DA.%26atitle%3DNeutral%2520endopeptidase%252024.11%253A%2520structure%252C%2520inhibition%252C%2520and%2520experimental%2520and%2520clinical%2520pharmacology%26jtitle%3DPharmacol%2520Rev.%26date%3D1993%26volume%3D45%26spage%3D87%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gros, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souque, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danvy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plaquevent, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duhamel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duhamel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecomte, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bralet, J.</span></span> <span> </span><span class="NLM_article-title">Mixed inhibitors of angiotensin-converting enzyme (EC 3.4.15.1) and enkephalinase (EC 3.4.24.11): rational design, properties, and potential cardiovascular applications of glycopril and alatriopril</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">4210</span>– <span class="NLM_lpage">4214</span>, <span class="refDoi"> DOI: 10.1073/pnas.88.10.4210</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1073%2Fpnas.88.10.4210" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1851998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADyaK3MXks1CgsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=4210-4214&author=C.+Grosauthor=N.+Noelauthor=A.+Souqueauthor=J.+C.+Schwartzauthor=D.+Danvyauthor=J.+C.+Plaqueventauthor=L.+Duhamelauthor=P.+Duhamelauthor=J.+M.+Lecomteauthor=J.+Bralet&title=Mixed+inhibitors+of+angiotensin-converting+enzyme+%28EC+3.4.15.1%29+and+enkephalinase+%28EC+3.4.24.11%29%3A+rational+design%2C+properties%2C+and+potential+cardiovascular+applications+of+glycopril+and+alatriopril&doi=10.1073%2Fpnas.88.10.4210"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Mixed inhibitors of angiotensin-converting enzyme (EC 3.4.15.1) and enkephalinase (EC 3.4.24.11):  rational design, properties, and potential cardiovascular applications of glycopril and alatriopril</span></div><div class="casAuthors">Gros, Claude; Noel, Nadine; Souque, Anny; Schwartz, Jean Charles; Danvy, Denis; Plaquevent, Jean Christophe; Duhamel, Lucette; Duhamel, Pierre; Lecomte, Jeanne Marie; Bralet, Jean</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4210-14</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Angiotensin-converting enzyme (ACE) and enkephalinase, two cell surface metallopeptidases, are responsible for angiotensin II formation and atrial natriuretic factor (ANF) degrdn., resp., and thereby play a crit. role in the metab. of hormonal peptides exerting essentially opposite actions in cardiovascular regulations.  To affect simultaneously both hormonal systems by a single mol. structure, glycoprilat and alatrioprilat [(S)-N-[3-(3,4-methylenedioxyphenyl)-2-(mercaptomethyl)-1-oxopropyl]glycine and -alanine, resp.] were designed.  In vitro the two compds. inhibit both ACE and enkephalinase activities with similar, nanomolar potencies, and in vivo, glycopril and alatriopril, the corresponding diester prodrugs, occupy the two enzyme mols. in lung at similar low dosages (0.2-0.5 mg/kg of body wt., per os).  The high potency of these compds. is attributable to interaction of the methylenedioxy group with the S1 subsite of ACE and of the arom. ring with the S1 subsite of enkephalinase.  In rodents, low doses of these mixed inhibitors exert typical actions of ACE inhibitors i.e., prevention of angiotensin I-induced hypertension, as well as of enkephalinase inhibitors i.e., protection from 125I-ANF degrdn. or enhancement of diuresis and natriuresis following acute extracellular vol. expansion.  In view of the known counterbalanced physiol. actions of the two hormone peptides, whose metab. is controlled by ACE and enkephalinase, mixed inhibitors of the two peptidases show promise for the treatment of various cardiovascular and salt-retention disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLpFAjkhE92rVg90H21EOLACvtfcHk0lgdkV_wpZhkPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXks1CgsbY%253D&md5=995e5d82e074b67c125d100e2704346f</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.88.10.4210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.88.10.4210%26sid%3Dliteratum%253Aachs%26aulast%3DGros%26aufirst%3DC.%26aulast%3DNoel%26aufirst%3DN.%26aulast%3DSouque%26aufirst%3DA.%26aulast%3DSchwartz%26aufirst%3DJ.%2BC.%26aulast%3DDanvy%26aufirst%3DD.%26aulast%3DPlaquevent%26aufirst%3DJ.%2BC.%26aulast%3DDuhamel%26aufirst%3DL.%26aulast%3DDuhamel%26aufirst%3DP.%26aulast%3DLecomte%26aufirst%3DJ.%2BM.%26aulast%3DBralet%26aufirst%3DJ.%26atitle%3DMixed%2520inhibitors%2520of%2520angiotensin-converting%2520enzyme%2520%2528EC%25203.4.15.1%2529%2520and%2520enkephalinase%2520%2528EC%25203.4.24.11%2529%253A%2520rational%2520design%252C%2520properties%252C%2520and%2520potential%2520cardiovascular%2520applications%2520of%2520glycopril%2520and%2520alatriopril%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1991%26volume%3D88%26spage%3D4210%26epage%3D4214%26doi%3D10.1073%2Fpnas.88.10.4210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robl, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryono, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simpkins, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cimarusti, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dejneka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slusarchyk, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratton, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misra, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bednarz, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asaad, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abboa-Offei, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathers, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seymour, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trippodo, N. C.</span></span> <span> </span><span class="NLM_article-title">Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1570</span>– <span class="NLM_lpage">1577</span>, <span class="refDoi"> DOI: 10.1021/jm970041e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970041e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADyaK2sXjtFSjtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1570-1577&author=J.+A.+Roblauthor=C.+Q.+Sunauthor=J.+Stevensonauthor=D.+E.+Ryonoauthor=L.+M.+Simpkinsauthor=M.+P.+Cimarustiauthor=T.+Dejnekaauthor=W.+A.+Slusarchykauthor=S.+Chaoauthor=L.+Strattonauthor=R.+N.+Misraauthor=M.+S.+Bednarzauthor=M.+M.+Asaadauthor=H.+S.+Cheungauthor=B.+E.+Abboa-Offeiauthor=P.+L.+Smithauthor=P.+D.+Mathersauthor=M.+Foxauthor=T.+R.+Schaefferauthor=A.+A.+Seymourauthor=N.+C.+Trippodo&title=Dual+metalloprotease+inhibitors%3A+mercaptoacetyl-based+fused+heterocyclic+dipeptide+mimetics+as+inhibitors+of+angiotensin-converting+enzyme+and+neutral+endopeptidase&doi=10.1021%2Fjm970041e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Dual Metalloprotease Inhibitors: Mercaptoacetyl-Based Fused Heterocyclic Dipeptide Mimetics as Inhibitors of Angiotensin-Converting Enzyme and Neutral Endopeptidase</span></div><div class="casAuthors">Robl, Jeffrey A.; Sun, Chong-Qing; Stevenson, Jay; Ryono, Denis E.; Simpkins, Ligaya M.; Cimarusti, Maria P.; Dejneka, Tamara; Slusarchyk, William A.; Chao, Sam; Stratton, Leslie; Misra, Raj N.; Bednarz, Mark S.; Asaad, Magdi M.; Cheung, Hong Son; Abboa-Offei, Benoni E.; Smith, Patricia L.; Mathers, Parker D.; Fox, Maxine; Schaeffer, Thomas R.; Seymour, Andrea A.; Trippodo, Nick C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1570-1577</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 7,6- and 7,5-fused bicyclic thiazepinones and oxazepinones were generated and incorporated as conformationally restricted dipeptide surrogates in mercaptoacyl dipeptides.  These compds. are potent inhibitors of angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP) both in vitro and in vivo.  Compd. 1a, a 7,6-fused bicyclic thiazepinone, demonstrated excellent blood pressure lowering in a variety of animal models characterized by various levels of plasma renin activity and significantly potentiated urinary sodium, ANP, and cGMP excretion in a cynomolgus monkey assay.  On the basis of its potency and duration of action, compd. 1a (BMS-186716) was advanced into clin. development for the treatment of hypertension and congestive heart failure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpA1AhNVtyuOrVg90H21EOLACvtfcHk0limYuT80RVDTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtFSjtbY%253D&md5=e255086829b24dd59c25c1991ba04264</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm970041e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970041e%26sid%3Dliteratum%253Aachs%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26aulast%3DSun%26aufirst%3DC.%2BQ.%26aulast%3DStevenson%26aufirst%3DJ.%26aulast%3DRyono%26aufirst%3DD.%2BE.%26aulast%3DSimpkins%26aufirst%3DL.%2BM.%26aulast%3DCimarusti%26aufirst%3DM.%2BP.%26aulast%3DDejneka%26aufirst%3DT.%26aulast%3DSlusarchyk%26aufirst%3DW.%2BA.%26aulast%3DChao%26aufirst%3DS.%26aulast%3DStratton%26aufirst%3DL.%26aulast%3DMisra%26aufirst%3DR.%2BN.%26aulast%3DBednarz%26aufirst%3DM.%2BS.%26aulast%3DAsaad%26aufirst%3DM.%2BM.%26aulast%3DCheung%26aufirst%3DH.%2BS.%26aulast%3DAbboa-Offei%26aufirst%3DB.%2BE.%26aulast%3DSmith%26aufirst%3DP.%2BL.%26aulast%3DMathers%26aufirst%3DP.%2BD.%26aulast%3DFox%26aufirst%3DM.%26aulast%3DSchaeffer%26aufirst%3DT.%2BR.%26aulast%3DSeymour%26aufirst%3DA.%2BA.%26aulast%3DTrippodo%26aufirst%3DN.%2BC.%26atitle%3DDual%2520metalloprotease%2520inhibitors%253A%2520mercaptoacetyl-based%2520fused%2520heterocyclic%2520dipeptide%2520mimetics%2520as%2520inhibitors%2520of%2520angiotensin-converting%2520enzyme%2520and%2520neutral%2520endopeptidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1570%26epage%3D1577%26doi%3D10.1021%2Fjm970041e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Azizi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massien, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corvol, P.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo inhibition of the 2 active sites of ACE by omapatrilat, a vasopeptidase inhibitor</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">1226</span>– <span class="NLM_lpage">1231</span>, <span class="refDoi"> DOI: 10.1161/01.HYP.35.6.1226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1161%2F01.HYP.35.6.1226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10856268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksVCntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2000&pages=1226-1231&author=M.+Aziziauthor=C.+Massienauthor=A.+Michaudauthor=P.+Corvol&title=In+vitro+and+in+vivo+inhibition+of+the+2+active+sites+of+ACE+by+omapatrilat%2C+a+vasopeptidase+inhibitor&doi=10.1161%2F01.HYP.35.6.1226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo inhibition of the 2 active sites of ACE by omapatrilat, a vasopeptidase inhibitor</span></div><div class="casAuthors">Azizi, Michel; Massien, Christine; Michaud, Annie; Corvol, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1226-1231</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">The vasopeptidase inhibitor omapatrilat inhibits both neutral endopeptidase and angiotensin-converting enzyme (ACE).  The in vitro and in vivo inhibitory potency of omapatrilat and the specific ACE inhibitor fosinopril toward the 2 active sites of ACE (called N- and C-domains) was investigated with the use of 3 substrates: angiotensin I, which is equally cleaved by the 2 ACE domains; hippuryl-histidyl-leucine, specific synthetic substrate of the C-domain in high-salt conditions; and a newly synthesized specific substrate of the N-domain designed by acetylating the lysine residue of AcSDKP.  In vitro, omapatrilat was 5 times more potent than fosinoprilat in inhibiting angiotensin I hydrolysis.  Omapatrilat inhibited similarly both N- and C-domain hydrolysis, whereas fosinoprilat was slightly more specific for the N-domain.  The in vivo selective inhibitory potency of single oral doses of 10 mg omapatrilat and 20 mg fosinopril were investigated in a double-blind, placebo-controlled, cross-over study in 9 mildly sodium-depleted normotensive subjects.  In accordance with the in vitro results, fosinopril appeared to be more specific for the N-domain than the C-domain in vivo, since plasma and urine AcSDKP concns. were significantly higher than those obsd. with omapatrilat.  This study shows that it is possible to assess sep. in vitro and in vivo the selectivity of ACE or ACE/neutral endopeptidase inhibitors.  A differential selectivity may explain some peculiar properties obsd. with some ACE inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpEX7zuaqkurVg90H21EOLACvtfcHk0limYuT80RVDTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksVCntr0%253D&md5=961802b4e2984e1d80acb5e49dbac749</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1161%2F01.HYP.35.6.1226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.HYP.35.6.1226%26sid%3Dliteratum%253Aachs%26aulast%3DAzizi%26aufirst%3DM.%26aulast%3DMassien%26aufirst%3DC.%26aulast%3DMichaud%26aufirst%3DA.%26aulast%3DCorvol%26aufirst%3DP.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520inhibition%2520of%2520the%25202%2520active%2520sites%2520of%2520ACE%2520by%2520omapatrilat%252C%2520a%2520vasopeptidase%2520inhibitor%26jtitle%3DHypertension%26date%3D2000%26volume%3D35%26spage%3D1226%26epage%3D1231%26doi%3D10.1161%2F01.HYP.35.6.1226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fryer, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segreti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banfor, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widomski, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backes, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballaron, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trevillyan, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhart, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Geldern, T. W.</span></span> <span> </span><span class="NLM_article-title">Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>153</i></span>,  <span class="NLM_fpage">947</span>– <span class="NLM_lpage">955</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0707641</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1038%2Fsj.bjp.0707641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=18084312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD1cXislWis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=947-955&author=R.+M.+Fryerauthor=J.+Segretiauthor=P.+N.+Banforauthor=D.+L.+Widomskiauthor=B.+J.+Backesauthor=C.+W.+Linauthor=S.+J.+Ballaronauthor=B.+F.+Coxauthor=J.+M.+Trevillyanauthor=G.+A.+Reinhartauthor=T.+W.+von+Geldern&title=Effect+of+bradykinin+metabolism+inhibitors+on+evoked+hypotension+in+rats%3A+rank+efficacy+of+enzymes+associated+with+bradykinin-mediated+angioedema&doi=10.1038%2Fsj.bjp.0707641"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema</span></div><div class="casAuthors">Fryer, R. M.; Segreti, J.; Banfor, P. N.; Widomski, D. L.; Backes, B. J.; Lin, C. W.; Ballaron, S. J.; Cox, B. F.; Trevillyan, J. M.; Reinhart, G. A.; von Geldern, T. W.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">947-955</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inhibition of bradykinin metabolizing enzymes (BMEs) can cause acute angioedema, as demonstrated in a recent clin. trial in patients administered the antihypertensive, omapatrilat.  However, the relative contribution of specific BMEs to this effect is unclear and confounded by the lack of a predictive pre-clin. model of angioedema.  Rats were instrumented to record blood pressure and heart rate; inhibitors were infused for 35 min and bradykinin was infused during the last 5 min to elicit hypotension, as a functional marker of circulating bradykinin and relative angioedema risk.  In the presence of omapatrilat, bradykinin produced dose-dependent hypotension, an effect abolished by B2 blockade.  In the presence of lisinopril (ACE inhibitor), but not candoxatril (NEP inhibitor) or apstatin (APP inhibitor), bradykinin also elicited hypotension.  Lisinopril-mediated hypotension was unchanged with concomitant blockade of NEP or NEP/DPPIV (candoxatril + A-899301).  However, hypotension was enhanced upon concomitant blockade of APP and further intensified in the presence of NEP inhibition to values not different from omapatrilat alone.  We demonstrated that bradykinin is degraded in vivo with an enzyme rank-efficacy of ACE>APP»NEP or DPPIV.  These results suggest the effects of omapatrilat are mediated by inhibition of three BMEs, ACE/APP/NEP.  However, dual inhibition of ACE/NEP or ACE/NEP/DPPIV elicits no increased risk of angioedema compared to ACE inhibition alone.  Thus, novel BME inhibitors must display no activity against APP to avoid angioedema risk due to high prevalence of ACE inhibitor therapy in patients with diabetes and cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHe-dQxhoWF7Vg90H21EOLACvtfcHk0lgm9CG0A_sXdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXislWis7Y%253D&md5=e3067cd71575b8f32a623ef6a0303569</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707641%26sid%3Dliteratum%253Aachs%26aulast%3DFryer%26aufirst%3DR.%2BM.%26aulast%3DSegreti%26aufirst%3DJ.%26aulast%3DBanfor%26aufirst%3DP.%2BN.%26aulast%3DWidomski%26aufirst%3DD.%2BL.%26aulast%3DBackes%26aufirst%3DB.%2BJ.%26aulast%3DLin%26aufirst%3DC.%2BW.%26aulast%3DBallaron%26aufirst%3DS.%2BJ.%26aulast%3DCox%26aufirst%3DB.%2BF.%26aulast%3DTrevillyan%26aufirst%3DJ.%2BM.%26aulast%3DReinhart%26aufirst%3DG.%2BA.%26aulast%3Dvon%2BGeldern%26aufirst%3DT.%2BW.%26atitle%3DEffect%2520of%2520bradykinin%2520metabolism%2520inhibitors%2520on%2520evoked%2520hypotension%2520in%2520rats%253A%2520rank%2520efficacy%2520of%2520enzymes%2520associated%2520with%2520bradykinin-mediated%2520angioedema%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3D947%26epage%3D955%26doi%3D10.1038%2Fsj.bjp.0707641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kostis, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Black, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmieder, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, E.</span></span> <span> </span><span class="NLM_article-title">Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial</span>. <i>Am. J. Hypertens.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">103</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1016/j.amjhyper.2003.09.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1016%2Fj.amjhyper.2003.09.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=14751650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvF2gtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=103-111&author=J.+B.+Kostisauthor=M.+Packerauthor=H.+R.+Blackauthor=R.+Schmiederauthor=D.+Henryauthor=E.+Levy&title=Omapatrilat+and+enalapril+in+patients+with+hypertension%3A+the+Omapatrilat+Cardiovascular+Treatment+vs.+Enalapril+%28OCTAVE%29+trial&doi=10.1016%2Fj.amjhyper.2003.09.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial</span></div><div class="casAuthors">Kostis, John B.; Packer, Milton; Black, Henry R.; Schmieder, Roland; Henry, David; Levy, Elliott</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Hypertension</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">103-111</span>CODEN:
                <span class="NLM_cas:coden">AJHYE6</span>;
        ISSN:<span class="NLM_cas:issn">0895-7061</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Recent reports suggest that existing antihypertensive agents may not have sufficient efficacy to control blood pressure (BP) in many patients.  Omapatrilat, an agent under development, has been shown to have significantly greater antihypertensive efficacy than existing agents, but may also carry increased risk of angioedema.  We compared the efficacy and safety of omapatrilat to a representative angiotensin-converting enzyme (ACE) inhibitor, enalapril.  The Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial is a multicenter, randomized, double-blind, active-controlled, 24-wk trial in 25,302 patients with untreated or uncontrolled hypertension conducted in 3298 office-based sites in 12 countries.  Subjects were randomized to omapatrilat 10 mg or enalapril 5 mg as initial therapy for hypertension (group 1, n = 9292), replacement for existing antihypertensive therapy (group 2, n = 11,224), or in addn. to existing antihypertensive therapy (group 3, n = 4751).  Study drug was force-titrated at week 2 and electively titrated at weeks 4 and 6 to a max. of omapatrilat 80 mg or enalapril 40 mg once daily.  At weeks 8 and 16, adjunctive antihypertensive medications were added electively to achieve target BP.  Omapatrilat reduced systolic BP 3.6 mm Hg more than enalapril at week 8, and was assocd. with less use of adjunctive antihypertensive therapy by week 24 (19% v 27%; P < 0.001 for both comparisons).  Subjects randomized to omapatrilat were more likely to reach BP target, regardless of demographics or comorbid conditions and whether omapatrilat was used as initial therapy, replacement for existing therapy, or in addn. to existing therapy.  Angioedema was more frequent with omapatrilat than enalapril (2.17% v 0.68%).  Two omapatrilat-treated subjects experienced angioedema with airway compromise, which was successfully treated.  Omapatrilat provided broadly superior antihypertensive efficacy when used in a setting resembling clin. practice.  Angioedema was more common than with enalapril but life-threatening angioedema was rare.  The risk-benefit profile for omapatrilat in clin. use therefore appears likely to be favorable in appropriate patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPTjmO9Y1hr7Vg90H21EOLACvtfcHk0lgm9CG0A_sXdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvF2gtw%253D%253D&md5=a783f9aa5c8d243ac3c077b601918535</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.amjhyper.2003.09.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.amjhyper.2003.09.014%26sid%3Dliteratum%253Aachs%26aulast%3DKostis%26aufirst%3DJ.%2BB.%26aulast%3DPacker%26aufirst%3DM.%26aulast%3DBlack%26aufirst%3DH.%2BR.%26aulast%3DSchmieder%26aufirst%3DR.%26aulast%3DHenry%26aufirst%3DD.%26aulast%3DLevy%26aufirst%3DE.%26atitle%3DOmapatrilat%2520and%2520enalapril%2520in%2520patients%2520with%2520hypertension%253A%2520the%2520Omapatrilat%2520Cardiovascular%2520Treatment%2520vs.%2520Enalapril%2520%2528OCTAVE%2529%2520trial%26jtitle%3DAm.%2520J.%2520Hypertens.%26date%3D2004%26volume%3D17%26spage%3D103%26epage%3D111%26doi%3D10.1016%2Fj.amjhyper.2003.09.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Natesh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwager, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K. R.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the human angiotensin-converting enzyme-lisinopril complex</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>421</i></span>,  <span class="NLM_fpage">551</span>– <span class="NLM_lpage">554</span>, <span class="refDoi"> DOI: 10.1038/nature01370</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1038%2Fnature01370" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=12540854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntFSqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2003&pages=551-554&author=R.+Nateshauthor=S.+L.+Schwagerauthor=E.+D.+Sturrockauthor=K.+R.+Acharya&title=Crystal+structure+of+the+human+angiotensin-converting+enzyme-lisinopril+complex&doi=10.1038%2Fnature01370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the human angiotensin-converting enzyme-lisinopril complex</span></div><div class="casAuthors">Natesh, Ramanathan; Schwager, Sylva L. U.; Sturrock, Edward D.; Acharya, K. Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">421</span>
        (<span class="NLM_cas:issue">6922</span>),
    <span class="NLM_cas:pages">551-554</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Angiotensin-converting enzyme (ACE) has a crit. role in cardiovascular function by cleaving the carboxy terminal His-Leu dipeptide from angiotensin I to produce a potent vasopressor octapeptide, angiotensin II.  Inhibitors of ACE are a first line of therapy for hypertension, heart failure, myocardial infarction and diabetic nephropathy.  Notably, these inhibitors were developed without knowledge of the structure of human ACE, but were instead designed on the basis of an assumed mechanistic homol. with carboxypeptidase A.  Here we present the x-ray structure of human testicular ACE and its complex with one of the most widely used inhibitors, lisinopril (N2-[(S)-1-carboxy-3-phenylpropyl]-l-lysyl-l-proline; also known as Prinivil or Zestril), at 2.0 Å resoln.  Anal. of the three-dimensional structure of ACE shows that it bears little similarity to that of carboxypeptidase A, but instead resembles neurolysin and Pyrococcus furiosus carboxypeptidase-zinc metallopeptidases with no detectable sequence similarity to ACE.  The structure provides an opportunity to design domain-selective ACE inhibitors that may exhibit new pharmacol. profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxHYbWU8PmP7Vg90H21EOLACvtfcHk0lgm9CG0A_sXdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntFSqtg%253D%253D&md5=84f2f474ac20541b0352691128782b1d</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnature01370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01370%26sid%3Dliteratum%253Aachs%26aulast%3DNatesh%26aufirst%3DR.%26aulast%3DSchwager%26aufirst%3DS.%2BL.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26atitle%3DCrystal%2520structure%2520of%2520the%2520human%2520angiotensin-converting%2520enzyme-lisinopril%2520complex%26jtitle%3DNature%26date%3D2003%26volume%3D421%26spage%3D551%26epage%3D554%26doi%3D10.1038%2Fnature01370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cozier, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwager, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K. R.</span></span> <span> </span><span class="NLM_article-title">Crystal structures of sampatrilat and sampatrilat-Asp in complex with human ACE - a molecular basis for domain selectivity</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">1477</span>– <span class="NLM_lpage">1490</span>, <span class="refDoi"> DOI: 10.1111/febs.14421</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1111%2Ffebs.14421" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=29476645" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC1cXktV2nur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2018&pages=1477-1490&author=G.+E.+Cozierauthor=S.+L.+Schwagerauthor=R.+K.+Sharmaauthor=K.+Chibaleauthor=E.+D.+Sturrockauthor=K.+R.+Acharya&title=Crystal+structures+of+sampatrilat+and+sampatrilat-Asp+in+complex+with+human+ACE+-+a+molecular+basis+for+domain+selectivity&doi=10.1111%2Ffebs.14421"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of sampatrilat and sampatrilat-Asp in complex with human ACE - a molecular basis for domain selectivity</span></div><div class="casAuthors">Cozier, Gyles E.; Schwager, Sylva L.; Sharma, Rajni K.; Chibale, Kelly; Sturrock, Edward D.; Acharya, K. Ravi</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1477-1490</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Angiotensin-1-converting enzyme (ACE) is a zinc metallopeptidase that consists of two homologous catalytic domains (known as nACE and cACE) with different substrate specificities.  Based on kinetic studies it was previously reported that sampatrilat, a tight-binding inhibitor of ACE, Ki = 13.8 nM and 171.9 nM for cACE and nACE resp. [Sharma et al., Journal of Chem. Information and Modeling (2016), 56, 2486-2494], was 12.4-fold more selective for cACE.  In addn., sampatrilat-Asp (samAsp), in which an aspartate group replaces the sampatrilat lysine, was found to be a nonspecific and lower micromolar affinity inhibitor.  Here, we report a detailed three-dimensional structural anal. of sampatrilat and samAsp binding to ACE using high-resoln. crystal structures elucidated by X-ray crystallog., which provides a mol. basis for differences in inhibitor affinity and selectivity for nACE and cACE.  The structures show that the specificity of sampatrilat can be explained by increased hydrophobic interactions and a H-bond from Glu403 of cACE with the lysine side chain of sampatrilat that are not obsd. in nACE.  In addn., the structures clearly show a significantly greater no. of hydrophilic and hydrophobic interactions with sampatrilat compared to samAsp in both cACE and nACE consistent with the difference in affinities.  Our findings provide new exptl. insights into ligand binding at the active site pockets that are important for the design of highly specific domain selective inhibitors of ACE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgO5eB50LzpbVg90H21EOLACvtfcHk0lhwEQAkd_o-MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXktV2nur8%253D&md5=407be458962d79e4fa0e512e01bb7e04</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1111%2Ffebs.14421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.14421%26sid%3Dliteratum%253Aachs%26aulast%3DCozier%26aufirst%3DG.%2BE.%26aulast%3DSchwager%26aufirst%3DS.%2BL.%26aulast%3DSharma%26aufirst%3DR.%2BK.%26aulast%3DChibale%26aufirst%3DK.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26atitle%3DCrystal%2520structures%2520of%2520sampatrilat%2520and%2520sampatrilat-Asp%2520in%2520complex%2520with%2520human%2520ACE%2520-%2520a%2520molecular%2520basis%2520for%2520domain%2520selectivity%26jtitle%3DFEBS%2520J.%26date%3D2018%26volume%3D285%26spage%3D1477%26epage%3D1490%26doi%3D10.1111%2Ffebs.14421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Larmuth, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuyer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwager, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span> <span> </span><span class="NLM_article-title">Kinetic and structural characterization of amyloid-beta peptide hydrolysis by human angiotensin-1-converting enzyme</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>283</i></span>,  <span class="NLM_fpage">1060</span>– <span class="NLM_lpage">1076</span>, <span class="refDoi"> DOI: 10.1111/febs.13647</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1111%2Ffebs.13647" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2016&pages=1060-1076&author=K.+M.+Larmuthauthor=G.+Masuyerauthor=R.+G.+Douglasauthor=S.+L.+Schwagerauthor=K.+R.+Acharyaauthor=E.+D.+Sturrock&title=Kinetic+and+structural+characterization+of+amyloid-beta+peptide+hydrolysis+by+human+angiotensin-1-converting+enzyme&doi=10.1111%2Ffebs.13647"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1111%2Ffebs.13647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.13647%26sid%3Dliteratum%253Aachs%26aulast%3DLarmuth%26aufirst%3DK.%2BM.%26aulast%3DMasuyer%26aufirst%3DG.%26aulast%3DDouglas%26aufirst%3DR.%2BG.%26aulast%3DSchwager%26aufirst%3DS.%2BL.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26atitle%3DKinetic%2520and%2520structural%2520characterization%2520of%2520amyloid-beta%2520peptide%2520hydrolysis%2520by%2520human%2520angiotensin-1-converting%2520enzyme%26jtitle%3DFEBS%2520J.%26date%3D2016%26volume%3D283%26spage%3D1060%26epage%3D1076%26doi%3D10.1111%2Ffebs.13647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akif, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuyer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingham, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaac, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K. R.</span></span> <span> </span><span class="NLM_article-title">Structural basis of peptide recognition by the angiotensin-1 converting enzyme homologue AnCE from Drosophila melanogaster</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>279</i></span>,  <span class="NLM_fpage">4525</span>– <span class="NLM_lpage">4534</span>, <span class="refDoi"> DOI: 10.1111/febs.12038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1111%2Ffebs.12038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=23082758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslKrtLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2012&pages=4525-4534&author=M.+Akifauthor=G.+Masuyerauthor=R.+J.+Binghamauthor=E.+D.+Sturrockauthor=R.+E.+Isaacauthor=K.+R.+Acharya&title=Structural+basis+of+peptide+recognition+by+the+angiotensin-1+converting+enzyme+homologue+AnCE+from+Drosophila+melanogaster&doi=10.1111%2Ffebs.12038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of peptide recognition by the angiotensin-1 converting enzyme homologue AnCE from Drosophila melanogaster</span></div><div class="casAuthors">Akif, Mohd; Masuyer, Geoffrey; Bingham, Richard J.; Sturrock, Edward D.; Isaac, R. Elwyn; Acharya, K. Ravi</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4525-4534</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Human somatic angiotensin-1 converting enzyme (ACE) is a zinc-dependent exopeptidase, that catalyzes the conversion of the decapeptide angiotensin I to the octapeptide angiotensin II, by removing a C-terminal dipeptide.  It is the principal component of the renin-angiotensin-aldosterone system that regulates blood pressure.  Hence it is an important therapeutic target for the treatment of hypertension and cardiovascular disorders.  Here, we report the structures of an ACE homolog from Drosophila melanogaster (AnCE; a proven structural model for the more complex human ACE) co-crystd. with mammalian peptide substrates (bradykinin, Thr6-bradykinin, angiotensin I, and a snake venom peptide inhibitor, bradykinin-potentiating peptide-b).  The structures detd. at 2-Å resoln. illustrate that both angiotensin II (the cleaved product of angiotensin I by AnCE) and bradykinin-potentiating peptide-b bind in an analogous fashion at the active site of AnCE, but also exhibit significant differences.  In addn., the binding of Arg-Pro-Pro, the cleavage product of bradykinin and Thr6- bradykinin, provides addnl. detail of the general peptide binding in AnCE.  Thus the new structures of AnCE complexes presented here improves our understanding of the binding of peptides and the mechanism by which peptides inhibit this family of enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1E5hdVAxySLVg90H21EOLACvtfcHk0lhwEQAkd_o-MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslKrtLbL&md5=0f8d7e8f1ff891560717214e2c7b6858</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1111%2Ffebs.12038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Ffebs.12038%26sid%3Dliteratum%253Aachs%26aulast%3DAkif%26aufirst%3DM.%26aulast%3DMasuyer%26aufirst%3DG.%26aulast%3DBingham%26aufirst%3DR.%2BJ.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26aulast%3DIsaac%26aufirst%3DR.%2BE.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26atitle%3DStructural%2520basis%2520of%2520peptide%2520recognition%2520by%2520the%2520angiotensin-1%2520converting%2520enzyme%2520homologue%2520AnCE%2520from%2520Drosophila%2520melanogaster%26jtitle%3DFEBS%2520J.%26date%3D2012%26volume%3D279%26spage%3D4525%26epage%3D4534%26doi%3D10.1111%2Ffebs.12038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cotton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yiotakis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaud, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassiliou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiracek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazeux, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauvet, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuniasse, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corvol, P.</span></span> <span> </span><span class="NLM_article-title">RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">4330</span>– <span class="NLM_lpage">4335</span>, <span class="refDoi"> DOI: 10.1073/pnas.96.8.4330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1073%2Fpnas.96.8.4330" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=4330-4335&author=V.+Diveauthor=J.+Cottonauthor=A.+Yiotakisauthor=A.+Michaudauthor=S.+Vassiliouauthor=J.+Jiracekauthor=G.+Vazeuxauthor=M.+T.+Chauvetauthor=P.+Cuniasseauthor=P.+Corvol&title=RXP+407%2C+a+phosphinic+peptide%2C+is+a+potent+inhibitor+of+angiotensin+I+converting+enzyme+able+to+differentiate+between+its+two+active+sites&doi=10.1073%2Fpnas.96.8.4330"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.8.4330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.8.4330%26sid%3Dliteratum%253Aachs%26aulast%3DDive%26aufirst%3DV.%26aulast%3DCotton%26aufirst%3DJ.%26aulast%3DYiotakis%26aufirst%3DA.%26aulast%3DMichaud%26aufirst%3DA.%26aulast%3DVassiliou%26aufirst%3DS.%26aulast%3DJiracek%26aufirst%3DJ.%26aulast%3DVazeux%26aufirst%3DG.%26aulast%3DChauvet%26aufirst%3DM.%2BT.%26aulast%3DCuniasse%26aufirst%3DP.%26aulast%3DCorvol%26aufirst%3DP.%26atitle%3DRXP%2520407%252C%2520a%2520phosphinic%2520peptide%252C%2520is%2520a%2520potent%2520inhibitor%2520of%2520angiotensin%2520I%2520converting%2520enzyme%2520able%2520to%2520differentiate%2520between%2520its%2520two%2520active%2520sites%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D4330%26epage%3D4335%26doi%3D10.1073%2Fpnas.96.8.4330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akif, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwager, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarny, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K. R.</span></span> <span> </span><span class="NLM_article-title">Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>436</i></span>,  <span class="NLM_fpage">53</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1042/BJ20102123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1042%2FBJ20102123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=21352096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsFGntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2011&pages=53-59&author=M.+Akifauthor=S.+L.+Schwagerauthor=C.+S.+Anthonyauthor=B.+Czarnyauthor=F.+Beauauthor=V.+Diveauthor=E.+D.+Sturrockauthor=K.+R.+Acharya&title=Novel+mechanism+of+inhibition+of+human+angiotensin-I-converting+enzyme+%28ACE%29+by+a+highly+specific+phosphinic+tripeptide&doi=10.1042%2FBJ20102123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide</span></div><div class="casAuthors">Akif, Mohd.; Schwager, Sylva L.; Anthony, Colin S.; Czarny, Bertrand; Beau, Fabrice; Dive, Vincent; Sturrock, Edward D.; Acharya, K. Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">436</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">53-59</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Human ACE (angiotensin-I-converting enzyme) has long been regarded as an excellent target for the treatment of hypertension and related cardiovascular diseases.  Highly potent inhibitors have been developed and are extensively used in the clinic.  To develop inhibitors with higher therapeutic efficacy and reduced side effects, recent efforts have been directed towards the discovery of compds. able to simultaneously block more than one zinc metallopeptidase (apart from ACE) involved in blood pressure regulation in humans, such as neprilysin and ECE-1 (endothelin-converting enzyme-1).  In the present paper, we show the first structures of testis ACE [C-ACE, which is identical with the C-domain of somatic ACE and the dominant domain responsible for blood pressure regulation, at 1.97Å (1 Å=0.1 nm)] and the N-domain of somatic ACE (N-ACE, at 2.15Å) in complex with a highly potent and selective dual ACE/ECE-1 inhibitor.  The structural determinants revealed unique features of the binding of two mols. of the dual inhibitor in the active site of C-ACE.  In both structures, the first mol. is positioned in the obligatory binding site and has a bulky bicyclic P1' residue with the unusual R configuration which, surprisingly, is accommodated by the large S2' pocket.  In the C-ACE complex, the isoxazole Ph group of the second mol. makes strong pi-pi stacking interactions with the amino benzoyl group of the first mol. locking them in a hand-shake' conformation.  These features, for the first time, highlight the unusual architecture and flexibility of the active site of C-ACE, which could be further utilized for structure-based design of new C-ACE or vasopeptidase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzDrSwHKC1kbVg90H21EOLACvtfcHk0lgfsiNAshxGrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsFGntbo%253D&md5=9f596a4891cc2645c711efe630b2bc81</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1042%2FBJ20102123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20102123%26sid%3Dliteratum%253Aachs%26aulast%3DAkif%26aufirst%3DM.%26aulast%3DSchwager%26aufirst%3DS.%2BL.%26aulast%3DAnthony%26aufirst%3DC.%2BS.%26aulast%3DCzarny%26aufirst%3DB.%26aulast%3DBeau%26aufirst%3DF.%26aulast%3DDive%26aufirst%3DV.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26atitle%3DNovel%2520mechanism%2520of%2520inhibition%2520of%2520human%2520angiotensin-I-converting%2520enzyme%2520%2528ACE%2529%2520by%2520a%2520highly%2520specific%2520phosphinic%2520tripeptide%26jtitle%3DBiochem.%2520J.%26date%3D2011%26volume%3D436%26spage%3D53%26epage%3D59%26doi%3D10.1042%2FBJ20102123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masuyer, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwager, S. L. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isaac, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K. R.</span></span> <span> </span><span class="NLM_article-title">Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">717</span>, <span class="refDoi"> DOI: 10.1038/srep00717</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1038%2Fsrep00717" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=23056909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1GksrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=717&author=G.+Masuyerauthor=S.+L.+U.+Schwagerauthor=E.+D.+Sturrockauthor=R.+E.+Isaacauthor=K.+R.+Acharya&title=Molecular+recognition+and+regulation+of+human+angiotensin-I+converting+enzyme+%28ACE%29+activity+by+natural+inhibitory+peptides&doi=10.1038%2Fsrep00717"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides</span></div><div class="casAuthors">Masuyer, Geoffrey; Schwager, Sylva L. U.; Sturrock, Edward D.; Isaac, R. Elwyn; Acharya, K. Ravi</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">717/1-717/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Angiotensin-I converting enzyme (ACE), a two-domain dipeptidylcarboxypeptidase, is a key regulator of blood pressure as a result of its crit. role in the renin-angiotensin-aldosterone and kallikrein-kinin systems.  Hence it is an important drug target in the treatment of cardiovascular diseases.  ACE is primarily known for its ability to cleave angiotensin I (Ang I) to the vasoactive octapeptide angiotensin II (Ang II), but is also able to cleave a no. of other substrates including the vasodilator bradykinin and N-acetyl-Ser-Asp-Lys-Pro (Ac-SDKP), a physiol. modulator of hematopoiesis.  For the first time we provide a detailed biochem. and structural basis for the domain selectivity of the natural peptide inhibitors of ACE, bradykinin potentiating peptide b and Ang II.  Moreover, Ang II showed selective competitive inhibition of the carboxy-terminal domain of human somatic ACE providing evidence for a regulatory role in the human renin-angiotensin system (RAS).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV83_WWdRH57Vg90H21EOLACvtfcHk0lgfsiNAshxGrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1GksrzF&md5=fbc1f0bafbe17a5f7fddb71ed18fe31d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fsrep00717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep00717%26sid%3Dliteratum%253Aachs%26aulast%3DMasuyer%26aufirst%3DG.%26aulast%3DSchwager%26aufirst%3DS.%2BL.%2BU.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26aulast%3DIsaac%26aufirst%3DR.%2BE.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26atitle%3DMolecular%2520recognition%2520and%2520regulation%2520of%2520human%2520angiotensin-I%2520converting%2520enzyme%2520%2528ACE%2529%2520activity%2520by%2520natural%2520inhibitory%2520peptides%26jtitle%3DSci.%2520Rep.%26date%3D2012%26volume%3D2%26spage%3D717%26doi%3D10.1038%2Fsrep00717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehlers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span> <span> </span><span class="NLM_article-title">Vasopeptidase inhibition - Solving the cardiovascular puzzle?</span>. <i>Drugs Future</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">33</span>, <span class="refDoi"> DOI: 10.1358/dof.2011.036.01.1537940</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1358%2Fdof.2011.036.01.1537940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmslyku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2011&pages=33&author=R.+Douglasauthor=M.+Ehlersauthor=E.+D.+Sturrock&title=Vasopeptidase+inhibition+-+Solving+the+cardiovascular+puzzle%3F&doi=10.1358%2Fdof.2011.036.01.1537940"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Vasopeptidase inhibition - solving the cardiovascular puzzle?</span></div><div class="casAuthors">Douglas, R. G.; Ehlers, M. R. W.; Sturrock, E. D.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-43</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  The therapeutic blockade of the renin-angiotensin-aldosterone system (RAAS) using angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers, aldosterone receptor antagonists and, more recently, renin inhibitors has been a mainstay for the treatment of hypertension, the main risk factor for cardiovascular disease.  Blood pressure and fluid homeostasis are regulated by the interconnected pathways of the RAAS, the endothelin system, the natriuretic peptide system and the kallikrein-kinin system.  The simultaneous modulation of several neurohumoral mediators has been an attractive approach that has received much attention.  The dual ACE/neutral endopeptidase (NEP) and triple ACE/NEP/endothelin-converting enzyme (ECE) inhibitors are the most celebrated vasopeptidase inhibitors, but their progress to the clinic has been stalled by kinin-mediated adverse effects.  NEP/ECE and ACE/ECE inhibitors and compds. targeting the angiotensin receptor and NEP are other attractive options that have been investigated.  In this review, we discuss the systems that regulate the concns. of vasoactive peptides, the current therapies and the mol. basis for the design and action of vasopeptidase inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrenr-odqPbGLVg90H21EOLACvtfcHk0lj3PFj47u8Vkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmslyku7o%253D&md5=026daed9c19adf0ffd94ea28651e2bfe</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1358%2Fdof.2011.036.01.1537940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2011.036.01.1537940%26sid%3Dliteratum%253Aachs%26aulast%3DDouglas%26aufirst%3DR.%26aulast%3DEhlers%26aufirst%3DM.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26atitle%3DVasopeptidase%2520inhibition%2520-%2520Solving%2520the%2520cardiovascular%2520puzzle%253F%26jtitle%3DDrugs%2520Future%26date%3D2011%26volume%3D36%26spage%3D33%26doi%3D10.1358%2Fdof.2011.036.01.1537940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watermeyer, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroger, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sewell, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span> <span> </span><span class="NLM_article-title">Probing the basis of domain-dependent inhibition using novel ketone inhibitors of Angiotensin-converting enzyme</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">5942</span>– <span class="NLM_lpage">5950</span>, <span class="refDoi"> DOI: 10.1021/bi8002605</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi8002605" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsVKltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=5942-5950&author=J.+M.+Watermeyerauthor=W.+L.+Krogerauthor=H.+G.+O%E2%80%99Neillauthor=B.+T.+Sewellauthor=E.+D.+Sturrock&title=Probing+the+basis+of+domain-dependent+inhibition+using+novel+ketone+inhibitors+of+Angiotensin-converting+enzyme&doi=10.1021%2Fbi8002605"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Probing the basis of domain-dependent inhibition using novel ketone inhibitors of angiotensin-converting enzyme</span></div><div class="casAuthors">Watermeyer, Jean M.; Kroeger, Wendy L.; O'Neill, Hester G.; Sewell, B. Trevor; Sturrock, Edward D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5942-5950</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human angiotensin-converting enzyme (ACE) has two homologous domains, the N and C domains, with differing substrate preferences.  X-ray crystal structures of the C and N domains complexed with various inhibitors have allowed identification of active site residues that might be important for the mol. basis of this selectivity.  However, it is unclear to what extent the different residues contribute to substrate domain selectivity.  Here, cocrystal structures of human testis ACE, equiv. to the C domain, have been detd. with two novel C domain-selective ketomethylene inhibitors, (5S)-5-[(N-benzoyl)amino]-4-oxo-6-phenylhexanoyl-L-tryptophan (kAW) and (5S)-5-[(N-benzoyl)amino]-4-oxo-6-phenylhexanoyl-L-phenylalanine (kAF).  The ketone groups of both inhibitors bind to the zinc ion as a hydrated geminal diolate, demonstrating the ability of the active site to catalyze the formation of the transition state.  Moreover, active site residues involved in inhibitor binding have been mutated to their N domain counterparts, and the effect of the mutations on inhibitor binding has been detd.  The C domain selectivity of these inhibitors was found to result from interactions between bulky hydrophobic side chain moieties and C domain-specific residues F391, V518, E376, and V380 (numbering of testis ACE).  Mutation of these residues decreased the affinity for the inhibitors 4-20-fold.  T282, V379, E403, D453, and S516 did not contribute individually to C domain-selective inhibitor binding.  Further domain-selective inhibitor design should focus on increasing both the affinity and selectivity of the side chain moieties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpizYhFPo2WMbVg90H21EOLACvtfcHk0lj3PFj47u8Vkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsVKltrs%253D&md5=62f38e6cfa609f11d467cb39df05ac93</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fbi8002605&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi8002605%26sid%3Dliteratum%253Aachs%26aulast%3DWatermeyer%26aufirst%3DJ.%2BM.%26aulast%3DKroger%26aufirst%3DW.%2BL.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DH.%2BG.%26aulast%3DSewell%26aufirst%3DB.%2BT.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26atitle%3DProbing%2520the%2520basis%2520of%2520domain-dependent%2520inhibition%2520using%2520novel%2520ketone%2520inhibitors%2520of%2520Angiotensin-converting%2520enzyme%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D5942%26epage%3D5950%26doi%3D10.1021%2Fbi8002605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watermeyer, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroger, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sewell, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span> <span> </span><span class="NLM_article-title">Characterization of domain-selective inhibitor binding in angiotensin-converting enzyme using a novel derivative of lisinopril</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>428</i></span>,  <span class="NLM_fpage">67</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1042/BJ20100056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1042%2FBJ20100056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=20233165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1Cmtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=428&publication_year=2010&pages=67-74&author=J.+M.+Watermeyerauthor=W.+L.+Krogerauthor=H.+G.+O%E2%80%99Neillauthor=B.+T.+Sewellauthor=E.+D.+Sturrock&title=Characterization+of+domain-selective+inhibitor+binding+in+angiotensin-converting+enzyme+using+a+novel+derivative+of+lisinopril&doi=10.1042%2FBJ20100056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of domain-selective inhibitor binding in angiotensin-converting enzyme using a novel derivative of lisinopril</span></div><div class="casAuthors">Watermeyer, Jean M.; Kroeger, Wendy L.; O'Neill, Hester G.; Sewell, B. Trevor; Sturrock, Edward D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">428</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-74</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Human ACE (angiotensin-converting enzyme) (EC 3.4.15.1) is an important drug target because of its role in the regulation of blood pressure via the renin-angiotensin-aldosterone system.  Somatic ACE comprises two homologous domains, the differing substrate preferences of which present a new avenue for domain-selective inhibitor design.  LisW-S, a C-domain-selective deriv. of the drug lisinopril, was co-crystd. with human testis ACE and a crystal structure was detd. using X-ray crystallog. to a resoln. of 2.30 Å (1 Å=0.1 nm).  In this structure, lisW-S is seen to have a similar binding mode to its parent compd. lisinopril, but the P2' tryptophan moiety takes a different conformation to that seen in other inhibitors having a tryptophan residue in this position.  The domain-specific interactions of this inhibitor was examd. further by mutating C-domain-specific active-site residues to their N domain equiv., then assessing the effect of the mutation on inhibition by lisW-S using a fluorescence-based assay.  Kinetics anal. shows a 258-fold domain-selectivity that is largely due to the co-operative effect of C-domain-specific residues in the S2' subsite.  The high affinity and selectivity of this inhibitor make it a good lead candidate for cardiovascular drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV_1gE3mSs_LVg90H21EOLACvtfcHk0lj3PFj47u8Vkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1Cmtr8%253D&md5=1957d1bed6004296c886e8a8088c256c</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1042%2FBJ20100056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20100056%26sid%3Dliteratum%253Aachs%26aulast%3DWatermeyer%26aufirst%3DJ.%2BM.%26aulast%3DKroger%26aufirst%3DW.%2BL.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DH.%2BG.%26aulast%3DSewell%26aufirst%3DB.%2BT.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26atitle%3DCharacterization%2520of%2520domain-selective%2520inhibitor%2520binding%2520in%2520angiotensin-converting%2520enzyme%2520using%2520a%2520novel%2520derivative%2520of%2520lisinopril%26jtitle%3DBiochem.%2520J.%26date%3D2010%26volume%3D428%26spage%3D67%26epage%3D74%26doi%3D10.1042%2FBJ20100056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kroger, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span> <span> </span><span class="NLM_article-title">Investigating the domain specificity of phosphinic inhibitors RXPA380 and RXP407 in angiotensin-converting enzyme</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">8405</span>– <span class="NLM_lpage">8412</span>, <span class="refDoi"> DOI: 10.1021/bi9011226</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi9011226" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=8405-8412&author=W.+L.+Krogerauthor=R.+G.+Douglasauthor=H.+G.+O%E2%80%99Neillauthor=V.+Diveauthor=E.+D.+Sturrock&title=Investigating+the+domain+specificity+of+phosphinic+inhibitors+RXPA380+and+RXP407+in+angiotensin-converting+enzyme&doi=10.1021%2Fbi9011226"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fbi9011226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi9011226%26sid%3Dliteratum%253Aachs%26aulast%3DKroger%26aufirst%3DW.%2BL.%26aulast%3DDouglas%26aufirst%3DR.%2BG.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DH.%2BG.%26aulast%3DDive%26aufirst%3DV.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26atitle%3DInvestigating%2520the%2520domain%2520specificity%2520of%2520phosphinic%2520inhibitors%2520RXPA380%2520and%2520RXP407%2520in%2520angiotensin-converting%2520enzyme%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D8405%26epage%3D8412%26doi%3D10.1021%2Fbi9011226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fienberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozier, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span> <span> </span><span class="NLM_article-title">The design and development of a potent and selective novel diprolyl derivative that binds to the N-domain of angiotensin-I converting enzyme</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">344</span>– <span class="NLM_lpage">359</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01478</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01478" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=344-359&author=S.+Fienbergauthor=G.+E.+Cozierauthor=K.+R.+Acharyaauthor=K.+Chibaleauthor=E.+D.+Sturrock&title=The+design+and+development+of+a+potent+and+selective+novel+diprolyl+derivative+that+binds+to+the+N-domain+of+angiotensin-I+converting+enzyme&doi=10.1021%2Facs.jmedchem.7b01478"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01478%26sid%3Dliteratum%253Aachs%26aulast%3DFienberg%26aufirst%3DS.%26aulast%3DCozier%26aufirst%3DG.%2BE.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26aulast%3DChibale%26aufirst%3DK.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26atitle%3DThe%2520design%2520and%2520development%2520of%2520a%2520potent%2520and%2520selective%2520novel%2520diprolyl%2520derivative%2520that%2520binds%2520to%2520the%2520N-domain%2520of%2520angiotensin-I%2520converting%2520enzyme%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D344%26epage%3D359%26doi%3D10.1021%2Facs.jmedchem.7b01478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazin, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dack, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeves, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ringer, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strang, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, C. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of heteroarylalanine diacids as potent and selective neutral endopeptidase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3404</span>– <span class="NLM_lpage">3406</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.03.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1016%2Fj.bmcl.2011.03.109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=21515054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsVOgurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3404-3406&author=M.+S.+Glossopauthor=R.+J.+Bazinauthor=K.+N.+Dackauthor=D.+N.+Foxauthor=G.+A.+MacDonaldauthor=M.+Millsauthor=D.+R.+Owenauthor=C.+Phillipsauthor=K.+A.+Reevesauthor=T.+J.+Ringerauthor=R.+S.+Strangauthor=C.+A.+Watson&title=Synthesis+and+evaluation+of+heteroarylalanine+diacids+as+potent+and+selective+neutral+endopeptidase+inhibitors&doi=10.1016%2Fj.bmcl.2011.03.109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of heteroarylalanine diacids as potent and selective neutral endopeptidase inhibitors</span></div><div class="casAuthors">Glossop, Melanie S.; Bazin, Richard J.; Dack, Kevin N.; Fox, David N. A.; MacDonald, Graeme A.; Mills, Mark; Owen, Dafydd R.; Phillips, Chris; Reeves, Keith A.; Ringer, Tracy J.; Strang, Ross S.; Watson, Christine A. L.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3404-3406</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Heteroarylalanine derivs. 4 were designed as potential inhibitors of neutral endopeptidase (NEP EC 3.4.24.11).  Selectivity over other zinc metalloproteinases was explored through occupation of the S2' subsite within NEP.  Structural optimization led to the identification of 5-Ph oxazole (I), a potent and selective NEP inhibitor.  A crystal structure of the inhibitor bound complex is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG2Cx7Omr7KrVg90H21EOLACvtfcHk0liQkQAGflFxbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsVOgurY%253D&md5=afebcffffd6a63edbb1278696dbdc7e1</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.03.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.03.109%26sid%3Dliteratum%253Aachs%26aulast%3DGlossop%26aufirst%3DM.%2BS.%26aulast%3DBazin%26aufirst%3DR.%2BJ.%26aulast%3DDack%26aufirst%3DK.%2BN.%26aulast%3DFox%26aufirst%3DD.%2BN.%26aulast%3DMacDonald%26aufirst%3DG.%2BA.%26aulast%3DMills%26aufirst%3DM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DPhillips%26aufirst%3DC.%26aulast%3DReeves%26aufirst%3DK.%2BA.%26aulast%3DRinger%26aufirst%3DT.%2BJ.%26aulast%3DStrang%26aufirst%3DR.%2BS.%26aulast%3DWatson%26aufirst%3DC.%2BA.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520heteroarylalanine%2520diacids%2520as%2520potent%2520and%2520selective%2520neutral%2520endopeptidase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3404%26epage%3D3406%26doi%3D10.1016%2Fj.bmcl.2011.03.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oefner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arcy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winkler, F. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, G. E.</span></span> <span> </span><span class="NLM_article-title">Structure of human neutral endopeptidase (Neprilysin) complexed with phosphoramidon</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>296</i></span>,  <span class="NLM_fpage">341</span>– <span class="NLM_lpage">349</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1999.3492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1006%2Fjmbi.1999.3492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10669592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD3cXps1GqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2000&pages=341-349&author=C.+Oefnerauthor=A.+D%E2%80%99Arcyauthor=M.+Hennigauthor=F.+K.+Winklerauthor=G.+E.+Dale&title=Structure+of+human+neutral+endopeptidase+%28Neprilysin%29+complexed+with+phosphoramidon&doi=10.1006%2Fjmbi.1999.3492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human neutral endopeptidase (neprilysin) complexed with phosphoramidon</span></div><div class="casAuthors">Oefner, Christian; D'Arcy, Allan; Hennig, Michael; Winkler, Fritz K.; Dale, Glenn E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">341-349</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Neprilysin (EC 3.4.24.11; neutral endopeptidase) (I) is a mammalian type II integral membrane Zn-contg. endopeptidase, which degrades and inactivates a no. of bioactive peptides.  The range of substrates cleaved by I in vitro includes the enkephalins, substance P, endothelin, bradykinin, and atrial natriuretic factor.  Due to the physiol. importance of I in the modulation of nociceptive and pressor responses there is considerable interest in inhibitors of this enzyme as novel analgesics and anti-hypertensive agents.  Here, the authors describe the crystal structure of the extracellular domain (residues 52-749) of human I complexed with the generic metalloproteinase inhibitor, phosphoramidon (II), at 2.1 Å resoln.  The structure revealed 2 multiply connected folding domains which embraced a large central cavity contg. the active site.  II was bound to one side of this cavity and its binding mode provided a detailed understanding of the ligand-binding and specificity determinants.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCc0rfNE03ULVg90H21EOLACvtfcHk0liQkQAGflFxbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXps1GqsA%253D%253D&md5=82d113a6b2e0349fd738bd62e6e59f9a</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1999.3492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1999.3492%26sid%3Dliteratum%253Aachs%26aulast%3DOefner%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DA.%26aulast%3DHennig%26aufirst%3DM.%26aulast%3DWinkler%26aufirst%3DF.%2BK.%26aulast%3DDale%26aufirst%3DG.%2BE.%26atitle%3DStructure%2520of%2520human%2520neutral%2520endopeptidase%2520%2528Neprilysin%2529%2520complexed%2520with%2520phosphoramidon%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2000%26volume%3D296%26spage%3D341%26epage%3D349%26doi%3D10.1006%2Fjmbi.1999.3492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oefner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, G. E.</span></span> <span> </span><span class="NLM_article-title">Structural studies of a bifunctional inhibitor of neprilysin and DPP-IV</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">975</span>– <span class="NLM_lpage">981</span>, <span class="refDoi"> DOI: 10.1107/S0907444907036281</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1107%2FS0907444907036281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=17704566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1aks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2007&pages=975-981&author=C.+Oefnerauthor=S.+Pierauauthor=H.+Schulzauthor=G.+E.+Dale&title=Structural+studies+of+a+bifunctional+inhibitor+of+neprilysin+and+DPP-IV&doi=10.1107%2FS0907444907036281"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Structural studies of a bifunctional inhibitor of neprilysin and DPP-IV</span></div><div class="casAuthors">Oefner, Christian; Pierau, Sabine; Schulz, Henk; Dale, Glenn E.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">975-981</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Neutral endopeptidase (NEP) is the major enzyme involved in the metabolic inactivation of a no. of bioactive peptides including the enkephalins, substance P, endothelin, bradykinin and atrial natriuretic factor, as well as the incretin hormone glucagon-like peptide 1 (GLP-1), which is a potent stimulator of insulin secretion.  The activity of GLP-1 is also rapidly abolished by the serine protease dipeptidyl peptidase IV (DPP-IV), which led to an elevated interest in inhibitors of this enzyme for the treatment of type II diabetes.  A dual NEP/DPP-IV inhibitor concept is proposed, offering an alternative strategy for the treatment of type 2 diabetes.  Here, the synthesis and crystal structures of the sol. extracellular domain of human NEP (residues 52-749) complexed with the NEP, competitive and potent dual NEP/DPP-IV inhibitor MCB3937 are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqq5V_VbcNwrVg90H21EOLACvtfcHk0liQkQAGflFxbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1aks7o%253D&md5=6fa2f31ff0e25cc4d6cbb91bf59b6109</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1107%2FS0907444907036281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444907036281%26sid%3Dliteratum%253Aachs%26aulast%3DOefner%26aufirst%3DC.%26aulast%3DPierau%26aufirst%3DS.%26aulast%3DSchulz%26aufirst%3DH.%26aulast%3DDale%26aufirst%3DG.%2BE.%26atitle%3DStructural%2520studies%2520of%2520a%2520bifunctional%2520inhibitor%2520of%2520neprilysin%2520and%2520DPP-IV%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2007%26volume%3D63%26spage%3D975%26epage%3D981%26doi%3D10.1107%2FS0907444907036281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oefner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roques, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournie-Zaluski, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, G. E.</span></span> <span> </span><span class="NLM_article-title">Structural analysis of neprilysin with various specific and potent inhibitors</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1107/S0907444903027410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1107%2FS0907444903027410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=14747736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD2cXms1Gjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=392-396&author=C.+Oefnerauthor=B.+P.+Roquesauthor=M.+C.+Fournie-Zaluskiauthor=G.+E.+Dale&title=Structural+analysis+of+neprilysin+with+various+specific+and+potent+inhibitors&doi=10.1107%2FS0907444903027410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Structural analysis of neprilysin with various specific and potent inhibitors</span></div><div class="casAuthors">Oefner, Christian; Roques, Bernard P.; Fournie-Zaluski, Marie Claude; Dale, Glenn E.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">392-396</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Neutral endopeptidase (NEP) is the major enzyme involved in the metabolic inactivation of a no. of bioactive peptides including the enkephalins, substance P, endothelin, bradykinin, and atrial natriuretic factor.  Owing to the physiol. importance of NEP in the modulation of nociceptive and pressor responses, there is considerable interest in inhibitors of this enzyme as novel analgesics and antihypertensive agents.  Here, the crystal structures of the sol. extracellular domain of human NEP (residues 52-749) complexed with various potent and competitive inhibitors are described.  The structures unambiguously reveal the binding mode of the different zinc-chelating groups and the subsite specificity of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_5u7pq3mc2bVg90H21EOLACvtfcHk0ljDU4QJVCj5kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXms1Gjuw%253D%253D&md5=e4a4aaaa854fedd851d83fa3615e8e53</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1107%2FS0907444903027410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444903027410%26sid%3Dliteratum%253Aachs%26aulast%3DOefner%26aufirst%3DC.%26aulast%3DRoques%26aufirst%3DB.%2BP.%26aulast%3DFournie-Zaluski%26aufirst%3DM.%2BC.%26aulast%3DDale%26aufirst%3DG.%2BE.%26atitle%3DStructural%2520analysis%2520of%2520neprilysin%2520with%2520various%2520specific%2520and%2520potent%2520inhibitors%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D392%26epage%3D396%26doi%3D10.1107%2FS0907444903027410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sahli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blum-Kaelin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aebi, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Böhm, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oefner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dale, G. E.</span></span> <span> </span><span class="NLM_article-title">Second-generation inhibitors for the metalloprotease neprilysin based on bicyclic heteroaromatic scaffolds: Synthesis, biological activity, and X-ray crystal-structure analysis</span>. <i>Helv. Chim. Acta</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">731</span>– <span class="NLM_lpage">750</span>, <span class="refDoi"> DOI: 10.1002/hlca.200590051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1002%2Fhlca.200590051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFSmsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2005&pages=731-750&author=S.+Sahliauthor=B.+Frankauthor=W.+B.+Schweizerauthor=F.+Diederichauthor=D.+Blum-Kaelinauthor=J.+D.+Aebiauthor=H.+B%C3%B6hmauthor=C.+Oefnerauthor=G.+E.+Dale&title=Second-generation+inhibitors+for+the+metalloprotease+neprilysin+based+on+bicyclic+heteroaromatic+scaffolds%3A+Synthesis%2C+biological+activity%2C+and+X-ray+crystal-structure+analysis&doi=10.1002%2Fhlca.200590051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Second-generation inhibitors for the metalloprotease neprilysin based on bicyclic heteroaromatic scaffolds: Synthesis, biological activity, and X-ray crystal-structure analysis</span></div><div class="casAuthors">Sahli, Stefan; Frank, Brian; Schweizer, W. Bernd; Diederich, Francois; Blum-Kaelin, Denise; Aebi, Johannes D.; Boehm, Hans-Joachim; Oefner, Christian; Dale, Glenn E.</div><div class="citationInfo"><span class="NLM_cas:title">Helvetica Chimica Acta</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">731-750</span>CODEN:
                <span class="NLM_cas:coden">HCACAV</span>;
        ISSN:<span class="NLM_cas:issn">0018-019X</span>.
    
            (<span class="NLM_cas:orgname">Verlag Helvetica Chimica Acta</span>)
        </div><div class="casAbstract">A new class of nonpeptidic inhibitors of the ZnII-dependent metalloprotease neprilysin with IC50 values in the nanomolar activity range (0.034-0.30 μM) were developed based on structure-based de novo design.  The inhibitors I (X = CH, N; R1 = H, Me; R2 = H, Ph; R3 = H, PhCH2) feature benzimidazole or imidazo[4,5-c]pyridine moieties as central scaffolds to undergo H-bonding to Asn542 and Arg717 and to engage in favorable π-π stacking interactions with the imidazole ring of His711.  The platform is decorated with a thiol vector to coordinate to the ZnII ion and an aryl residue to occupy the hydrophobic S1' pocket, but lack a substituent for binding in the S2' pocket, which remains closed by the side chains of Phe106 and Arg110 when not occupied.  The enantioselective syntheses of optically active I (X = CH, N; R1 = R3 = H; R2 = H, Ph) were accomplished using Evans auxiliaries.  The inhibitors with an imidazo[4,5-c]pyridine core are ca. 8 times more active than those with a benzimidazole core.  The predicted binding mode was established by X-ray anal. of the complex of neprilysin with (+)-I (X = N; R1 = R2 = R3 = H) at 2.25-Å resoln.  The ligand coordinates with its sulfanyl residue to the ZnII ion, and the benzyl residue occupies the S1' pocket.  The 1H-imidazole moiety of the central scaffold forms the required H-bonds to the side chains of Asn542 and Arg717.  The heterobicyclic platform addnl. undergoes π-π stacking with the side chain of His711 as well as edge-to-face-type interactions with the side chain of Trp693.  According to the X-ray anal., the substantial advantage in biol. activity of the imidazopyridine inhibitors over the benzimidazole ligands arises from favorable interactions of the pyridine N-atom in the former with the side chain of Arg102.  Unexpectedly, replacement of the Ph group pointing into the deep S1' pocket by a biphenyl group does not enhance the binding affinity for this class of inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTE2Tw27MeUrVg90H21EOLACvtfcHk0ljDU4QJVCj5kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFSmsrc%253D&md5=7c0b5c22602e76531023fffce5b0d3fe</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fhlca.200590051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhlca.200590051%26sid%3Dliteratum%253Aachs%26aulast%3DSahli%26aufirst%3DS.%26aulast%3DFrank%26aufirst%3DB.%26aulast%3DSchweizer%26aufirst%3DW.%2BB.%26aulast%3DDiederich%26aufirst%3DF.%26aulast%3DBlum-Kaelin%26aufirst%3DD.%26aulast%3DAebi%26aufirst%3DJ.%2BD.%26aulast%3DB%25C3%25B6hm%26aufirst%3DH.%26aulast%3DOefner%26aufirst%3DC.%26aulast%3DDale%26aufirst%3DG.%2BE.%26atitle%3DSecond-generation%2520inhibitors%2520for%2520the%2520metalloprotease%2520neprilysin%2520based%2520on%2520bicyclic%2520heteroaromatic%2520scaffolds%253A%2520Synthesis%252C%2520biological%2520activity%252C%2520and%2520X-ray%2520crystal-structure%2520analysis%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D2005%26volume%3D88%26spage%3D731%26epage%3D750%26doi%3D10.1002%2Fhlca.200590051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dimitropoulos, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papakyriakou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalkas, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spyroulias, G. A.</span></span> <span> </span><span class="NLM_article-title">A computational approach to the study of the binding mode of dual ACE/NEP inhibitors</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">388</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1021/ci9005047</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci9005047" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFyhsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=388-396&author=N.+Dimitropoulosauthor=A.+Papakyriakouauthor=G.+A.+Dalkasauthor=E.+D.+Sturrockauthor=G.+A.+Spyroulias&title=A+computational+approach+to+the+study+of+the+binding+mode+of+dual+ACE%2FNEP+inhibitors&doi=10.1021%2Fci9005047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A Computational Approach to the Study of the Binding Mode of Dual ACE/NEP Inhibitors</span></div><div class="casAuthors">Dimitropoulos, Nikolaos; Papakyriakou, Athanasios; Dalkas, Georgios A.; Sturrock, Edward D.; Spyroulias, Georgios A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">388-396</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Combined blockade of the renin-angiotensin-aldosterone system (RAAS) is an attractive therapeutic strategy for the treatment of cardiovascular diseases.  Vasopeptidase inhibitors are a group of compds. capable of inhibiting more than one enzyme, which leads to potentiation of natriuretic peptide actions and suppression of the RAAS.  In this study, mol. modeling has been used to elucidate key structural features that govern the binding and/or selectivity of a single compd. toward the zinc catalytic sites of the N- and C-domains of the angiotensin-converting enzyme (ACE) and the neutral endopeptidase (NEP).  Eleven dual inhibitors were categorized in three classes, according to their zinc binding groups.  Anal. of their docked conformers revealed the mol. environment of the catalytic sites and the specific interactions between the inhibitors and amino acid residues that are important for selectivity and cooperativity.  In addn., inhibitors were predicted to bind to the C-domain of the ACE with greater affinity than the N-domain, with an av. difference in the free energy of binding ∼2-3 kcal mol-1.  Residues that were identified to actively participate in the binding and stabilizing of the enzyme-inhibitor complexes were analyzed in a consensus way for both the ACE and the NEP.  These at.-level insights into enzyme-ligand binding can be used to drive new structure-based drug design processes in the quest for more selective and effective vasopeptidase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlmtVNKnY-CbVg90H21EOLACvtfcHk0ljDU4QJVCj5kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFyhsLg%253D&md5=b88dadb9dc6da855a31264c038e51212</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fci9005047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci9005047%26sid%3Dliteratum%253Aachs%26aulast%3DDimitropoulos%26aufirst%3DN.%26aulast%3DPapakyriakou%26aufirst%3DA.%26aulast%3DDalkas%26aufirst%3DG.%2BA.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26aulast%3DSpyroulias%26aufirst%3DG.%2BA.%26atitle%3DA%2520computational%2520approach%2520to%2520the%2520study%2520of%2520the%2520binding%2520mode%2520of%2520dual%2520ACE%252FNEP%2520inhibitors%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D388%26epage%3D396%26doi%3D10.1021%2Fci9005047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anthony, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corradi, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwager, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redelinghuys, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiadis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span> <span> </span><span class="NLM_article-title">The N domain of human angiotensin-I-converting enzyme: the role of N-glycosylation and the crystal structure in complex with an N domain-specific phosphinic inhibitor, RXP407</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">35685</span>– <span class="NLM_lpage">35693</span>, <span class="refDoi"> DOI: 10.1074/jbc.M110.167866</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1074%2Fjbc.M110.167866" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=35685-35693&author=C.+S.+Anthonyauthor=H.+R.+Corradiauthor=S.+L.+Schwagerauthor=P.+Redelinghuysauthor=D.+Georgiadisauthor=V.+Diveauthor=K.+R.+Acharyaauthor=E.+D.+Sturrock&title=The+N+domain+of+human+angiotensin-I-converting+enzyme%3A+the+role+of+N-glycosylation+and+the+crystal+structure+in+complex+with+an+N+domain-specific+phosphinic+inhibitor%2C+RXP407&doi=10.1074%2Fjbc.M110.167866"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M110.167866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M110.167866%26sid%3Dliteratum%253Aachs%26aulast%3DAnthony%26aufirst%3DC.%2BS.%26aulast%3DCorradi%26aufirst%3DH.%2BR.%26aulast%3DSchwager%26aufirst%3DS.%2BL.%26aulast%3DRedelinghuys%26aufirst%3DP.%26aulast%3DGeorgiadis%26aufirst%3DD.%26aulast%3DDive%26aufirst%3DV.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26atitle%3DThe%2520N%2520domain%2520of%2520human%2520angiotensin-I-converting%2520enzyme%253A%2520the%2520role%2520of%2520N-glycosylation%2520and%2520the%2520crystal%2520structure%2520in%2520complex%2520with%2520an%2520N%2520domain-specific%2520phosphinic%2520inhibitor%252C%2520RXP407%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D35685%26epage%3D35693%26doi%3D10.1074%2Fjbc.M110.167866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redelinghuys, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwager, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehlers, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papageorgiou, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natesh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acharya, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturrock, E. D.</span></span> <span> </span><span class="NLM_article-title">Deglycosylation, processing and crystallization of human testis angiotensin-converting enzyme</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>371</i></span>,  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">442</span>, <span class="refDoi"> DOI: 10.1042/bj20021842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1042%2Fbj20021842" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=437-442&author=K.+Gordonauthor=P.+Redelinghuysauthor=S.+L.+Schwagerauthor=M.+R.+Ehlersauthor=A.+C.+Papageorgiouauthor=R.+Nateshauthor=K.+R.+Acharyaauthor=E.+D.+Sturrock&title=Deglycosylation%2C+processing+and+crystallization+of+human+testis+angiotensin-converting+enzyme&doi=10.1042%2Fbj20021842"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1042%2Fbj20021842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021842%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DK.%26aulast%3DRedelinghuys%26aufirst%3DP.%26aulast%3DSchwager%26aufirst%3DS.%2BL.%26aulast%3DEhlers%26aufirst%3DM.%2BR.%26aulast%3DPapageorgiou%26aufirst%3DA.%2BC.%26aulast%3DNatesh%26aufirst%3DR.%26aulast%3DAcharya%26aufirst%3DK.%2BR.%26aulast%3DSturrock%26aufirst%3DE.%2BD.%26atitle%3DDeglycosylation%252C%2520processing%2520and%2520crystallization%2520of%2520human%2520testis%2520angiotensin-converting%2520enzyme%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26spage%3D437%26epage%3D442%26doi%3D10.1042%2Fbj20021842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Waterman, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gildea, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkhurst, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brewster, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauter, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, G.</span></span> <span> </span><span class="NLM_article-title">Diffraction-geometry refinement in the DIALS framework</span>. <i>Acta Crystallogr. D Struct Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">558</span>– <span class="NLM_lpage">575</span>, <span class="refDoi"> DOI: 10.1107/S2059798316002187</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1107%2FS2059798316002187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=27050135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsFSkurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2016&pages=558-575&author=D.+G.+Watermanauthor=G.+Winterauthor=R.+J.+Gildeaauthor=J.+M.+Parkhurstauthor=A.+S.+Brewsterauthor=N.+K.+Sauterauthor=G.+Evans&title=Diffraction-geometry+refinement+in+the+DIALS+framework&doi=10.1107%2FS2059798316002187"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Diffraction-geometry refinement in the DIALS framework</span></div><div class="casAuthors">Waterman, David G.; Winter, Graeme; Gildea, Richard J.; Parkhurst, James M.; Brewster, Aaron S.; Sauter, Nicholas K.; Evans, Gwyndaf</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Structural Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">558-575</span>CODEN:
                <span class="NLM_cas:coden">ACSDAD</span>;
        ISSN:<span class="NLM_cas:issn">2059-7983</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Rapid data collection and modern computing resources provide the opportunity to revisit the task of optimizing the model of diffraction geometry prior to integration.  A comprehensive description is given of new software that builds upon established methods by performing a single global refinement procedure, utilizing a smoothly varying model of the crystal lattice where appropriate.  This global refinement technique extends to multiple data sets, providing useful constraints to handle the problem of correlated parameters, particularly for small wedges of data.  Examples of advanced uses of the software are given and the design is explained in detail, with particular emphasis on the flexibility and extensibility it entails.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowmCZHkbbl6bVg90H21EOLACvtfcHk0liGi4azwfZXrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsFSkurs%253D&md5=0041260941cd2e0581c8a1db0b5add97</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS2059798316002187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2059798316002187%26sid%3Dliteratum%253Aachs%26aulast%3DWaterman%26aufirst%3DD.%2BG.%26aulast%3DWinter%26aufirst%3DG.%26aulast%3DGildea%26aufirst%3DR.%2BJ.%26aulast%3DParkhurst%26aufirst%3DJ.%2BM.%26aulast%3DBrewster%26aufirst%3DA.%2BS.%26aulast%3DSauter%26aufirst%3DN.%2BK.%26aulast%3DEvans%26aufirst%3DG.%26atitle%3DDiffraction-geometry%2520refinement%2520in%2520the%2520DIALS%2520framework%26jtitle%3DActa%2520Crystallogr.%2520D%2520Struct%2520Biol.%26date%3D2016%26volume%3D72%26spage%3D558%26epage%3D575%26doi%3D10.1107%2FS2059798316002187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span> <span> </span><span class="NLM_article-title">How good are my data and what is the resolution?</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1204</span>– <span class="NLM_lpage">1214</span>, <span class="refDoi"> DOI: 10.1107/S0907444913000061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1107%2FS0907444913000061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=23793146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVejsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1204-1214&author=P.+R.+Evansauthor=G.+N.+Murshudov&title=How+good+are+my+data+and+what+is+the+resolution%3F&doi=10.1107%2FS0907444913000061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">How good are my data and what is the resolution?</span></div><div class="casAuthors">Evans, Philip R.; Murshudov, Garib N.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1204-1214</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Following integration of the obsd. diffraction spots, the process of  data redn.' initially aims to det. the point-group symmetry of the data and the likely space group.  This can be performed with the program POINTLESS.  The scaling program then puts all the measurements on a common scale, avs. measurements of symmetry-related reflections (using the symmetry detd. previously) and produces many statistics that provide the first important measures of data quality.  A new scaling program, AIMLESS, implements scaling models similar to those in SCALA but adds some addnl. analyses.  From the analyses, a no. of decisions can be made about the quality of the data and whether some measurements should be discarded.  The effective  resoln.' of a data set is a difficult and possibly contentious question (particularly with referees of papers) and this is discussed in the light of tests comparing the data-processing statistics with trials of refinement against obsd. and simulated data, and automated model-building and comparison of maps calcd. with different resoln. limits.  These trials show that adding weak high-resoln. data beyond the commonly used limits may make some improvement and does no harm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreOyPAR8GLBrVg90H21EOLACvtfcHk0liGi4azwfZXrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVejsL8%253D&md5=3f649426c21e9d423f94ef8d7c568233</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS0907444913000061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444913000061%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26atitle%3DHow%2520good%2520are%2520my%2520data%2520and%2520what%2520is%2520the%2520resolution%253F%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26spage%3D1204%26epage%3D1214%26doi%3D10.1107%2FS0907444913000061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Collaborative
Computational Project, Number 4</span> <span> </span><span class="NLM_article-title">The CCP4 suite: programs for protein crystallography</span>. <i>Acta Crystallogr. D, Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">760</span>– <span class="NLM_lpage">763</span>, <span class="refDoi"> DOI: 10.1107/S0907444994003112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1107%2FS0907444994003112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=15299374" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=760-763&author=Collaborative%0AComputational+Project%2C+Number+4&title=The+CCP4+suite%3A+programs+for+protein+crystallography&doi=10.1107%2FS0907444994003112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1107%2FS0907444994003112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444994003112%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DThe%2520CCP4%2520suite%253A%2520programs%2520for%2520protein%2520crystallography%26jtitle%3DActa%2520Crystallogr.%2520D%252C%2520Biol.%2520Crystallogr.%26date%3D1994%26volume%3D50%26spage%3D760%26epage%3D763%26doi%3D10.1107%2FS0907444994003112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0ljL7vsP6geWCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodson, E. J.</span></span> <span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1107/S0907444996012255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=15299926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method&doi=10.1107%2FS0907444996012255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. σA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial α-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0ljL7vsP6geWCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26spage%3D240%26epage%3D255%26doi%3D10.1107%2FS0907444996012255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Afonine, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunkoczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echols, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moriarty, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oeffner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terwilliger, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwart, P. H.</span></span> <span> </span><span class="NLM_article-title">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">213</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.+W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+Python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0ljL7vsP6geWCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.%2BW.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2126</span>– <span class="NLM_lpage">2132</span>, <span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lhQ9gPPWSC6Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arendall, W. B.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Headd, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keedy, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Immormino, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapral, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, D. C.</span></span> <span> </span><span class="NLM_article-title">MolProbity: all-atom structure validation for macromolecular crystallography</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">12</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1107/S0907444909042073</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1107%2FS0907444909042073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=20057044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC3cXit1Kktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=12-21&author=V.+B.+Chenauthor=W.+B.+Arendallauthor=J.+J.+Headdauthor=D.+A.+Keedyauthor=R.+M.+Immorminoauthor=G.+J.+Kapralauthor=L.+W.+Murrayauthor=J.+S.+Richardsonauthor=D.+C.+Richardson&title=MolProbity%3A+all-atom+structure+validation+for+macromolecular+crystallography&doi=10.1107%2FS0907444909042073"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">MolProbity: all-atom structure validation for macromolecular crystallography</span></div><div class="casAuthors">Chen, Vincent B.; Arendall, W. Bryan, III; Headd, Jeffrey J.; Keedy, Daniel A.; Immormino, Robert M.; Kapral, Gary J.; Murray, Laura W.; Richardson, Jane S.; Richardson, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-21</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">MolProbity is a structure-validation web service that provides broad-spectrum solidly based evaluation of model quality at both the global and local levels for both proteins and nucleic acids.  It relies heavily on the power and sensitivity provided by optimized hydrogen placement and all-atom contact anal., complemented by updated versions of covalent-geometry and torsion-angle criteria.  Some of the local corrections can be performed automatically in MolProbity and all of the diagnostics are presented in chart and graphical forms that help guide manual rebuilding.  X-ray crystallog. provides a wealth of biol. important mol. data in the form of at. three-dimensional structures of proteins, nucleic acids and increasingly large complexes in multiple forms and states.  Advances in automation, in everything from crystn. to data collection to phasing to model building to refinement, have made solving a structure using crystallog. easier than ever.  However, despite these improvements, local errors that can affect biol. interpretation are widespread at low resoln. and even high-resoln. structures nearly all contain at least a few local errors such as Ramachandran outliers, flipped branched protein side chains and incorrect sugar puckers.  It is crit. both for the crystallographer and for the end user that there are easy and reliable methods to diagnose and correct these sorts of errors in structures.  MolProbity is the authors' contribution to helping solve this problem and this article reviews its general capabilities, reports on recent enhancements and usage, and presents evidence that the resulting improvements are now beneficially affecting the global database.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIjgsh59dO-7Vg90H21EOLACvtfcHk0lhQ9gPPWSC6Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXit1Kktg%253D%253D&md5=b5fc7574f43f01dd6e43c3663ca4f779</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1107%2FS0907444909042073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909042073%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DArendall%26aufirst%3DW.%2BB.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DKeedy%26aufirst%3DD.%2BA.%26aulast%3DImmormino%26aufirst%3DR.%2BM.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DMurray%26aufirst%3DL.%2BW.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26atitle%3DMolProbity%253A%2520all-atom%2520structure%2520validation%2520for%2520macromolecular%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D12%26epage%3D21%26doi%3D10.1107%2FS0907444909042073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McNicholas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potterton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noble, M. E.</span></span> <span> </span><span class="NLM_article-title">Presenting your structures: the CCP4mg molecular-graphics software</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">386</span>– <span class="NLM_lpage">394</span>, <span class="refDoi"> DOI: 10.1107/S0907444911007281</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1107%2FS0907444911007281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=21460457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=386-394&author=S.+McNicholasauthor=E.+Pottertonauthor=K.+S.+Wilsonauthor=M.+E.+Noble&title=Presenting+your+structures%3A+the+CCP4mg+molecular-graphics+software&doi=10.1107%2FS0907444911007281"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Presenting your structures: The CCP4mg molecular-graphics software</span></div><div class="casAuthors">McNicholas, S.; Potterton, E.; Wilson, K. S.; Noble, M. E. M.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">386-394</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">CCP4mg is a mol.-graphics program that is designed to give rapid access to both straightforward and complex static and dynamic representations of macromol. structures.  It has recently been updated with a new interface that provides more sophisticated atom-selection options and a wizard to facilitate the generation of complex scenes.  These scenes may contain a mixt. of coordinate-derived and abstr. graphical objects, including text objects, arbitrary vectors, geometric objects and imported images, which can enhance a picture and eliminate the need for subsequent editing.  Scene descriptions can be saved to file and transferred to other mols.  Here, the substantially enhanced version 2 of the program, with a new underlying GUI toolkit, is described.  A built-in rendering module produces publication-quality images.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdtflrxrILlbVg90H21EOLACvtfcHk0lhQ9gPPWSC6Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqurw%253D&md5=d96403a39bc723a66f11a730f81f76c3</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1107%2FS0907444911007281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911007281%26sid%3Dliteratum%253Aachs%26aulast%3DMcNicholas%26aufirst%3DS.%26aulast%3DPotterton%26aufirst%3DE.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26aulast%3DNoble%26aufirst%3DM.%2BE.%26atitle%3DPresenting%2520your%2520structures%253A%2520the%2520CCP4mg%2520molecular-graphics%2520software%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D386%26epage%3D394%26doi%3D10.1107%2FS0907444911007281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span> <i>The PyMOL Molecular
Graphics System</i>, <span class="NLM_edition">version
2.0</span>; <span class="NLM_publisher-name">Schrodinger, LLC</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+The+PyMOL+Molecular%0AGraphics+System%2C+version%0A2.0%3B+Schrodinger%2C+LLC%2C+2018."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520PyMOL%2520Molecular%250AGraphics%2520System%26pub%3DSchrodinger%252C%2520LLC%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laskowski, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swindells, M. B.</span></span> <span> </span><span class="NLM_article-title">LigPlot+: multiple ligand-protein interaction diagrams for drug discovery</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2778</span>– <span class="NLM_lpage">2786</span>, <span class="refDoi"> DOI: 10.1021/ci200227u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci200227u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1KjtrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=2778-2786&author=R.+A.+Laskowskiauthor=M.+B.+Swindells&title=LigPlot%2B%3A+multiple+ligand-protein+interaction+diagrams+for+drug+discovery&doi=10.1021%2Fci200227u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery</span></div><div class="casAuthors">Laskowski, Roman A.; Swindells, Mark B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2778-2786</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe a graphical system for automatically generating multiple 2D diagrams of ligand-protein interactions from 3D coordinates.  The diagrams portray the hydrogen-bond interaction patterns and hydrophobic contacts between the ligand(s) and the main-chain or side-chain elements of the protein.  The system is able to plot, in the same orientation, related sets of ligand-protein interactions.  This facilitates popular research tasks, such as analyzing a series of small mols. binding to the same protein target, a single ligand binding to homologous proteins, or the completely general case where both protein and ligand change.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYuWvYH7Nel7Vg90H21EOLACvtfcHk0ljstIBjvVrs1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1KjtrzP&md5=576e59ad4f0c4304d01c6c80301ecf39</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fci200227u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200227u%26sid%3Dliteratum%253Aachs%26aulast%3DLaskowski%26aufirst%3DR.%2BA.%26aulast%3DSwindells%26aufirst%3DM.%2BB.%26atitle%3DLigPlot%252B%253A%2520multiple%2520ligand-protein%2520interaction%2520diagrams%2520for%2520drug%2520discovery%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26spage%3D2778%26epage%3D2786%26doi%3D10.1021%2Fci200227u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruswitz, F.</span></span> <span> </span><span class="NLM_article-title">HOLLOW: generating accurate representations of channel and interior surfaces in molecular structures</span>. <i>BMC Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">49</span>, <span class="refDoi"> DOI: 10.1186/1472-6807-8-49</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1186%2F1472-6807-8-49" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=19014592" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FitFKisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=49&author=B.+K.+Hoauthor=F.+Gruswitz&title=HOLLOW%3A+generating+accurate+representations+of+channel+and+interior+surfaces+in+molecular+structures&doi=10.1186%2F1472-6807-8-49"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">HOLLOW: generating accurate representations of channel and interior surfaces in molecular structures</span></div><div class="casAuthors">Ho Bosco K; Gruswitz Franz</div><div class="citationInfo"><span class="NLM_cas:title">BMC structural biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">49</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  An accurate rendering of interior surfaces can facilitate the analysis of mechanisms at atomic-level detail, such as the transport of substrates in the ammonia channel.  In molecular viewers, one must remove the exterior surface that obscures the channel surface by clipping the viewing plane or manually selecting the channel residues in order to display a partial surface.  Neither method is entirely satisfactory, as unwanted additional pieces of surfaces are always generated.  RESULTS:  To cleanly visualize a channel surface, we present HOLLOW, a program that generates a "casting" of the interior volume of the protein as dummy atoms.  We show that the molecular surface of the dummy atoms closely approximates the channel surface, where this complementary surface of the protein channel can be displayed without superfluous surfaces.  CONCLUSION:  The use of HOLLOW significantly simplifies the generation of channel surfaces, and other interior surfaces of protein structures.  HOLLOW is written in PYTHON and is available at http://hollow.sourceforge.net.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtLhsJjctkvyCEBeYuoi7AfW6udTcc2eZDhIUnLn0gSbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FitFKisQ%253D%253D&md5=3bb9c4ca98489d16571ca4d7ee5751c2</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1186%2F1472-6807-8-49&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1472-6807-8-49%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DB.%2BK.%26aulast%3DGruswitz%26aufirst%3DF.%26atitle%3DHOLLOW%253A%2520generating%2520accurate%2520representations%2520of%2520channel%2520and%2520interior%2520surfaces%2520in%2520molecular%2520structures%26jtitle%3DBMC%2520Struct.%2520Biol.%26date%3D2008%26volume%3D8%26spage%3D49%26doi%3D10.1186%2F1472-6807-8-49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dolinsky, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCammon, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, N. A.</span></span> <span> </span><span class="NLM_article-title">PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">W665</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1093/nar/gkh381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1093%2Fnar%2Fgkh381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=15215472" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFKmsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=W665-667&author=T.+J.+Dolinskyauthor=J.+E.+Nielsenauthor=J.+A.+McCammonauthor=N.+A.+Baker&title=PDB2PQR%3A+an+automated+pipeline+for+the+setup+of+Poisson-Boltzmann+electrostatics+calculations&doi=10.1093%2Fnar%2Fgkh381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">PDB2PQR: An automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations</span></div><div class="casAuthors">Dolinsky, Todd J.; Nielsen, Jens E.; McCammon, J. Andrew; Baker, Nathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">Web Server</span>),
    <span class="NLM_cas:pages">W665-W667</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Continuum solvation models, such as Poisson-Boltzmann and Generalized Born methods, have become increasingly popular tools for investigating the influence of electrostatics on biomol. structure, energetics and dynamics.  However, the use of such methods requires accurate and complete structural data as well as force field parameters such as at. charges and radii.  Unfortunately, the limiting step in continuum electrostatics calcns. is often the addn. of missing at. coordinates to mol. structures from the Protein Data Bank and the assignment of parameters to biomol. structures.  To address this problem, we have developed the PDB2PQR web service (http://agave.wustl.edu/pdb2pqr/).  This server automates many of the common tasks of prepg. structures for continuum electrostatics calcns., including adding a limited no. of missing heavy atoms to biomol. structures, estg. titrn. states and protonating biomols. in a manner consistent with favorable hydrogen bonding, assigning charge and radius parameters from a variety of force fields, and finally generating "PQR" output compatible with several popular computational biol. packages.  This service is intended to facilitate the setup and execution of electrostatics calcns. for both experts and non-experts and thereby broaden the accessibility to the biol. community of continuum electrostatics analyses of biomol. systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-GebFAmzzkrVg90H21EOLACvtfcHk0ljstIBjvVrs1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFKmsbY%253D&md5=678d2d58f5cb2c1dd862e2d71cf9dbe1</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkh381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkh381%26sid%3Dliteratum%253Aachs%26aulast%3DDolinsky%26aufirst%3DT.%2BJ.%26aulast%3DNielsen%26aufirst%3DJ.%2BE.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26aulast%3DBaker%26aufirst%3DN.%2BA.%26atitle%3DPDB2PQR%253A%2520an%2520automated%2520pipeline%2520for%2520the%2520setup%2520of%2520Poisson-Boltzmann%2520electrostatics%2520calculations%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2004%26volume%3D32%26spage%3DW665%26epage%3D667%26doi%3D10.1093%2Fnar%2Fgkh381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baker, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sept, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holst, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCammon, J. A.</span></span> <span> </span><span class="NLM_article-title">Electrostatics of nanosystems: application to microtubules and the ribosome</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">10037</span>– <span class="NLM_lpage">10041</span>, <span class="refDoi"> DOI: 10.1073/pnas.181342398</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=10.1073%2Fpnas.181342398" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=11517324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvFWisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2001&pages=10037-10041&author=N.+A.+Bakerauthor=D.+Septauthor=S.+Josephauthor=M.+J.+Holstauthor=J.+A.+McCammon&title=Electrostatics+of+nanosystems%3A+application+to+microtubules+and+the+ribosome&doi=10.1073%2Fpnas.181342398"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Electrostatics of nanosystems: application to microtubules and the ribosome</span></div><div class="casAuthors">Baker, Nathan A.; Sept, David; Joseph, Simpson; Holst, Michael J.; McCammon, J. Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">10037-10041</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Evaluation of the electrostatic properties of biomols. has become a std. practice in mol. biophysics.  Foremost among the models used to elucidate the electrostatic potential is the Poisson-Boltzmann equation; however, existing methods for solving this equation have limited the scope of accurate electrostatic calcns. to relatively small biomol. systems.  Here we present the application of numerical methods to enable the trivially parallel soln. of the Poisson-Boltzmann equation for supramol. structures that are orders of magnitude larger in size.  As a demonstration of this methodol., electrostatic potentials have been calcd. for large microtubule and ribosome structures.  The results point to the likely role of electrostatics in a variety of activities of these structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA_CAlhE0uX7Vg90H21EOLACvtfcHk0liXcUQZEDd-Tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvFWisbc%253D&md5=1b861999ef12c6972e82e8ada0f387cb</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1073%2Fpnas.181342398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.181342398%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DN.%2BA.%26aulast%3DSept%26aufirst%3DD.%26aulast%3DJoseph%26aufirst%3DS.%26aulast%3DHolst%26aufirst%3DM.%2BJ.%26aulast%3DMcCammon%26aufirst%3DJ.%2BA.%26atitle%3DElectrostatics%2520of%2520nanosystems%253A%2520application%2520to%2520microtubules%2520and%2520the%2520ribosome%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2001%26volume%3D98%26spage%3D10037%26epage%3D10041%26doi%3D10.1073%2Fpnas.181342398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6H5W" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6H5W','PDB','6H5W'); return false;">PDB: 6H5W</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6H5X" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6H5X','PDB','6H5X'); return false;">PDB: 6H5X</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6F9V" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6F9V','PDB','6F9V'); return false;">PDB: 6F9V</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6F9T" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6F9T','PDB','6F9T'); return false;">PDB: 6F9T</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R1H" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R1H','PDB','1R1H'); return false;">PDB: 1R1H</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EN5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6EN5','PDB','6EN5'); return false;">PDB: 6EN5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1DMT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1DMT','PDB','1DMT'); return false;">PDB: 1DMT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R1I" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R1I','PDB','1R1I'); return false;">PDB: 1R1I</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R1J" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1R1J','PDB','1R1J'); return false;">PDB: 1R1J</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Y8J" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Y8J','PDB','1Y8J'); return false;">PDB: 1Y8J</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QPJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2QPJ','PDB','2QPJ'); return false;">PDB: 2QPJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YB9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YB9','PDB','2YB9'); return false;">PDB: 2YB9</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i24"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01309">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_83841"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01309">10.1021/acs.jmedchem.8b01309</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01309/suppl_file/jm8b01309_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01309/suppl_file/jm8b01309_si_001.csv">jm8b01309_si_001.csv (0.45 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The atomic coordinates and structure factors for N- and C-domains ACE bound to omapatrilat complexes have been deposited in the RCSB Protein Data Bank with the codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6H5W">6H5W</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6H5X">6H5X</a>, respectively. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01309&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-22%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01309%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01309" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                12MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a9ee2ef431243","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
